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A B S T R A C T
Background
This is an updated version of the original Cochrane Review published in the Cochrane Liibrary 2013, Issue 9. Despite good evidence
for the health benefits of regular exercise for people living with or beyond cancer, understanding how to promote sustainable exercise
behaviour change in sedentary cancer survivors, particularly over the long term, is not as well understood. A large majority of people
living with or recovering from cancer do not meet current exercise recommendations. Hence, reviewing the evidence on how to promote
and sustain exercise behaviour is important for understanding the most effective strategies to ensure benefit in the patient population
and identify research gaps.
Objectives
To assess the effects of interventions designed to promote exercise behaviour in sedentary people living with and beyond cancer and
to address the following secondary questions: Which interventions are most effective in improving aerobic fitness and skeletal muscle
strength and endurance?Which interventions aremost effective in improving exercise behaviour amongst patients with different cancers?
Which interventions are most likely to promote long-term (12 months or longer) exercise behaviour? What frequency of contact with
exercise professionals and/or healthcare professionals is associated with increased exercise behaviour? What theoretical basis is most
often associated with better behavioural outcomes? What behaviour change techniques (BCTs) are most often associated with increased
exercise behaviour? What adverse effects are attributed to different exercise interventions?
Search methods
Weused standard methodological procedures expected by Cochrane.We updated our 2013 Cochrane systematic review by updating the
searches of the following electronic databases: Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library,
MEDLINE, Embase, AMED, CINAHL, PsycLIT/PsycINFO, SportDiscus and PEDro up to May 2018. We also searched the grey
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literature, trial registries, wrote to leading experts in the field and searched reference lists of included studies and other related recent
systematic reviews.
Selection criteria
We included only randomised controlled trials (RCTs) that compared an exercise intervention with usual care or ’waiting list’ control
in sedentary people over the age of 18 with a homogenous primary cancer diagnosis.
Data collection and analysis
In the update, review authors independently screened all titles and abstracts to identify studies that might meet the inclusion criteria,
or that could not be safely excluded without assessment of the full text (e.g. when no abstract is available). We extracted data from all
eligible papers with at least two members of the author teamworking independently (RT, LS and RG). We coded BCTs according to the
CALO-RE taxonomy. Risk of bias was assessed using the Cochrane’s tool for assessing risk of bias. When possible, and if appropriate,
we performed a fixed-effect meta-analysis of study outcomes. If statistical heterogeneity was noted, a meta-analysis was performed using
a random-effects model. For continuous outcomes (e.g. cardiorespiratory fitness), we extracted the final value, the standard deviation
(SD) of the outcome of interest and the number of participants assessed at follow-up in each treatment arm, to estimate the standardised
mean difference (SMD) between treatment arms. SMD was used, as investigators used heterogeneous methods to assess individual
outcomes. If a meta-analysis was not possible or was not appropriate, we narratively synthesised studies. The quality of the evidence
was assessed using the GRADE approach with the GRADE profiler.
Main results
We included 23 studies in this review, involving a total of 1372 participants (an addition of 10 studies, 724 participants from the
original review); 227 full texts were screened in the update and 377 full texts were screened in the original review leaving 35 publications
from a total of 23 unique studies included in the review. We planned to include all cancers, but only studies involving breast, prostate,
colorectal and lung cancer met the inclusion criteria. Thirteen studies incorporated a target level of exercise that could meet current
recommendations for moderate-intensity aerobic exercise (i.e.150 minutes per week); or resistance exercise (i.e. strength training
exercises at least two days per week).
Adherence to exercise interventions, which is crucial for understanding treatment dose, is still reported inconsistently. Eight studies
reported intervention adherence of 75% or greater to an exercise prescription that met current guidelines. These studies all included
a component of supervision: in our analysis of BCTs we designated these studies as ’Tier 1 trials’. Six studies reported intervention
adherence of 75% or greater to an aerobic exercise goal that was less than the current guideline recommendations: in our analysis of
BCTs we designated these studies as ’Tier 2 trials.’ A hierarchy of BCTs was developed for Tier 1 and Tier 2 trials, with programme
goal setting, setting of graded tasks and instruction of how to perform behaviour being amongst the most frequent BCTs. Despite
the uncertainty surrounding adherence in some of the included studies, interventions resulted in improvements in aerobic exercise
tolerance at eight to 12 weeks (SMD 0.54, 95% CI 0.37 to 0.70; 604 participants, 10 studies; low-quality evidence) versus usual care.
At six months, aerobic exercise tolerance was also improved (SMD 0.56, 95% CI 0.39 to 0.72; 591 participants; 7 studies; low-quality
evidence).
Authors’ conclusions
Since the last version of this review, none of the new relevant studies have provided additional information to change the conclusions.
We have found some improved understanding of how to encourage previously inactive cancer survivors to achieve international physical
activity guidelines. Goal setting, setting of graded tasks and instruction of how to perform behaviour, feature in interventions that meet
recommendations targets and report adherence of 75% or more. However, long-term follow-up data are still limited, and the majority
of studies are in white women with breast cancer. There are still a considerable number of published studies with numerous and varied
issues related to high risk of bias and poor reporting standards. Additionally, the meta-analyses were often graded as consisting of low-
to very low-certainty evidence. A very small number of serious adverse effects were reported amongst the studies, providing reassurance
exercise is safe for this population.
P L A I N L A N G U A G E S U M M A R Y
Interventions for promoting habitual exercise in people living with and beyond cancer
The issue
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Being regularly active can bring a range of health benefits for people living with and beyond cancer, including improved quality of life
and physical function. Being physically active might also reduce the risk of cancer recurrence and of dying from cancer. Because most
cancer survivors are not regularly physically active, there is a need to understand how best to promote and sustain physical activity in
this population.
The aim of the review
To understand what are the most effective ways to improve and sustain exercise behaviour in people living with and beyond cancer.
Study characteristics
We included only studies that compared an exercise intervention with a usual care comparison or ’waiting list’ control. Only studies
that included sedentary people over the age of 18 with the same cancer diagnosis were eligible. Participants must have been allocated
to exercise or usual care at random. We searched for evidence from research databases from 1946 to May 2018.
What are the main findings?
We included 23 studies involving 1372 participants in total. Evidence suggests that exercise studies that incorporate an element of
supervision can help cancer survivors. However, we still have a poor understanding of how to promote exercise long term (over six
months). There is some concern that research is not being reported as clearly as it should be.We found that setting goals, graded physical
activity tasks and providing instructions on how to perform the exercises could help people to do beneficial amounts of exercise. In
addition, we found some evidence that in people who do meet recommended exercise levels, get fitter for up to six months.
Quality of the evidence
The main problems that we found regarding the quality of studies in this review included: not knowing how study investigators
conducted randomisation for the trials and not knowing whether investigators who were doing trial assessments knew to which group
the person they were assessing had been randomly assigned. The quality of the evidence from these studies was found to be low due to
the majority of the trials often containing a low number of participants.
What are the conclusions?
The main conclusions from this review are that exercise is generally safe for cancer survivors. We have a better understanding of how
to encourage cancer survivors to meet current exercise recommendations. However, there is still a lack of evidence of how to encourage
exercise in cancer survivors over six months.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Exercise interventions compared to usual care for promoting habitual exercise in people living with and beyond cancer to improve aerobic exercise tolerance
Outcomes of participants
(studies)
Follow-up
Certainty of the evidence
(GRADE)
Anticipated absolute effects∗ (95% CI)
Risk with usual care Risk difference with exercise in-
terventions
Aerobic exercise tolerance (all
cancers: 8 to 12 weeks of follow-
up)
604
(10 RCTs)
⊕⊕©©
LOW 12
The mean aerobic exercise toler-
ance (all cancers: 8 to 12 weeks
of follow-up) was 0
SMD 0.54 higher
(0.37 higher to 0.70 higher)
Aerobic exercise tolerance (all
cancers: 8 to 12 weeks of follow-
up sensit ivity analysis)
201
(4 RCTs)
⊕⊕©©
LOW 23
The mean aerobic exercise toler-
ance (all cancers: 8 to 12 weeks
of follow-up sensit ivity analysis)
was 0
SMD 0.85 higher
(0.56 higher to 1.14 higher)
Aerobic exercise tolerance (all
cancers: 6 months)
591
(7 RCTs)
⊕⊕©©
LOW 12
The mean aerobic exercise toler-
ance (all cancers: 6 months) was
0
SMD 0.56 higher
(0.39 higher to 0.72 higher)
Aerobic exercise toler-
ance (breast cancer: 8-12 weeks
of follow-up)
441
(6 RCTs)
⊕©©©
VERY LOW 124
The mean aerobic exercise toler-
ance (breast cancer: 8-12 weeks
of follow-up) was 0
SMD 0.57 higher
(0.22 higher to 0.93 higher)
Aerobic exercise tolerance (all
cancers: combinat ion of super-
vised and home-based exercise:
8 to 12 weeks of follow-up)
357
(4 RCTs)
⊕©©©
VERY LOW 234
The mean aerobic exercise toler-
ance (all cancers: combinat ion of
supervised and home-based exer-
cise: 8 to 12 weeks of follow-up)
was 0
SMD 0.53 higher
(0.01 higher to 1.04 higher)
Aerobic exercise tolerance (all
cancers: home-based exercise: 8
to 12 weeks of follow-up)
155
(3 RCTs)
⊕©©©
VERY LOW 123
The mean aerobic exercise tol-
erance (all cancers: home-based
exercise: 8 to 12 weeks of follow-
up) was 0
SMD 0.70 higher
(0.37 higher to 1.03 higher)
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Aerobic exercise tolerance (all
cancers:supervised exercise: 8 to
12 weeks of follow-up)
92
(3 RCTs)
⊕©©©
VERY LOW 235
The mean aerobic exercise toler-
ance (all cancers:supervised ex-
ercise: 8 to 12 weeks of follow-
up) was 0
SMD 1.07 higher
(0.26 higher to 1.89 higher)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; SMD: standarised mean dif ference
GRADE Working Group grades of evidence
High-certainty: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate-certainty: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low-certainty: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low-certainty: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Some concerns with high number of part icipants lost to follow-up, select ive report ing of data and other risks of bias
2 Concerns over number of small studies included with posit ive results
3 Low number of part icipants in the studies overall and large conf idence intervals
4 Some concerns over variat ions in ef fect sizes, the test for heterogeneity is signif icant and I2 value is high (> 50)
5 Some concerns over the variat ions in ef fect sizes.
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B A C K G R O U N D
This review is an update of a previously published review in the
Cochrane Database of Systematic Reviews (2013, Issue 9) Bourke
2013.
Description of the condition
Cancer is a major public health issue. In 2015, there were 17.5
million cases of cancer globally, 8.7 million deaths and the dis-
ease is estimated to be responsible for 208 million disability ad-
justed life years (Global Burden of Disease Cancer Collaboration
2017). Age-standardised cancer mortality rates are decreasing (in
theWestern hemisphere), which is encouraging progress (Hashim
2016). However, although increasing numbers of cancer survivors
live longer, this does not equate to living well. Survivors face a
multitude of unique, debilitating health problems, even after treat-
ment with curative intent. These range from an increased risk of
recurrent cancers (Low 2014), persistent symptoms such as fatigue
(Low 2014), ongoing poor health and well-being (Elliott 2011),
and mental health comorbidity (Nakash 2014). The burden of
these problems can lead to negative impacts on health-related qual-
ity of life (HRQoL) (Corner 2013). Throughout this review, the
term we define as ’cancer survivor’ is synonymous with someone
’living with and beyond cancer’, in accordance with theMacmillan
Cancer Support definition (Macmillan Cancer Support 2011).
Description of the intervention
The goal of any exercise intervention is to offer a sustained physi-
ological challenge that, over time, will induce a spectrum of ben-
eficial cardiovascular, respiratory, musculoskeletal, neurological,
metabolic adaptations as well as bringing a host of psychoso-
cial benefits. In the context of living with and beyond cancer,
such adaptations underpin improvements in cancer-related fa-
tigue, HRQoL and physical function (Mishra 2014; Stout 2017).
TheUKChiefMedical Officer recommends that in adults, weekly
activity should add up to at least 150 minutes of moderate inten-
sity aerobic activity, performed in bouts of 10 minutes or longer
(Department of Health 2011), with similar international recom-
mendations for cancer survivors (Rock 2012). For example, this
could translate to 30 minutes of aerobic activity that raises heart
rate and breathing rate, five times per week. Alternatively, 75 min-
utes of vigorous intensity aerobic activity spread across the week
has been suggested to confer similar benefit (Schmitz 2010a).
We have deliberately chosen the term ’habitual’ over ’regular’ to
reflect the intention to assess which interventions could both A)
improve and B) sustain exercise behaviour. ’Regular exercise’ can
be applied to both short-term and long-term contexts, where as
a ’habitual’ exerciser indicates a sustained and regular pattern of
behaviour. Whilst ’habitual’ refers to the process of behavioural
’habit forming’ and an automaticity of behaviour (Gardner 2011;
Verplanken 2009), we recognise there are other theoretical princi-
pals underpinning physical activity behaviour (Kwasnica 2016).
How the intervention might work
Encouraging people to participate in regular exercise from a back-
ground of an inactive lifestyle is difficult, requiring attention to
important psychosocial and behavioural influences (Kampshoff
2014; Ormel 2017). A major challenge is to provide a support
structure for physical activity until it becomes a pattern of sus-
tained healthy behaviour. Randomised controlled trials (RCTs) in
cancer survivors have assessed a number of exercise interventions,
with the aim of promoting short- and long-term habitual exer-
cise. A wide range of approaches have been investigated; including
supervised exercise and home-based exercise (Bourke 2014), and
inclusive of group counselling sessions, (Rogers 2015). Tailored
exercise interventions commonly comprise aerobic exercise train-
ing, strength training or a combination of both, with or without
behaviour change support. Behaviour change theory within exer-
cise interventions is often viewed as essential, with the UK Medi-
cal Research Council (MRC) recommending the use of theory in
intervention development for complex interventions to help im-
prove behaviour change (Craig 2008). However, the application of
behaviour change theory or specific behaviour change techniques
is often generally poor, unclear and not clearly examined for im-
pact of effectiveness.
Why it is important to do this review
The majority of people living with and beyond cancer are not reg-
ularly active, with estimates ranging from less than 10% to 20%
to 30% of cancer survivors meeting the physical activity guide-
lines (Garcia 2014). There are a number of important beneficial
effects of exercise participation in cancer survivors reported from
RCTs including improvedHRQoL, reduced fatigue and improved
physical function, (Bourke 2014; Dittus 2017; Meneses-Echavez
2015; Mishra 2012a; Mishra 2012b; Stout 2017). However, the
original review (Bourke 2013) found that most of the current ev-
idence comes from studies with short-term interventions and fol-
low-up. Understanding which interventions are most efficacious
in supporting the maintenance of long-term exercise behaviour is
critical not just because of the HRQoL benefits (Bourke 2012a),
but multiple observational reports link being regularly active to
reduced chances of dying from cancer after diagnosis (Li 2016).
The original review showed that there is a poor understanding of
how to encourage people living with and beyond cancer to meet
current exercise recommendations (Bourke 2013). Poor study re-
porting standards was a pervasive issue e.g. failure to report ad-
herence data. However, there were some useful data regarding the
use of behaviour change techniques (BCTs). An updated review
can firstly, offer insight as to whether interventions being tested
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in contemporary studies are mapping to the existing international
recommendations i.e. the American Cancer Society (ACS) guid-
ance (i.e. provided by Rock 2012). Secondly, this will allow us
to evaluate if there have been any improvements in the quality
of intervention reporting around specifics of set prescriptions (i.e.
frequency, intensity, duration etc). Thirdly, and critically, we can
use a larger data set from our updated searches to assess if both
the quality of reporting of exercise adherence has improved and
if there is more to learn about how to promote and sustain better
adherence to exercise behaviour interventions in previously inac-
tive cancer survivors.
In the UK, the Independent Cancer Taskforce strategy document
sets out a number of initiatives to achieve world class outcomes
in cancer; ensuring survivors have the best possible quality of life
and improving rates of mortality. Promoting habitual exercise par-
ticipation could help to accomplish these high priority agendas
within the UK.
O B J E C T I V E S
Primary objective
To assess the effects of interventions designed to promote exercise
behaviour in sedentary people living with and beyond cancer.
Secondary objectives
To address the following questions.
• Which interventions are most effective in improving
aerobic fitness and skeletal muscle strength and endurance?
• What adverse effects are attributed to different exercise
interventions?
• Which interventions are most effective in improving
exercise behaviour amongst patients with different cancers?
• Which interventions are most likely to promote long-term
(12 months or longer) exercise behaviour?
• What frequency of contact with exercise professionals and/
or healthcare professionals is associated with increased exercise
behaviour?
• What theoretical basis is most often associated with
increased exercise behaviour?
• What behaviour change techniques are most often
associated with increased exercise behaviour?
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) that allocated participants
or clusters of participants by a random method to an exercise-
promoting intervention compared with usual care or ’waiting list’
control. We included studies conducted both during and after pri-
mary treatment or during active monitoring. Only interventions
that included a component targeted at increasing aerobic exercise
and/or resistance exercise behaviour were included in this review.
We did not include studies of heterogeneous cancer cohorts (i.e.
participants with different primary cancer sites). We did not in-
clude studies in ’at risk’ populations (i.e. studies involving indi-
viduals who have risk factors for cancer but who have not yet been
diagnosed with the disease) that addressed primary prevention re-
search questions.
Types of participants
We included only studies involving adults (18 years of age or older)
who had a sedentary lifestyle or physically inactive at baseline (i.e.
not undertaking 30 minutes or more of exercise of at least moder-
ate intensity, three days per week, or 90 minutes in total of mod-
erate intensity exercise per week). Participants must have been his-
tologically or clinically diagnosed with cancer regardless of sex, tu-
mour site, tumour type, tumour stage and type of anticancer treat-
ment received. We excluded studies directed specifically at end-
of-life-care patients and individuals who were currently hospital
inpatients.
Types of interventions
For the purposes of this review, the phrases ’exercise’ and ’phys-
ical activity’ were used interchangeably. Definitions of exercise,
related terms and nomenclature that describe the performance of
exercise must adhere to principles of science and must satisfy the
Système International d’Unités (SI), which was adopted univer-
sally in 1960. Hence, we referred to the appropriate, combined
definition that applies to all situations: ’A potential disruption to
homeostasis by muscle activity that is either exclusively or in com-
bination, concentric, eccentric or isometric’ (Winter 2009). Inves-
tigators must have reported the frequency, duration and intensity
of aerobic exercise behaviour or frequency, intensity, type, sets and
repetitions of resistance exercise behaviour that was prescribed in
the intervention.
We acknowledge that the maximal aerobic capacity (V O2max)/
peak is often the most informative metric for setting aerobic exer-
cise intensity; however, given the nature of the population involved
(elderly, potentially with multiple comorbidities), it is often dif-
ficult to conduct maximal testing protocols to prescribe intensity
on the basis of this measures because of the requirements for med-
ically qualified staff to be present during assessment. As such, for
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reasons of pragmatism, we accepted that exercise intensity is more
frequently reported in cancer the cohorts in terms of age-predicted
maximum heart rate(HRmax ) or Borg Rating of Perceived Exer-
tion (RPE) (Borg 1982). The interventions in this review were
categorised as achieving a mild (less than 60% HRmax /10 RPE or
less), moderate (60% to 84% HRmax /11 to 14 RPE) or vigorous
(85% HRmax or more/15 RPE or more) exercise intensity.
Types of outcome measures
Primary outcomes
Aerobic exercise behaviour as measured by:
• exercise frequency (number of bouts per week);
• exercise duration (total minutes of exercise achieved);
• exercise intensity (e.g. % HRmax , RPE);
• estimated energy expenditure from free-living physical
activity (e.g. from accelerometer readings (where available));
• adherence to the exercise intervention (% of exercise
sessions completed/attended); total duration of intervention
when ≥75% adherence is achieved (in weeks);
• total duration of sustained exercise behaviour meeting
American Cancer Society guidelines for exercise in people living
with and beyond cancer (Rock 2012; i.e. aim to exercise at least
150 minutes per week, with at least two days per week of
strength training).
Resistance exercise behaviour as measured by:
• exercise frequency (number of bouts per week);
• exercise intensity (e.g. % of 1 repetition max or % of body
mass);
• type of exercise (e.g. free weights, body weight exercise);
• repetitions;
• sets.
Secondary outcomes
• Change in aerobic fitness or exercise tolerance (maximal or
submaximal when measured directly or by a standard field test).
• Change in skeletal muscle strength and endurance.
• Adverse effects.
• study recruitment rate.
• Intervention attrition rate.
Interventions were judged as successful in achieving exercise goals
if investigators reported at least 75%adherence over a given follow-
up period as done in the original review (Bourke 2013). Data on
compliancewith the interventionwere quantified in terms of num-
ber of prescribed exercise sessions completed as a proportion of the
total set. The intervention must have included at least six weeks of
follow-up. Interventions were described according to whether they
reported being based on a behaviour change theory e.g. control
theory, social cognitive theory; (Bandura 2000; Bandura 2002;
Carver 1982. This relates to the National Institute for Health and
Clinical Excellence (NICE) guidance for behaviour change, which
recommends that clinicians should be explicit about the theoret-
ical constructs on which interventions are based (NICE 2007).
Interventions were also coded using the ‘Coventry, Aberdeen &
London Refined’ (CALO-RE) taxonomy (Michie 2011). This
is a validated taxonomy of behaviour change techniques (BCTs)
that can be used to help people change their exercise behaviour.
Coding interventions according to this taxonomy allows for a bet-
ter understanding of which techniques are employed by current
interventions and how they are related to short- and longer-term
exercise behaviour change.
Search methods for identification of studies
Electronic searches
The searches were run for the original review from inception to
August 2012. The subsequent searches from the following elec-
tronic databases were run from August 2012 up to 3 May 2018.
We carried out the following searches:
• the Cochrane Central Register of Controlled Trials
(CENTRAL; 2018, Issue 5) in The Cochrane Library;
• MEDLINE via OVID August 2012 to April week 4 2018;
• Embase via OVID August 2012 to 2018 week 18;
• AMED (Allied and Alternative Medicine Database; covers
occupational therapy, physiotherapy and complementary
medicine) August 2012 to May 2018;
• CINAHL (Cumulative Index to Nursing and Allied Health
Literature) August 2012 to May 2018;
• PsycINFO (Database of the American Psychological
Association) August 2012 to May 2018;
• SportDiscus (Sports Evidence Database) August 2012 to
April 2017;
• PEDro (Physiotherapy Evidence Database) August 2012 to
April 2017.
The search strategies are presented in the Appendices, with both
the 2018 updated strategy and previous 2012 strategy reported.
CENTRAL search strategy is presented in Appendix 1 and the
MEDLINE search strategy in Appendix 2. For databases other
thanMEDLINE, we adapted the search strategy accordingly: Em-
base (Appendix 3), AMED (Appendix 4), CINAHL (Appendix
5) PsycINFO (Appendix 6) PEDro (Appendix 7) SportsDiscus
(Appendix 8).
The search strategies were developed with the Cochrane Gynaeco-
logical Cancer Group Information Specialist and included MeSH
and text word terms as appropriate.
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Searching other resources
We used snowballing, by searching reference lists of retrieved ar-
ticles and published reviews on the topic.
We expanded the database search by identifying additional rel-
evant studies for this review, including unpublished studies and
references in the grey literature. This was done by searching the
OpenGrey database (www.opengrey.eu/), which includes techni-
cal or research reports, doctoral dissertations, conference papers
and other types of grey literature. We also searched the following
clinical trials web pages.
• World Health Organisation apps.who.int/trialsearch/
Default.aspx
• National cancer institute www.cancer.gov/about-cancer/
treatment/clinical-trials/search
Furthermore, wewrote toCancerResearchUK (CRUK),Macmil-
lan Cancer Support, the World Cancer Research Fund ( WCRF),
Worldwide Cancer Research , the American Association for Can-
cer Research ( AACR), the American Cancer Society ( ACS) and
the American Society of Clinical Oncology ( ASCO) to enquire
about relevant unpublished papers.
Data collection and analysis
Since publication of the previous version of this review, we have
included the use of the GRADE assessment to assess the quality
of the evidence and produced a Summary of findings for the main
comparison.
Selection of studies
We imported results from each database into the reference man-
agement software package Endnote, from which we removed du-
plicates. After training on the first 100 references retrieved from
two different databases to ensure a consistent approach, two re-
view authors (RT and HQ) worked independently to screen all
titles and abstracts to identify studies that met the inclusion cri-
teria, or that could not be safely excluded without assessment of
the full text (e.g. when no abstract was available). Disagreements
were resolved by discussion with another review author (LB). Full
texts were retrieved for these articles.
After training was provided to ensure a consistent approach to
study assessment and data abstraction, two review authors worked
independently to assess the retrieved full texts (RT and HQ). We
linked together multiple publications and reports on the same
study. Studies that appeared to be relevant but were excluded at this
stage are listed in the ’Characteristics of excluded studies’ table.We
resolved disagreements by discussion with other group members.
We attempted to contact study corresponding authors if we could
not access a full text (e.g. if only an abstract was available), if we
required more information to determine whether a study could
be included (e.g. to determine baseline exercise behaviour of a
cohort), or if we required supplementary information about an
already eligible study (please also see Excluded studies).
Data extraction and management
Review authors (RT andLB) extracted the following data using the
same data extraction form used in the original review and entered
data into RevMan 5.3 (Review Manager 2014).
• Study details: author; year; title; journal; research question/
study aim; country where the research was carried out; funding
source; recruitment source (e.g. consecutive sampling from
outpatient appointments; advertising in the community;
convenient sample from support groups); inclusion and exclusion
criteria; study design (cluster RCT, non-cluster RCT, single
centre or multi-centre); sample size; number of participants per
arm; length of follow-up; description of usual care.
• Intervention details: categorisation of intervention (e.g.
supervised, independent, educational); setting (e.g. dedicated
exercise facility, community, home); exercise prescription
components (e.g. aerobic exercise, resistance exercise, stretching);
theoretical basis, behaviour change techniques (using CALO-RE
taxonomy), frequency of contact with an exercise professional
and or healthcare professional; instructions to controls.
• Participant characteristics: primary cancer diagnosis; any
cancer treatment currently undertaken; metastatic disease status;
age; sex; body mass index (BMI); ethnicity; reported
comorbidities.
• Resulting exercise behaviour: method of measuring exercise
(e.g. self-report questionnaire). Numbers of participants
randomly assigned and assessed at specified follow-up points.
Frequency, duration, intensity of aerobic exercise achieved;
frequency, intensity, type, sets and repetitions of resistance
exercise achieved; total duration of the intervention; total
duration of sustained meaningful exercise behaviour as a result of
the intervention and whether the Rock 2012 guidelines were
met, adherence to the intervention; rate of attrition and adverse
effects reported.
• Resulting change in other outcomes: changes in aerobic
fitness and estimated energy expenditure from free-living
physical activity.
Three members of the group worked independently (RT, RG and
LS) to extract data from all eligible papers using the data collection
form. Data were entered into the Cochrane’s statistical software,
Review Manager 2014, by one review author and checked by a
second review author.
Assessment of risk of bias in included studies
Risk of bias and methodological quality were assessed in accor-
dance with Cochrane’s tool for assessing risk of bias (Higgins
2011). The tool includes the following seven domains:
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• sequence generation (method of randomisation);
• allocation concealment (selection bias);
• blinding (masking) of participants and personnel
(detections bias);
• blinding (masking) of outcome assessors (detection bias);
• incomplete outcome data;
• selective outcome reporting;
• other sources of bias.
However, we did not include blinding to group allocation, as it is
not possible (e.g. in a supervised exercise setting) to blind partici-
pants to an intervention while promoting exercise behaviour. Two
review authors (RT and RG) independently applied the ’Risk of
bias’ tool, and differences were resolved by discussion with a third
review author (LB). We summarised results in both a ’Risk of bias’
graph and a ’Risk of bias’ summary. Results of meta-analyses were
interpreted in light of the findings with respect to risk of bias. We
contacted study authors to ask for additional information or for
further clarification of study methods if any doubt surrounded
potential sources of bias. Individual ’Risk of bias’ items can be seen
in Appendix 9.
Measures of treatment effect
For the purposes of this review, all exercise behaviour was syn-
thesised as specified in the primary outcomes. For comparison of
measures of change in fitness levels or estimated energy expen-
diture from free-living physical activity, please see the section on
’Continuous data’ in Data synthesis.
Unit of analysis issues
We did not include any cross-over trials in this review because of
the high risk of contamination. It can be very difficult to “wash
out” exercise behaviour. Cancer survivors in particular can be a
highly-motivated cohort, and significant contamination has been
reported even in conventional RCT settings (Courneya 2003;
Mock 2005). Hence this learning effect distorts results. Further-
more, asking individuals to revert to sedentary behaviour could be
considered unethical (Das 2012). Therefore, any cross-over trials
identified were rejected at the title and abstract screening stage.
Dealing with missing data
Weassessedmissingdata anddropout rates for each of the included
studies and reported the numbers of participants included in the
final analysis as a proportion of all participants included in the
study. We assessed the extent to which studies conformed to an
intention-to-treat analysis.
Assessment of heterogeneity
Consistency of results was assessed visually and through examina-
tion of the I2 statistic, a quantity that describes approximately the
proportion of variation in point estimates that is due to hetero-
geneity rather than sampling error.An I2 greater than or equal to
50% was considered significant heterogeneity. We addressed this
by performing a sensitivity analysis that excluded any heteroge-
neous trials. We supplemented this with a test of homogeneity
to determine the strength of evidence that the heterogeneity was
genuine. When significant statistical heterogeneity was detected,
differences in characteristics of the studies or other factors were
explored as possible sources of explanation. Any differences were
summarised in a narrative synthesis.
Assessment of reporting biases
Publication bias
We intended to examine funnel plots corresponding tometa-anal-
ysis of the primary outcomes to assess the potential for small study
effects such as publication bias if a sufficient number of studies
(i.e. more than 10) was identified. However, this was not the case;
therefore this step was not included in the analysis.
Data synthesis
Continuous data
For continuous outcomes (e.g. cardiorespiratory fitness), we ex-
tracted the final value, the standard deviation (SD) of the outcome
of interest and the number of participants assessed at endpoint for
each treatment arm at the end of follow-up, to estimate standard-
ised mean differences (SMD) between treatment arms.
Dichotomous outcomes
For dichotomous outcomes (e.g. adverse effects, deaths), if it was
not possible to use a hazard ratio (HR), we extracted the number of
participants in each treatment arm who experienced the outcome
of interest and the number of participants assessed at endpoint, to
estimate a risk ratio (RR).
Meta-analysis
When possible, and if appropriate, we performed a meta-analysis
of review outcomes. If statistical heterogeneity was noted, a meta-
analysis was performed using a random-effects model.We planned
to use a fixed-effect model if no significant statistical heterogeneity
was observed.
When possible, all data extracted were those relevant to an inten-
tion-to-treat analysis inwhich participants were analysed in groups
to which they were assigned. We noted the time points at which
outcomes were collected and reported.
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Subgroup analysis and investigation of heterogeneity
If a sufficient number of studies were identified, we performed
subgroup analyses for the following.
• Cancer site.
• Type of intervention (i.e. supervised, home-based, etc).
• Age of individuals (i.e. elderly versus non-elderly).
• Current treatment (currently undergoing treatment versus
not currently undergoing treatment).
• Participants with metastatic disease (metastatic cohort
versus non-metastatic cohort).
• Accordance with behaviour change theory.
• Interventions in obese individuals (mean body mass index
(BMI) of intervention group > 30 kg/m2 versus mean BMI of
intervention group < 30 kg/m2).
Sensitivity analysis
Methodological strength was judged using Cochrane’s tool for as-
sessing risk of bias to identify studies of high and low quality
(Higgins 2011). Sensitivity analyses were performedwith the stud-
ies of low quality excluded.
Summary of findings
To assess the overall quality of the evidence for each outcome
of the meta-analysis, we employed the GRADE approach. The
GRADE profile ( https://gradepro.org) enabled us to import data
directly from Review Manager 5.3 to create Summary of findings
for the main comparison. These tables provide outcome-specific
information concerning the overall certainty of the evidence from
studies included in the meta-analysis. Risk of bias, inconsistency
of the data, the preciseness of the data publication bias and the
indirectness of the data were all considered in assessing the quality
of the data.
We downgraded the evidence from ’high’ certainty by one level for
serious (or by two for very serious) concerns for each limitation.
• High certainty: we are very confident that the true effect
lies close to that of the estimate of the effect.
• Moderate certainty: we are moderately confident in the
effect estimate: the true effect is likely to be close to the estimate
of the effect, but there is a possibility that it is substantially
different.
• Low certainty: our confidence in the effect estimate is
limited: the true effect may be substantially different from the
estimate of the effect.
• Very low certainty: we have very little confidence in the
effect estimate: the true effect is likely to be substantially
different from the estimate of effect.
The following outcomes were included in the ’Summary of find-
ings’ table.
• Aerobic exercise tolerance (all cancers: eight to 12 weeks of
follow-up)
• Aerobic exercise tolerance (all cancers: eight to 12 weeks of
follow-up sensitivity analysis)
• Aerobic exercise tolerance (all cancers: six months of follow-
up)
• Aerobic exercise tolerance (breast cancer: eight to 12 weeks
of follow-up)
• Aerobic exercise tolerance (all cancers: combination of
supervised and home-based exercise: eight to 12 weeks of follow-
up)
• Aerobic exercise tolerance (all cancers: supervised exercise:
eight to 12 weeks of follow-up)
• Aerobic exercise tolerance (all cancers: home-based exercise:
eight to 12 weeks of follow-up)
R E S U L T S
Description of studies
Please see Table 1, ’Summary of included studies’. See ’
Characteristics of included studies’; ’Characteristics of excluded
studies’; ’Characteristics of studies awaiting classification’; and
’Characteristics of ongoing studies’.
Results of the search
Figure 1 illustrates the process of the literature search and study se-
lection for the review. The updated search identified 5442 unique
records from databases searched. In addition, we identified 2750
records from grey literature and ’snowballing’ techniques for this
update. Given that the details of prescribed exercise are rarely re-
ported in manuscript abstracts (e.g. frequency, intensity, duration
of exercise prescription), this led to evaluation of a large number of
manuscripts at full text stage (n = 227). From these full-text arti-
cles, 212 manuscripts were excluded, leaving 15 publications from
10 unique studies included in the review (total unique studies =
23). Reasons for excluding these 212 publications and a subset of
the original review total (n = 377) are covered in the Excluded
studies section below.
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Figure 1. PRISMA flow diagram.
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Included studies
This update identified 15 publications from10 new studies, which
when combined with the studies from the original review equates
to 40publications in total from23 studies. (al-Majid 2015; Bourke
2014; Cadmus 2009; Campbell 2017; Cantarero-Villanueva
2012b; Cavalheri 2017; Daley 2007a; Drouin 2005; Hayes 2009;
Irwin 2015; Kaltsatou 2011; Kim 2006; Kim 2017; McKenzie
2003; Mohamady 2017; Musanti 2012; Perna 2010; Pinto 2003;
Pinto 2005; Pinto 2011; Rogers 2015; Scott 2013; Thomas 2013).
One study (Bourke 2014) was a efficacy study, following on from
a previous feasibility study (Bourke 2011a) from the original re-
view.
For the 2018 update, we sent an additional 112 emails to request
unpublished information for manuscripts that were unclear in
reporting relative to our inclusion and exclusion criteria. We were
able to include an additional seven published manuscripts and to
exclude an additional eight published manuscripts on the basis of
information received in correspondence from authors.
Only randomised controlled trials (RCTs) were included in the
review. All included studies used a parallel-group design with base-
line assessment and follow-up of 12 months maximum. All in-
cluded studies were conducted using participant-level randomisa-
tion. The format of reporting precluded data extraction for meta-
analytical combination in two studies (Drouin 2005; Pinto 2003).
Sample size ranged from 14 to 222, with a total of 1372 partici-
pants included in this review (mean age range 51 to 72).
Participants
Twenty of the included trials were on breast cancer survivors
(al-Majid 2015; Cadmus 2009; Campbell 2017; Cantarero-
Villanueva 2012b; Daley 2007a; Drouin 2005;Hayes 2009; Irwin
2015; Kaltsatou 2011; Kim 2006; Kim 2017; McKenzie 2003;
Mohamady 2017; Musanti 2012; Perna 2010; Pinto 2003; Pinto
2005; Rogers 2015; Scott 2013; Thomas 2013); only two stud-
ies involved colorectal cancer (Bourke 2011a; Pinto 2011), one
prostate cancer (Bourke 2014,) and one lung cancer (Cavalheri
2017). Of these studies, 12 included participants who were cur-
rently undergoing active treatment inclusive of hormone-based
therapy (al-Majid 2015; Bourke 2014; Cadmus 2009; Daley
2007a; Drouin 2005; Irwin 2015; Kim 2006; Mohamady 2017;
Musanti 2012; Perna 2010; Pinto 2005; Scott 2013). We found
only one study that reported data fromparticipantswithmetastatic
disease (Bourke 2014), and six studies that were conducted in
obese cohorts (i.e. mean BMI > 30 kg/m2; (Cadmus 2009;Drouin
2005;Mohamady 2017;Rogers 2015; Scott 2013;Thomas 2013).
The majority of participants were white, and only five studies re-
ported data from an ethnically diverse sample (al-Majid 2015;
Irwin 2015; Perna 2010; Rogers 2015; Thomas 2013). Comor-
bidities at baseline were largely unclear or unreported.
Interventions
Type of exercise
Fourteen studies prescribed exclusively aerobic exercise (al-Majid
2015; Cadmus 2009; Campbell 2017; Cantarero-Villanueva
2012b; Daley 2007a; Drouin 2005; Kaltsatou 2011; Kim 2006;
Mohamady 2017; Pinto 2003; Pinto 2005; Pinto 2011; Rogers
2015; Thomas 2013); the remaining RCTs used a mix of aero-
bic and resistance training (no exclusively resistance training stud-
ies met our inclusion criteria). Ten studies used a combination
of supervised and home-based exercise (Bourke 2011a; Bourke
2014; Cadmus 2009; Campbell 2017; Hayes 2009; Irwin 2015;
Kim 2006; Perna 2010; Pinto 2003; Rogers 2015), four stud-
ies opted to use an exclusively home-based design (Drouin 2005;
Musanti 2012; Pinto 2005; Pinto 2011), and 10 studies were ex-
clusively supervised studies (al-Majid 2015; Cantarero-Villanueva
2012b; Cavalheri 2017; Daley 2007a; Kaltsatou 2011; Kim 2017;
McKenzie 2003; Mohamady 2017; Scott 2013; Thomas 2013).
Exercise sessions and the role of exercise professionals and
healthcare professionals
Contact with exercise professionals or study researchers ranged
from two to three weekly supervised sessions (Rogers 2015), to
weekly phone calls after an initial one-to-one exercise consulta-
tion (Pinto 2005; Pinto 2011). Most commonly however, su-
pervised sessions were offered two to three times per week. Of
note, seven studies (Drouin 2005; Kaltsatou 2011; Kim 2006;
McKenzie 2003; Pinto 2003; Pinto 2005; Pinto 2011), placed re-
strictions on the control group regarding exercise behaviour during
the course of the study, usually taking the form of direct instruc-
tion to refrain from changing exercise behaviour. However, the
2018 update found no additional studies that placed restrictions
on the control group, usual activities were encouraged. Contact
with healthcare professionals was not frequent amongst the stud-
ies, with three studies having healthcare professionals carry out
medical assessments for eligibility (Cantarero-Villanueva 2012b;
Kim 2017; Mohamady 2017), two studies having oncologists re-
fer the participants onto the study, but it was not stated explicitly
if they delivered any aspects of the intervention (al-Majid 2015;
Campbell 2017).
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Level of exercise and adherence
Thirteen studies incorporated prescriptions that would meet the
Rock 2012 recommendations for aerobic exercise (i.e.150minutes
per week); (Cadmus 2009; Campbell 2017; Cantarero-Villanueva
2012b; Pinto 2011; Rogers 2015) or resistance exercise (i.e. re-
sistance training strength training exercises at least two days
per week); (Bourke 2011a; Bourke 2014; Cavalheri 2017; Irwin
2015; Kim 2017; Musanti 2012; Perna 2010; Scott 2013). How-
ever, only eight of these studies reported 75% adherence to
these guidelines, (Bourke 2011a; Bourke 2014; Campbell 2017;
Cantarero-Villanueva 2012b; Irwin 2015; Kim 2017; Rogers
2015; Scott 2013).
Theoretical basis
Of the interventions provided, only six were explicitly based on a
theoretical model (Daley 2007a;Musanti 2012; Perna 2010; Pinto
2005; Pinto 2011; Rogers 2015); the trans-theoretical model was
most common, followed by social cognitive theory and exercise,
and self-esteem theory. Only one intervention from the 2018 up-
date was found to be based on a theoretical model (Rogers 2015).
Behaviour change techniques (BCT) and adherence
Full details of intervention BCT coding according to the CALO-
RE taxonomy for the previous review (Bourke 2013) and the 2018
update can be seen in Table 2 and Table 3 (respectively). In the
previous review, there was a lack of identified studies that met the
Rock 2012 guidelines. For this updated version of the review, our
searches found more instances of studies (eight in total) that meet
the 150 minutes per week or two strength sessions per week Rock
2012 target. Also, there were other studies with lower exercise
targets but good adherence (i.e. over 75%). Hence, we presented
BCTs in a hierarchy format: Tier 1 and Tier 2. Tier 1 BCTs are
presented from interventions that set prescriptions whichmeet the
Rock 2012 target and achieved 75% or more adherence. Tier 2
BCTs are presented from interventions that reported good adher-
ence (i.e. 75% or more) but set prescriptions that are below the
150 minutes per week Rock 2012 target. BCTs reported in the
eight Tier 1 trials are presented in Table 4. It is notable that four of
these studies incorporated both a supervised and an independent
exercise component as part of their intervention and four were ex-
clusively supervised, with all placing no restrictions on the control
group in terms of exercise behaviour. Six studies were included in
Tier 2 BCTs and reported adherence of 75% or greater to a speci-
fied exercise aerobic prescription which was lower than the targets
set in the Rock 2012 guidelines (al-Majid 2015; Bourke 2011a;
Bourke 2014; Cadmus 2009; Kim 2017; Scott 2013). BCTs re-
ported in Tier 2 studies are presented in Table 5.
Few interventions (Bourke 2014; Cadmus 2009; Daley 2007a;
Kim 2006; Perna 2010; Rogers 2015) reported providing infor-
mation on the consequences of behaviour (BCT #1). All interven-
tions had programme set goals, whichwe have highlighted as being
different for the purpose of this review to goal setting (behaviour)
and goal setting (outcome). Only seven studies set exercise goals in
conjunction with participants (BCT # 5) (Bourke 2014; Cadmus
2009; Daley 2007a; Perna 2010; Pinto 2005; Pinto 2011; Rogers
2015). These same seven studies also reported problem-solving
with barriers identified (BCT #8) and solutions facilitated. Three
interventions (Daley 2007a; Perna 2010; Rogers 2015) which par-
ticipants had some input into setting of goals were these reviewed
(BCT #10). When monitoring did occur (BCT #16) or monitor-
ing of outcome behaviour occurred (BCT #17), feedback on per-
formance (BCT #19) was provided in only five out of 10 (Cadmus
2009; Perna 2010; Pinto 2005; Pinto 2011;Rogers 2015), which is
important to note. Fourteen studies (Bourke 2011a; Bourke 2014;
Cadmus 2009;Daley2007a;Drouin 2005;Hayes 2009;Kaltsatou
2011; Kim 2006; Musanti 2012; Perna 2010; Pinto 2003; Pinto
2011; Rogers 2015; Scott 2013) reported providing instruction
on how to perform the behaviour (BCT #21), although it may
be anticipated that this did occur but just was not reported. In
addition, 15 studies prompted practise of the behaviour (BCT #
26) (Bourke 2011a; Bourke 2014; Cadmus 2009; Daley 2007a;
Drouin 2005; Hayes 2009; Kaltsatou 2011; Kim 2006;McKenzie
2003; Musanti 2012; Perna 2010; Pinto 2003; Pinto 2005; Pinto
2011; Rogers 2015), Only four studies used techniques to in-
crease social support (BCT #29); (Bourke 2014; Cadmus 2009;
Daley 2007a; Perna 2010). Other common BCTs included setting
of graded tasks (i.e. increased exercise duration or intensity over
time) and self-monitoring of behaviour (exercise) and outcomes
of behaviour (e.g. heart rate), although it is not clear for all inter-
ventions whether this was done primarily for data collection or as
a mechanism of behaviour change.. Only three studies reported
relapse prevention (BCT #35) (Daley 2007a; Perna 2010; Rogers
2015).
Measurement of exercise behaviour
Ten studies were identified that attempted to objectively validate
independent exercise behaviour with accelerometers or heart rate
monitoring (al-Majid 2015; Bourke 2014; Cadmus 2009; Irwin
2015; Mohamady 2017; Pinto 2005; Pinto 2011; Rogers 2015;
Scott 2013; Thomas 2013). Seven of these studies attempted to
validate self-reported independent exercise behaviour by using ac-
celerometers or heart rate monitors (al-Majid 2015; Bourke 2014;
Irwin 2015; Pinto 2005; Pinto 2011;Rogers 2015;Thomas 2013),
however in three studies (Pinto 2005; Pinto 2011; Rogers 2015),
data either were not supportive of exercise behaviour recorded by
participants or were not reported in their entirety.
Excluded studies
Reasons for excluding published studies included the following.
• Non-RCTs (e.g. review manuscripts, comment/editorial
articles).
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• Mixed cancer cohorts or cohorts that included non-cancer
populations.
• Studies that failed to describe essential metrics of exercise
prescription used in the intervention (e.g. frequency, intensity,
duration).
• Studies involving active participants at baseline.
• Studies involving hospital inpatients.
• Interventions that provided follow-up of less than 6 weeks.
• Studies involving participants younger than 18 years of age.
All excluded studies (N = 180) for the 2018 update, are presented
in the Characteristics of excluded studies. However for the origi-
nal review only a subset of excluded studies could be included in
the ’Characteristics of excluded studies’ section. This is a result of
the large volume of studies that had to be full text screened (N =
402) and the high proportion (around 90%) that were excluded.
In accordance with editorial advice, we divided this large number
(N = 365) into initially unclear studies that required further in-
vestigation (N = 76) and those that clearly were not eligible after
full text had been retrieved (N = 289). This approach is analogous
to the approach adopted in recent reviews (Galway 2012), and is
detailed in the existing PRISMA diagram (Figure 1).
For the 2018 update, we sent an additional 101 emails to cor-
responding authors to request additional information (regarding
included studies, excluded studies and studies that we could not
access) to determine eligibility and to supplement published data
for this review.
Risk of bias in included studies
Only seven studieswere judgednot to include a high risk of bias (al-
Majid 2015; Bourke 2011a; Cadmus 2009; Cantarero-Villanueva
2012b; Drouin 2005; Irwin 2015; Scott 2013). Full results of the
methodological quality assessment for allocation bias, blinding,
incomplete data outcome and selective reporting (along with justi-
fications) are covered in the ’Risk of bias’ tables for each study and
are illustrated in Figure 2; Figure 3. Twelve studies stated that an
intention-to-treat analysis was used (Bourke 2011a; Bourke 2014;
Cadmus 2009; Cantarero-Villanueva 2012b; Cavalheri 2017;
Daley 2007a; Irwin 2015; Perna 2010; Pinto 2005; Rogers 2015;
Scott 2013; Thomas 2013).
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
Eleven studies had an unclear risk in their description of conceal-
ment in randomisation allocation. However, no study was judged
to have a high risk of bias in this respect.
Blinding
Eleven studies had undertaken the blinding of study asses-
sors (Bourke 2011a; Bourke 2014; Cantarero-Villanueva 2012b;
Cavalheri 2017; Hayes 2009; Kim 2017; Musanti 2012; Perna
2010; Rogers 2015; Scott 2013; Thomas 2013). The remaining
studies did not include enough information for the review authors
to make a definitive judgement on this criterion.
Incomplete outcome data
Five studies were judged to have been subject to incomplete data
outcome bias: Kim 2006 reported data from only 41 of 74 partic-
ipants randomly assigned; Musanti 2012 reported that 13 women
(24%) did not complete their assigned 12-week programme; and
Pinto 2003 did not report control group data for the exercise
tolerance test. Bourke 2014 had incomplete outcome data at six
months follow-up. Cavalheri 2017 reported missing patient data
in both arms with no reasons given.
Selective reporting
Most studies reported all listed outcomes; however, four stud-
ies were judged to omit outcomes from their results reporting.
Musanti 2012 did not report waist and upper, mid and lower arm
circumference outcomes; Pinto 2003 reported none of the physio-
logical assessments in the control group at 12 weeks of follow-up;
Pinto 2011 did not report data derived from the use of accelerom-
eters; and Thomas 2013 did not report on body fat or lean mass
values and no data were given from food frequency questionnaire.
Other potential sources of bias
Other sources of bias found in the included studies that are
worth highlighting include adherence data missing or not clear
(Cavalheri 2017; Hayes 2009; Kaltsatou 2011; Kim 2017;
McKenzie 2003; Mohamady 2017; Musanti 2012); high attrition
at follow-up (Pinto 2003); low recruitment rate (Bourke 2011a;
Campbell 2017; Thomas 2013); Significant differences in partici-
pants excluded from study analysis/dropouts (Kim 2006; Musanti
2012; Pinto 2003); numbers randomly assigned to study arms
with study completion rate unclear (Perna 2010); significant dif-
ferences in cohorts at baseline (Kim 2017; Musanti 2012; Pinto
2003; Pinto 2005); and inconsistencies between objective and sub-
jective measures of exercise behaviour (Pinto 2005; Pinto 2011;
Rogers 2015). Insufficient information was reported to permit a
judgement about any single element of bias because of lack of
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data (al-Majid 2015; Bourke 2011a; Cadmus 2009; Campbell
2017; Drouin 2005; Hayes 2009; Irwin 2015; Kaltsatou 2011;
Kim 2006; McKenzie 2003; Mohamady 2017; Pinto 2003; Pinto
2005; Pinto 2011).
Effects of interventions
See: Summary of findings for the main comparison Exercise
interventions compared to usual care for promoting habitual
exercise in people living with and beyond cancer to improve
aerobic exercise tolerance
Primary outcome
To assess the effects of interventions designed to promote
exercise behaviour in sedentary people living with and
beyond cancer
Please see Table 1, ’Summary of included studies’. As it is not
meaningful to interpret individually the componentmetrics of aer-
obic (frequency, intensity and duration) or resistance exercise (fre-
quency, intensity, type of exercise, sets and repetitions) behaviour,
these primary outcomes are presented in the narrative synthesis
below of interventions achieving 75% or greater adherence.
In Rogers 2015, adherence to planned intervention components
was 98% for supervised exercise sessions, 96% for update sessions,
and 91% for discussion group sessions. Only five participants did
not receive the allocated intervention (i.e. did not complete 75 %
of all intervention components combined). With the intervention
group reporting an average of 169 minutes of moderate intensity
exercise per week at 12 weeks, and 137 minutes of moderate in-
tensity exercise per week at six months. Although, there is a high
risk of bias around how ’in-active’ the recruited participants were
at baseline, as baseline accelerometer recordings are incongruent
with the inclusion criteria.
Four of the studies included in this review reported that 75%
or more of the intervention group met the (Rock 2012) aero-
bic exercise guidelines at any given follow-up (Campbell 2017;
Cantarero-Villanueva 2012b; Irwin 2015; Rogers 2015). Four
studies reported that 75% or more of the intervention group met
the (Rock 2012) resistance exercise guidelines. (Bourke 2011a;
Bourke 2014; Kim 2017; Scott 2013). Behaviour change tech-
niques (BCTs) reported in these eight studies are presented in
Table 4. Of these studies, only one study explicitly stated it had
theoretical basis (Rogers 2015).
Due to of unclear reporting it was not possible to make a judge-
ment on whether some trials achieved adherence of 75% or greater
. Reasons for an unclear judgement or unsuccessful adherence are
detailed below.
• Daley 2007a: judgement unclear; adherence reported as a
proportion of participants attending a proportion of set exercise
sessions (i.e. 77% of the intervention group attending 70% of
sessions).
• Drouin 2005: judgement unclear; adherence reported as
mean number of days per week when exercise was undertaken,
relative to a range within the prescription (i.e. 3.6 days per week,
when the prescription was for three to five days per week).
• Kaltsatou 2011: judgement unclear; no adherence data
reported.
• Kim 2006: judgement unclear; high adherence was
reported (78%), but in tandem with substantial attrition (i.e.
data missing for 45% of the cohort).
• Pinto 2003: judgement unclear; high adherence was
reported (88%) but in tandem with substantial attrition (i.e.
25% of the intervention group dropped out over the
intervention period).
• Pinto 2005: judgement unsuccessful; 75% adherence
threshold was not met after week four.
• Pinto 2011: judgement unsuccessful; three-day Physical
Activity Recall (PAR) questionnaire indicates that 64.7% of the
intervention group and 40.9% of controls were adhering to the
exercise guidelines at three months.
• Hayes 2009: judgement unclear; adherence reported as a
proportion of participants attending a proportion of set exercise
sessions (i.e. 88% allocated to the intervention group participated
in 70% or more of scheduled supervised exercise sessions).
Further, adherence from the unsupervised aspect is not reported.
• McKenzie 2003: judgement unclear; no adherence data
reported.
• Musanti 2012: judgement unclear; high adherence reported
but only 50% of activity logs returned.
• Perna 2010: judgment unclear; women assigned to the
structured intervention completed an average of 83% of their
scheduled hospital-based exercise sessions (four weeks in total).
Home-based adherence is not clear.
• Mohamady 2017: judgement unclear; no adherence data
reported.
• Thomas 2013: judgement unsuccessful; the goal of the
intervention was for participants to achieve 150 minutes of
moderate intensity exercise per week; 33% of the intervention
group achieved 150 minutes per week, 56% of the intervention
group achieved 120 minutes per week and 75% achieved 90
minutes per week.
• Irwin 2015: judgement unsuccessful; resistance exercise - an
average of 70% of strength-training sessions completed.
• Cavalheri 2017: judgement unsuccessful; of the nine
participants randomised to the exercise intervention, four (44%)
adhered to exercise training by completing 15 or more training
sessions (i.e.≥60%).
Ideally, ameta-analysis of objectively verified (e.g. using accelerom-
eters or heart rate monitoring) minutes per week of moderate in-
tensity aerobic exercise achieved in an intervention group, com-
pared with controls, for whom the exercise prescription adherence
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is at least 75%, would be most informative. However, due to varia-
tion in measurement and reporting amongst included studies, this
was not possible. Insufficient data were available for a synthesis of
evidence to be conducted around free-living energy expenditure.
Secondary outcomes
Aerobic exercise tolerance
1.1 All cancers: eight to 12 weeks of follow-up
A meta-analysis of change in aerobic exercise tolerance was car-
ried out on 10 studies that reported these outcomes and also re-
ported means for final value scores. Standardised mean differences
(SMDs) were used to produce effect estimates as variation in how
studies assessed this outcome was evident. Standard deviations
(SDs) were calculated from 95% confidence intervals (CIs) using
the formula in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011) (i.e. SD =
√
N * (upper limit-lower
limit)/(t distribution *2), and from standard errors (SEs) using
SD = SE*
√
N, when they were not reported. Length of follow-up
ranged from eight (Cavalheri 2017; Daley 2007a; Kim 2006), to
12 weeks (al-Majid 2015; Bourke 2011a; Bourke 2014; Musanti
2012; Pinto 2005; Pinto 2011; Rogers 2015) . Aerobic exercise
tolerance was significantly better in intervention versus control
groups in 604 participants: (SMD 0.54, 95% CI 0.37 to 0.70;
10 studies, 604 participants: low-certainty evidence; Analysis 1.1).
Results were analysed using a fixed-effect model. Certainty of the
evidence assessed using GRADE and was graded as low. As there
was some serious concerns over risk of bias and concerns over the
number of small studies with positive results (please see Summary
of findings for the main comparison).
1.2 All cancers: eight to 12 weeks of follow-up (sensitivity
analysis)
We then removed studies with a high risk of bias relative to this
outcome and repeated the analysis with the four remaining stud-
ies (al-Majid 2015; Bourke 2011a; Bourke 2014; Pinto 2005),
and aerobic exercise tolerance was better in intervention versus
control groups (SMD 0.85, 95% CI 0.56 to 1.14; 4 studies, 201
participants; low-certainty evidence; Analysis 1.2). The certainty
of the evidence was graded as low using GRADE as there were
concerns imprecision as there were variations in effect sizes and
concerns over the low number of participants in the studies (please
see Summary of findings for the main comparison).
1.3 All cancers: six months of follow-up
Seven studies included data from a follow-up of six months
(Bourke 2014; Daley 2007a; Kaltsatou 2011; Pinto 2005; Pinto
2011; Rogers 2015; Scott 2013) showing that aerobic exercise tol-
erance was significantly better at six months in intervention versus
control groups (SMD 0.56, 95% CI 0.39 to 0.72; 7 studies; 591
participants: low-certainty evidence; Analysis 1.3). It should be
highlighted that six of these studies have a high risk of bias, which
could affect this outcome at six months; specifically, Bourke 2014
had high attrition at six months follow-up; no adherence data in
the Kaltsatou 2011 study; substantial contamination among con-
trols in the Pinto 2011 study; Rogers 2015 objective and subjec-
tive measures of exercise results varied greatly and non-blinded
assessors in the Daley 2007a study. Note that in all meta-analyses,
data from Pinto 2005 have been multiplied by -1 to control for
direction of effect (i.e. lower values in a timed test indicate a bet-
ter outcome). Brief narrative descriptions of studies not suitable
for meta-analyses include the following: Drouin 2005 VO2 peak
data are reported as medians and interquartile ranges; for Pinto
2003, no control group data are presented for the exercise tests; for
Campbell 2017, no means or SDs present at baseline and follow-
up. For grading of data please see Summary of findings for the
main comparison.
1.4 Breast cancers: eight to 12 weeks of follow-up
We were able to carry out one subgroup analysis in breast cancer
patients This was a meta-analysis of change in aerobic exercise
tolerance carried out on six studies (al-Majid 2015; Daley 2007a;
Kim2006;Musanti 2012; Pinto 2005;Rogers 2015), showing that
aerobic exercise tolerancewas significant (SMD0.57, 95%CI 0.22
to 0.93; 6 studies, 441 participants; very low-certainty evidence;
Analysis 1.4). However, it should be noted that four of the studies
were considered to have high risk of bias (Daley 2007a; Kim 2006;
Musanti 2012; Rogers 2015). The certainty of the evidence was
graded as very low as there was high risk of bias, concerns over
the precision of the data as the confidence intervals were wide
and there were serious concerns over the heterogeneity of the data
(please see Summary of findings for the main comparison).
1.5 All cancers: combination of supervised and home-based
exercise: eight to 12 weeks of follow-up
A meta-analysis of aerobic exercise tolerance was carried out in
the following subgroups: supervised exercise interventions, home-
based interventions, and a combination of both. In a combina-
tion of home-based and supervised exercise interventions (Bourke
2014; Bourke 2011a; Kim 2006; Rogers 2015), aerobic exercise
tolerance was better in the intervention than the control : (SMD
0.53, 95% CI 0.01 to 1.04; 4 studies, 357 participants; very low-
certainty evidence; Analysis 1.5). The certainty of the evidence
was graded as very low as there were concerns over the precision
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of the data as the confidence intervals were wide and there were
very serious concerns over inconsistency due to the heterogeneity
of the data and variations in effect sizes (please see Summary of
findings for the main comparison).
1.6 All cancers: home-based exercise: eight to 12 weeks of
follow-up
In home-based interventions (Musanti 2012; Pinto 2005; Pinto
2011), aerobic exercise tolerance was better in the intervention
than the control (SMD 0.70, 95% CI 0.37 to 1.03: 3 studies,
155 participants; very low-certainty evidence; Analysis 1.6). The
certainty of the evidence was graded as very low due to high risk
of bias, low number of participants within the studies and wide
confidence intervals (please see Summary of findings for the main
comparison).
1.7 All cancers: supervised exercise: eight to 12 weeks of
follow-up
In supervised interventions (al-Majid 2015;Cavalheri 2017;Daley
2007a), aerobic exercise tolerance was better in the intervention
group versus control (SMD 1.07, 95% CI 0.26 to 1.89; 3 studies,
92 participants; very low-certainty evidence; Analysis 1.7). Serious
concerns with inconsistency and imprecision were presented due
to wide variations in effect sizes and wide confidence intervals.
Therefore the certainty of evidence was classed as very low (please
see Summary of findings for the main comparison).
1.8 All cancers: undergoing active treatment: eight to 12
weeks of follow-up
A meta-analysis of active treatment and no current treatment for
aerobic exercise tolerance was carried out. For participants under-
going active treatment in six studies, (al-Majid 2015; Bourke 2014;
Daley 2007a; Kim 2006; Musanti 2012; Pinto 2005), demon-
strated aerobic exercise tolerance was better in the intervention
than the control (SMD 0.72, 95% CI 0.49 to 0.95; 6 studies, 313
participants; Analysis 1.8). However, five of these studies had a
high risk of bias so interpretation of these results should be done
with caution.
1.9 All cancers: no active treatment: eight to 12 weeks of
follow-up
Ameta-analysis of aerobic exercise tolerance in participants not un-
dergoing active treatment was carried out in four studies (Bourke
2011a; Cavalheri 2017; Pinto 2011; Rogers 2015), showing that
aerobic exercise tolerance was better in the intervention than the
control (SMD 0.61, 95% CI 0.10 to 1.12; 4 studies, 291 partici-
pants: Analysis 1.9).
Sketal muscle strength
2.1 All cancers: eight to 12 weeks of follow-up
Four studies that used resistance exercise as a component of the
intervention reported changes in lower- (Bourke 2011a; Rogers
2015 ) and upper limb (Musanti 2012; Kim 2017) strength. All
four studies had reported strength changes at 12 weeks of follow-
up. No significant improvement in strength was found (SMD
0.20, 95% CI -0.03 to 0.44; 4 studies, 278 participants: Analysis
2.1).
2.2 All cancers: eight to 12 weeks of follow-up
After two studies was removed for high risk of bias (Kim 2017;
Musanti 2012), effect estimates remained non-significant (SMD
0.17, 95% CI -0.09 to 0.43; 2 studies, 231 participants; Analysis
2.2).
Planned subgroup analysis was not possible according to partici-
pant age, presence of metastatic disease, theoretical underpinning
of interventions or participant body mass index (BMI).
Adverse effects
Thirteen studies reported adverse effects (Bourke 2011a; Bourke
2014; Cadmus 2009; Cantarero-Villanueva 2012b; Cavalheri
2017; Daley 2007a; Irwin 2015; Kim 2006; Musanti 2012; Pinto
2005; Pinto 2011; Rogers 2015; Thomas 2013); these ranged
fromminor (e.g.musculoskeletal problems;Musanti 2012; Rogers
2015), to major events (e.g. death; Kim 2006). However, only five
studies (Cadmus 2009; Cantarero-Villanueva 2012b; Irwin 2015;
Rogers 2015; Thomas 2013) were explicit as to which of these
adverse effects were caused by inclusion of the participant in the
intervention group (two instances of plantar fasciitis).
Study recruitment rate
Study recruitment rate ranged from 9.5% (Thomas 2013) to
94% (Thomas 2013, Cantarero-Villanueva 2012b, respectively).
Eleven studies reported a priori sample size estimates (Bourke
2014; Cadmus 2009; Campbell 2017; Daley 2007a; Hayes 2009;
Kaltsatou 2011; Musanti 2012; Perna 2010; Pinto 2003; Pinto
2011; Scott 2013), and seven (Bourke 2014; Cadmus 2009;
Cantarero-Villanueva 2012b; Hayes 2009; Perna 2010; Rogers
2015; Scott 2013) met their recruitment target.
Intervention attrition rate
Fifteen studies produced CONSORT diagrams (al-Majid 2015;
Bourke 2011a; Bourke 2014; Cadmus 2009; Campbell 2017;
Cantarero-Villanueva 2012b; Cavalheri 2017;Daley 2007a; Irwin
2015; Kim 2017; Pinto 2005; Pinto 2011; Rogers 2015; Scott
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2013; Thomas 2013). Intervention attrition rates from the in-
cluded studies ranged from 0% to 25% (Campbell 2017, Pinto
2003) ,respectively, with seven studies not clearly reporting attri-
tion in the intervention arm (Cavalheri 2017; Kaltsatou 2011;
Kim 2006; McKenzie 2003; Mohamady 2017; Musanti 2012;
Perna 2010).
D I S C U S S I O N
Summary of main results
In this review update we have found more evidence that there
are interventions that meet the Rock 2012 guidelines for aero-
bic (Campbell 2017; Cantarero-Villanueva 2012b; Irwin 2015;
Rogers 2015) and resistance (Bourke 2011a; Bourke 2014; Kim
2017; Scott 2013) exercise with 75% adherence in previously in-
active cancer cohorts. We have identified a hierarchy of the most
commonbehaviour change techniques (BCTs) that feature in these
studies (Table 4). The most frequent of these interventions were
setting of graded tasks (#BCT 9), programme set goal and instruc-
tion of how to perform behaviour (#21). These studies were pre-
dominantly exclusively supervised studies or a combination of su-
pervised and home-based studies. Supervision usually consisted of
contactwith the exercise professional or research teamat least twice
weekly. However, from our review of studies at full-text screening
stage, it is still true that adherence to exercise interventions, which
is crucial for understanding treatment dose, is frequently either
poorly reported or not reported at all in randomised controlled
trials (RCTs).
Despite the uncertainty surrounding adherence in many of the
included studies, interventions caused improvement in aerobic ex-
ercise tolerance at eight to 12 weeks (Analysis 1.1) in interven-
tion participants compared with controls. There is also evidence
that this can be sustained at six months of follow-up, but owing
to potential high risk of bias, this should be viewed with caution
(Analysis 1.3). We were able to carry out one cancer subgroup
analysis in breast cancer patients, showing that aerobic exercise tol-
erance was significantly improved up to 12 weeks (Analysis 1.4),
however caution is again warranted when interpreting the result,
due to frequent high risk of bias.
Adverse effects these ranged fromminor e.g.musculoskeletal prob-
lems ( Musanti 2012; Rogers 2015) to major events e.g. death
(Kim 2006). However, only five studies were explicit as to which
of these adverse effects were caused by inclusion of the partici-
pant in the intervention group (two instances of plantar fasciitis)
(Cadmus 2009; Cantarero-Villanueva 2012b; Irwin 2015; Rogers
2015; Thomas 2013).
Overall completeness and applicability of
evidence
We included 23 studies in this systematic review, all of which were
RCTs. These studies randomly assigned 1372 participants to ex-
ercise or comparison groups. A large majority of these studies in-
cluded women with breast cancer, two involved colorectal cancer
survivors, one involved men with advanced prostate cancer, and
one involved lung cancer survivors. As found in the original re-
view (Bourke 2013), although these four primary cancers account
for most of the population living with and beyond cancer, other
common cancers such as lymphoma do not appear at all in this
review and less common cancers also are not represented in the
evidence base.
Furthermore, an overwhelming majority of participants were
white, and only five studies included an ethnically diverse popu-
lation. As such, other ethnicities are still substantially underrep-
resented, as found previously (Bourke 2013). Comorbidities were
rarely reported at baseline and only six studies were carried out
in obese cohorts. Although we set a limit in this review of 90
minutes per week of moderate-intensity exercise at baseline as the
criterion for categorising participants as ’sedentary’ or ’physically
inactive’, we did not specify any threshold for vigorous exercisers.
It is possible that we could have included individuals who were
performing as much as 90 minutes per week of vigorous intensity
exercise. However, it is important to note that baseline reporting
of behaviour in terms of how much ’vigorous’ exercise these co-
horts were undertaking was rare.
Nineteen of the included studies were conducted in Northern
America or Western Europe, and two studies were completed in
Australia, one in Egypt and one in North Korea. The majority
all are considered high-income nations according to the World
Health Organization (WHO) taxonomy. Very little evidence was
derived from developing countries, and it is uncertain whether the
resources, infrastructure or both required for some of the inter-
ventions included in this review would be applicable in these parts
of the world.
Although no single tool for measuring physical activity is infallible
(Warren 2010), when possible it is desirable to have self-reported
exercise behaviour supported by objective measurements such as
accelerometers or heart rate data. Ten studies were identified that
attempted to objectively validate independent exercise behaviour
with accelerometers or heart rate monitoring (al-Majid 2015;
Bourke 2014; Cadmus 2009; Irwin 2015;Mohamady 2017; Pinto
2005; Pinto 2011;Rogers 2015; Scott 2013;Thomas 2013). Seven
studies of these studies attempted to validate self-reported inde-
pendent exercise behaviour by using accelerometers or heart rate
monitors (al-Majid 2015; Bourke 2014; Irwin 2015; Pinto 2005;
Pinto 2011; Rogers 2015; Thomas 2013), however in three stud-
ies, data either were not supportive of exercise behaviour recorded
by participants or were not reported in their entirety (Pinto 2005;
Pinto 2011; Rogers 2015). Still a number of studies evaluated non-
supervised exercise behaviour by using self-report logs or seven-
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day physical activity questionnaires. Whilst these tools are rela-
tively non-complex and affordable for implementation in study
design, they are prone to well-established bias, including difficul-
ties in ascertaining the frequency, duration and intensity of physi-
cal activity; social desirability bias; the cognitive demands of recall
and overestimation of behaviour, particularly when such data are
used to extrapolate MET/hours of exercise per week performed,
or kcal/week of energy expenditure.
Analysis by behaviour change techniques as it relates to any given
outcome (e.g. aerobic exercise tolerance) was not possible given
that few studies stated a theoretical basis for their intervention,
and only one study in this update being based on theory i.e. the
trans theoretical model in Rogers 2015. It is worthy of note, how-
ever, that interventions frequently consisted of little more than
telling people how to exercise and providing opportunities for this
to occur, with little consideration of the psychological aspects of
changing behaviour. A number of interventions were excluded at
full-text screening stage, that had a theoretical basis but did not
meet our inclusion criteria. Whilst, the use of theory is variable
amongst behaviour change interventions generally, the lack of in-
terventions based on a theoretical model in this review is a con-
cern.
It is also acknowledged that although coding of BCTs was done
primarily on the basis of study reports, it is possible that some
BCTs may have been implemented but not reported. To overcome
this possibility and enhance understanding of the techniques im-
portant for changing behaviour in cancer patients, adoption of the
CALO-RE taxonomy or the broader BCT v1 taxonomy is recom-
mended.
We acknowledge that in this review, we have undertaken a synthe-
sis of RCTs that represent a combination of exercise efficacy and
behaviour change studies (Courneya 2010), we recognise the dis-
tinction and this is reflected in the literature. During the screening
process, there were a number of behaviour change studies based
on theory that we excluded as they did not meet our inclusion
criteria. However, it should be noted by the reader that all eight
studies that we judged as successful (i.e. reported 75% or greater
adherence over the intervention period to the Rock 2012 guide-
lines) incorporated intervention elements that were designed to
promote independent exercise behaviour and did not place any
restrictions on the control group in terms of the exercise they were
permitted to undertake during the study.
Finally, we stated in the justification for this review that a better
understanding of the types of interventions that could promote
long-term, habitual physical activity (i.e. 12 months or longer) in
people living with and beyond cancer was a valuable addition to
our knowledge due to the original review not being able to address
this issue. Unfortunately, because of limitations in the evidence
that we identified, we have not been able to address this issue. As
such, this is an area of uncertainty that represents an important
research gap. Whilst there is more research available of how to
promote exercise behaviour at around eight to 12 weeks up until
six months, there is still a lack of long-term follow-up of anything
beyond this amongst these studies.
Quality of the evidence
Most of the uncertainty in judging study bias came from lack of
clarity around randomisation procedures, allocation concealment
and blinding of study outcome assessors. Most of the studies in
this review were judged to include at least one element of high risk
of non-standard bias, as described in the ’Other potential sources
of bias outcome. Of note, we chose to refrain from judging studies
according to the performance bias criterion because we considered
it not possible to realistically blind intervention participants to
’sham’ conditions. Public health guidelines (e.g. the UK CMO
report) for aerobic and resistance exercise (which are identical to
theRock 2012 recommendations) are freely available to the public,
and given their ease of access via the Internet, the validity of a ’sham’
condition is highly dubious. The Summary of findings for the
main comparison and ’Risk of bias’ tables and Figure 2 and Figure
3 provide a summary of the certainty of evidence. Reporting of
adherence of exercise behaviour within the studies was infrequent,
which impacted upon the certainty of evidence.
We found the certainty of evidence assessed using the GRADE
methodology for the majority of the outcomes to be low to very
low; this was mainly due to high risk of bias, inconsistency of
the results and imprecise results. One of the main reasons for a
very low-certainty of evidence grading was due to the high num-
ber of studies presenting a low number of participants in their
study. Concerns over inconsistency were present due to variations
in effect sizes and heterogeneity. Additionally, the serious concerns
were present with the imprecision of the data due to wide con-
fidence intervals and overall low numbers of participants in each
study.
Additionally, attrition ranged from 0% to 25%, some studies with
longer term follow-up (post six months) demonstrated poorer at-
trition rates, but reasons for this were seldom explained. Ensuring
reasons for dropout is reported in future studies is important.
Potential biases in the review process
We were not able to translate all non-English language studies
identified through our database, grey literature and snowballing
searches, due to not having access to or resources for translation
services. However, a huge effort was made to identify all relevant
RCTs in this field. To the review authors’ knowledge, we have
identified and evaluated more RCTs involving exercise interven-
tions in sedentary people living with or beyond cancer than any
other systematic review in this field. More than 190 papers were
screened at full-text stage for eligibility for this update, in addition
to the 400 papers screen at full text for the original review. For this
2018 update, we sent 112 emails in addition to the 116 emails to
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request data to inform the screening and data extraction process,
so that the conclusions of the review would be as accurate and
informative as possible. Dual data extraction was used throughout
the review, except for study characteristics.
Agreements and disagreements with other
studies or reviews
To the review authors’ knowledge, this is still the most compre-
hensive systematic review of exercise behaviour interventions in
sedentary cancer cohorts. A recent systematic review of predictors
of adherence to exercise in people living with and beyond cancer
found that the trans-theoretical model of behaviour change and
the theory of planned behaviour were significantly associated with
better exercise adherence (Husebø 2013). The current review does
not explicitly support such conclusions: mainly due to reporting
in the included studies.
Howlett 2018 conducted a systematic review and meta-analysis
that aimed to evaluate physical activity interventions for healthy
inactive adults. The BCTanalysis found that interventions that in-
cluded ’biofeedback’, ’demonstration of the behaviour’, ’behaviour
practice/rehearsal’ and ’setting of graded tasks’ showed larger effect
sizes for physical activity outcomes than studies that did not in-
clude these BCTs. Our review also found ’setting of graded tasks’
to be common amongst the studies with higher adherence rates.
Additionally, this review reported a number of studies that were
judged as having high risk of bias or were judged as being unclear
due to the lack of clear reporting. A suggestion was for future stud-
ies to use the TIDieR (Template for Intervention Description and
Rreplication) framework (Hoffman 2014), particularly around the
description of intervention content. Our review findings support
this recommendation, as a number of exercise studies appear to
display problems with reporting and are often judged with high
risk of bias.
Ormel 2017 carried out a recent systematic review of predictors of
adherence and identified the issues with low adherence to exercise
interventions for people with cancer. Home-based interventions
were found to possibly address the issue of time and travelling to
a location, which was identified as a potential barrier. Our review
found that interventions that incorporated an element of super-
vision have better adherence rates to the set exercise target than
home-based interventions. However, as previously stated adher-
ence was infrequently reported amongst the studies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Since the last version of this review none of the new relevant stud-
ies have provided additional information to change the conclu-
sions. Service provision to promote exercise in sedentary people
living with and beyond cancer could incorporate components of
both supervised and independent exercise requirements, with su-
pervision being most important for adherence. The majority of
the studies in this review were undertaken in breast cancer cohorts
and included mainly white females: these limitations to generalis-
ability that were also present in our 2013 review (Bourke 2013).
A number of behaviour change techniques (BCTs) were identified
in studies which achieved 75% adherence to the aerobic or re-
sistance guidelines (Rock 2012). Most commonly reported BCTs
were goal setting, instruction on how to perform behaviour, and
setting graded tasks. In the original review, we argued that expect-
ing the most sedentary survivors to achieve at least 150 minutes
per week of aerobic exercise is likely to be unrealistic. This review
update has found studies that can achieve these guidelines, but
only for limited follow-up. Exercise interventions were found to
significantly improve aerobic exercise tolerance compared to usual
care at eight to 12 weeks and six months follow-up. However, there
is low to very low-certainty evidence according to the GRADE
methodology to suggest this is due to issues of high risk of bias,
inconsistency and imprecision. So caution is warranted when in-
terpreting these results for future practice. A very small number of
serious adverse effects were reported amongst the studies, ensuring
researchers, clinicians and guideline developers that these aerobic
and resistance exercise studies are safe in cancer survivors. The role
of healthcare professionals involved in cancer care is still unclear
from the studies we synthesised.
Implications for research
The majority of cancer survivors are not regularly active. Future
research needs to address the following issues.
• How to promote and sustain exercise behaviour in other
cancer survivorship cohorts who are inactive.
• Studies need to improve the standards of reporting adverse
effects and if they are related or unrelated to the intervention or
study participation.
• Studies need to be explicit about baseline exercise behaviour
and about how it was assessed.
• Studies should attempt to use objective measures of exercise,
which may be supported with the use of subjective measures.
• Studies should clearly state reasons for drop out.
• Studies need to report as standard frequency, intensity and
duration of aerobic exercise, as well as repetitions, sets and
intensity of resistance exercise used in intervention prescriptions.
• There needs to be a standardisation of adherence reporting
in clinical studies investigating the effects of exercise in cancer
survivors. We still recommend that adherence is reported as a
single proportion of the cohort who attended/performed exercise
according to the set prescription. If adherence were to be clearly
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reported, there is a much better chance of understanding which
factors improve adherence.
• Reporting of BCTS used in such interventions should be
standardised. Adoption of the CALO-RE taxonomy or the
broader BCT v1 taxonomy is recommended.
• Future interventions should use the TIDieR (Template for
Intervention Description and Rreplication) checklist as a guide
when designing and when reporting interventions.
By achieving these standards, researchers and clinicians can aim
to have an acceptable level of rigour that will demonstrate dose
response relationship between exercise and given clinically relevant
outcomes. Such rigor can underpin clinical exercise guidelines and
so that practitioners are able to communicate achievable exercise
recommendations for sedentary people living with and beyond
cancer.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
al-Majid 2015
Methods • Study design: RCT individual participant level randomisation.
• Study location: Central Virginia and Southern California, USA
• Funding source: Oncology Nursing Society Grant
• Inclusion criteria: patients eligible to participate included women aged 21 years or
older diagnosed with Stage I or II breast cancer who were scheduled to receive
chemotherapy, spoke and read English, and were willing to be randomly assigned to
either group.
• Exclusion criteria: consistent with the exclusion criteria stipulated by the
American College of Sports Medicine, patients who had recent or uncontrolled cardiac
conditions were excluded. Other exclusion criteria included self-reported history of
unstable or severe clinical depression, activity-limiting arthritis, having had joint
surgery within the previous 3 months, and having been engaged in regular exercise (5
days per week) in the past 3 months.
• CONSORT diagram included: yes
• Number of participants in each arm: 7,7 (intervention vs control)
• Study recruitment rate: 16/35
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline =15-16 weeks.
Participants • Primary cancer diagnosis: stage I or stage II breast cancer
• Current cancer treatment: scheduled chemotherapy
• Metastatic disease: none
• Age, years, mean (SD): exercise group 47.9 +/- 10.4 & control group 52.7 +/- 10.7
• Gender: female
• BMI: unknown
• Ethnicity: for both groups: Hispanic 29%, Non Hispanic 71%
• Comorbidities reported: unclear
Interventions • Group or individual intervention: individual
• Setting: rehabilitation suite
• Exercise prescription components: aerobic
• Theoretical basis: none
• CALO-RE taxonomy components: programme set goal
• Frequency of contact with researcher or exercise professional: every exercise
session was supervised, two to three times per week contact with exercise physiologist
over nine to 12 weeks. 4 Assessments over the intervention and follow-up period.
• Frequency of contact with healthcare professional: eligible participants were
informed about the study by referring oncologists and were approached by study staff
who invited them to participate.
• Instructions to controls: instructed to document and report any exercise activities
they engaged in while on the study.
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al-Majid 2015 (Continued)
Outcomes • Change in fitness reported: aerobic exercise tolerance was measured using VO2
Max test.
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: adherence to exercise protocol, and the
amount (duration HR) of exercise was achieved by participants during sessions was
recorded using heart rate watch monitors.
• Aerobic exercise frequency: two to three times per week.
• Aerobic exercise duration: twenty to forty minutes.
• Aerobic exercise intensity: progression throughout the 12-week period; from 40%
heart rate reserve to 80% heart rate reserve.
• Description aerobic exercise mode: treadmills
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 14/14
• Adherence: ranging between 95% and 97% to exercise protocol.
• Attrition: 12.5%
• Adverse effects: none reported.
• Achieves Rock et al guidelines: no
Description of usual care Participants in the usual-care group received usual care, which did not involve exercise,
and were instructed to document and report any exercise activities they engaged in while
on the study. Similarly, the exercise-group participants to report engagement in non-
protocol exercise activities during the study
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
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al-Majid 2015 (Continued)
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Unclear risk None
Bourke 2011a
Methods • Study design: RCT participant level randomisation
• Study location (WHO income taxonomy): Sheffield, UK (high)
• Funding source: Sheffield Hallam University
• Inclusion criteria: patients who had histologically-confirmed colon cancer (Dukes
stages A to C) respected 6 to 24 months previously
• Exclusion criteria: existing participation in regular physical activity (purposeful
activity of at least moderate intensity of 30 minutes or longer, three times a week), a
Karnofsky rating of less than 80, unstable angina, uncontrolled hypertension, recent
myocardial infarction or a pacemaker
• CONSORT diagram included: yes
• Study recruitment rate: 18/180
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 12 weeks
Participants • Primary cancer diagnosis: histologically-confirmed colon cancer (Dukes stages A
to C)
• Current cancer treatment: none
• Metastatic disease: none
• Age, years: mean (SD) = control: 70.3 (8.7), intervention: 67.9 (5.7)
• Sex: 12 males, 6 females
• BMI: mean (SD): control: 26.0 (3.5), intervention: 26.9 (3.8)
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 9), control (n = 9)
• Group or individual intervention: group
• Setting: university rehabilitation suite
• Exercise prescription components: aerobic and resistance
• Theoretical basis: not stated
• CALO-RE taxonomy components: #15, #16, #26, #27
• Frequency of contact with researchers or exercise professionals: 18 supervised
exercise sessions
• Instructions to controls: continue behaviour as normal
Outcomes • Change in fitness reported: aerobic
exercise tolerance using the Borg treadmill protocol. Resistance
maximal voluntary torque of the knee extensors using isokinetic dynamometry
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: attendance at supervised session with
HR monitors, exercise diaries and (Godin 1986) LSI at assessment points
• Aerobic exercise frequency: three or more times per week
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• Aerobic exercise duration: 30 minutes per session or longer
• Aerobic exercise intensity: intensity of 55% to 85% of age-predicted maximum
heart rate and/or ratings of perceived exertion, 11 to 15/fairly light to hard, on the
Borg Rating Perceived Exertion (RPE) scale
• Description aerobic exercise mode: cycle/rowing ergometers, treadmill work. Plus
brisk walking, cycling or gym exercise, etc, during independent exercise sessions
• Resistance exercise frequency: three or more times per week
• Resistance exercise sets: between 2 and 4 sets of resistance exercises
• Resistance exercise repetitions: 8 to 12 repetitions
• Resistance exercise intensity: 60% of 1 repetition max
• Description of resistance exercise: large skeletal muscle groups (quadriceps,
deltoids, pectorals, latissimus dorsi, hamstring muscles) were targeted using body
weight resistance and free weights
Compliance • Intervention uptake: 9/9
• Adherence: attendance was 146 of 162 of the supervised sessions attended (90%
compliance). The median (range) rating of perceived exertion (Borg RPE scale) during
the exercise sessions was 12 (7 to 16). On average, 94% of the independent exercise
sessions (i.e. participants reporting at least 25 to 30 minutes of aerobic exercise) were
completed
• Attrition: one participant in the intervention arm was lost to follow-up. 89%
completed final follow-up in the intervention arm
• Adverse effects: one stroke in the intervention group occurred but was deemed
unrelated to the study
• Achieves Rock et al guidelines: six weeks of resistance training
Description of usual care Both groups had access to standard care, which consisted of a holistic nurse-led colorectal
cancer follow-up service
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly assigned by an
independent researcher via code numbers
using nQuery statistical software
Allocation concealment (selection bias) Low risk Randomisation was undertaken by a senior
academic who was not directly involved in
the recruitment or assessment of partici-
pants
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All outcomes were assessed by an experi-
enced exercise physiologist, who was blind
to the group allocation
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat analysis was used to
compare participants in the groups to
which they were randomly assigned, with
data carried over from previous visits in
cases of participant withdrawal
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Unclear risk Low recruitment rate (18/180) could rep-
resent a biased sample
Bourke 2014
Methods • Study design: RCT individual participant level randomisation
• Study location: Sheffield, UK
• Funding source: Sheffield Hallam University
• Inclusion criteria: eligible men were sedentary (i.e. exercising < 90 min per week
at a moderate intensity) and receiving continuous ADT for a minimum of 6 mo prior
to recruitment, with planned long-term retention on ADT.
• Exclusion criteria: Men with unstable angina, uncontrolled hypertension, recent
myocardial infarction, pacemakers, and painful or unstable bony metastases were
excluded.
• CONSORT diagram included: yes
• Study recruitment rate: 100/136
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 6 months.
Participants • Primary cancer diagnosis: prostate cancer
• Current cancer treatment: androgen Deprivation Therapy
• Metastatic disease: 20/100 men had metastatic disease
• Age, years, mean (SD): intervention: 71 (6), control: 71 (6)
• Gender: male
• BMI: Intervention: 29.3 (4.4), control: 28.1 (4.1)
• Ethnicity: unclear
• Comorbidities reported: 4% previous MI, 3% previous stroke, 5% angina, 7%
diabetes, 27% hypertension, 5% hypertension diagnosed since ADT commencement
*from linked paper Gilbert 2016*.
Interventions • Sample size: intervention (n = 25), control (n = 25)
• Group or individual intervention: group
• Setting: dedicated rehabilitation suite plus home-based.
• Exercise prescription components: aerobic and resistance
• Theoretical basis: none
• CALO-RE taxonomy components: #1 #5 #8 #9 #15 #17 #20 #21 #26 #29
• Frequency of contact with researcher or exercise professional: men would be
supervised by an exercise physiologist, this was undertaken twice a week from weeks 1-
6, and once per week from weeks 7-12. Small-group healthy eating seminars, lasting
approximately 20 minutes, were carried out every 2 week throughout the 12-week
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intervention. Outcomes would be assessed by a trained technician at 3 points over the
intervention.
• Frequency of contact with healthcare professional: men randomised to usual care
were followed up in the urology clinic and seen by an oncology nurse specialist and
urologist.
• Instructions to controls: no restrictions were placed on exercise/dietary behaviours
over the period of the study.
Outcomes • Change in fitness reported: aerobic exercise tolerance was tested using the Borg
treadmill protocol
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: adherence to exercise protocol, Godin
Questionnaire and Borg scales.
• Aerobic exercise frequency: supervised - twice a week from weeks 1-6, and once
per week from weeks 7-12. Independent - once a week from weeks 1-6 and twice a
week from weeks 7-12.
• Aerobic exercise duration: 30 minutes per supervised and independent exercise.
• Aerobic exercise intensity: the aerobic exercise prescription was 30 minutes at an
intensity of 55% to 75% of age predicted maximum heart rate or 11-13 on the Borg
Rating of Perceived Exertion scale.
• Description aerobic exercise mode: use of stationary cycles, rowing ergometers
and treadmills. Independent - brisk walking, cycling and gym exercise.
• Resistance exercise frequency: supervised - twice a week from weeks 1-6, and once
per week from weeks 7-12.
• Resistance exercise sets: between 2-4 sets
• Resistance exercise repetitions: 8-12 reps
• Resistance exercise intensity: intensity of 60% of one repetition max with
progression through increasing volume before weight was increased.
• Description of resistance exercise: body weight resistance and free weights
targeting large skeletal muscle groups.
Compliance • Intervention uptake: 25.
• Adherence: adherence was 94% for the supervised and 82% of the prescribed
independent exercise sessions over the first 12 weeks.
• Attrition: 85% cohort completing 12-week follow-up, 68% men attending 6-
month follow-up.
• Adverse effects: 2 unrelated deaths *from linked paper Gilbert 2016*
• Achieves Rock et al guidelines: yes, six weeks of resistance training
Description of usual care Men randomised to usual care were followed up in the urology clinic and seen by an
oncology nurse specialist and urologist. The treating physicians were informed that the
man was participating in a lifestyle intervention study and further information would
be available on application. No restrictions were placed on exercise/dietary behaviours
over the period of the study
Notes
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was undertaken (1:1) by a
senior academic independent of the study,
at the patient level using nQuery statistical
software
Allocation concealment (selection bias) Low risk Randomisation was undertaken (1:1) by a
senior academic independent of the study,
at the patient level using nQuery statistical
software
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Randomisation was undertaken (1:1) by a
senior academic independent of the study,
at the patient level using nQuery statistical
software
Incomplete outcome data (attrition bias)
All outcomes
High risk Incomplete outcome data at 6 months fol-
low-up.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk None.
Cadmus 2009
Methods • Study design: RCT participant level randomisation
• Study location (WHO income taxonomy): USA, Connecticut (high)
• Funding source: supported in part by a General Clinical Research Center grant
from the National Center of Research Resources, National Institutes of Health (Grant
# M01-RR00125) awarded to Yale University School of Medicine
• Inclusion criteria: postmenopausal women, aged 40 to 75 years, AJCC Stages 0 to
IIIa breast cancer, 1 to 10 years post diagnosis, > 12 months post completion of
adjuvant treatment, physically able to exercise with physician consent to begin an
exercise programme, sedentary activity pattern (< 60 minutes/week) with physician
consent to begin an exercise programme
• Exclusion criteria: diagnosis of recurrent or other primary cancer event. Current
smoker, diabetes mellitus, current or planned enrolment in a structured weight-loss
programme
• CONSORT diagram included: yes, in Irwin 2008
• Study recruitment rate: 75/88
• Length of follow-up: length of intervention = 6 months, length of follow-up from
baseline = 6 months
Participants • Primary cancer diagnosis: AJCC Stages 0 to IIIa breast cancer
• Current cancer treatment: completed adjuvant treatment (with the exception of
hormonal therapy) at least six months before enrolment. 57% versus 70% on hormone
therapy in the intervention group versus controls; 30% on tamoxifen in both arms; 27
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versus 40% versus control on aromatase inhibitors
• Metastatic disease: none
• Age, years: mean (SD): intervention: 56.5 (9.5), control: 55.1 (7.7)
• Sex: women
• BMI: mean (SD): intervention: 30.4 (6.0), control: 30.1 (7.4)
• Ethnicity: 84% white in both groups
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 37), control (n = 38)
• Group or individual intervention: supervised and home-based
• Setting: a supervised training programme at a local health club. Participants
exercised at the club during designated sessions
• Exercise prescription components: aerobic training
• Theoretical basis: not stated
• CALO-RE taxonomy components: #1, #5, #8. #9, #15, #16, #17, #19, #21, #26,
#29, #35
• Frequency of contact with researchers or exercise professionals: unclear exactly
how many exercise sessions were supervised
• Instructions to controls: participants assigned to the usual care groups were told
that they could exercise on their own if they chose, but that the study’s physical activity
programme would not be available to them. They received all exercise programme
materials at six-month follow-up
Outcomes • Change in fitness reported: not reported
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: heart rate monitors, physical activity
questionnaire, a seven-day physical activity log and a seven-day pedometer log.
Adherence to the intervention among exercise group participants was assessed by seven-
day physical activity logs weekly
• Aerobic exercise frequency: three sessions per week supervised, two sessions per
week at home or at a health club: total five days a week
• Aerobic exercise duration: participants were asked to perform three 15-minute
sessions during week 1, building to five 30-minute moderate-intensity sessions by week
5
• Aerobic exercise intensity: 60% to 80% of maximal heart rate reserve
• Description aerobic exercise mode: from Irwin 2008: The intervention consisted
primarily of walking, an activity preferred by most women and breast cancer survivors,
although participants could choose to meet the exercise goal through swimming,
aerobics, other forms of activity or a combination of different activities. Activities that
did not involve sustained aerobic effort, such as weight lifting and yoga, could be
performed but did not count toward the exercise goal for each week
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
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Compliance • Intervention uptake: 37/37
Adherence:
• Cadmus 2009: regarding the weekly goals of thrice-weekly supervised exercise
sessions at the health club and twice-weekly unsupervised sessions on their own, women
participated in 67% of the supervised exercise sessions, and 96% of women reported
exercising on their own two other days of the week and exercised on average at 76% of
their maximal heart rate (82% as a mean over both supervised and unsupervised)
• Irwin 2008: 33% reported 150 minutes/week of aerobic exercise at an average of
76% HR over the six-month intervention. Women randomly assigned to exercise chose
weight-bearing activities most often, with 82% walking. Few women reported doing
resistance training (3%). 75% of women were doing between 90 and 119 minutes of
moderate-intensity exercise per week, over six months
• Latka 2009: the variables that predict adherence were BMI and trans theoretical
model stage of change. Specifically, a lower BMI and a higher degree of readiness to
change physical activity behaviour were associated with better adherence
• Attrition: one participant lost to follow-up in the intervention group, five lost to
follow-up in the control group. 97% completed final follow-up in the intervention
group
• Adverse effects: five of the 37 women randomly assigned to exercise experienced
an adverse effect; two were related to the study (plantar fascitis), and three were
unrelated (swollen Achilles, stress fracture in foot and plantar fasciitis) to the study. No
women developed lymphoedema during the study
• Achieves Rock et al guidelines: 33% reported 150 minutes/week of moderate
intensity aerobic exercise at an average of 76% HR for six months
Description of usual care Unclear
Notes Only YES study included in the review because of the requirement that participants
must be sedentary at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A computer programme randomly assigned
each YES study participant with equal
probability to the exercise group or the
usual care group
Allocation concealment (selection bias) Low risk The randomisation code for each partici-
pant was obtained by the principal inves-
tigator (who was not involved in recruit-
ment or data collection) only after baseline
measures for that individual had been com-
pleted and staff conducting clinic visits did
not have access to the randomisation pro-
gramme
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Analyses were conducted according to the
intention-to-treat principle. Baseline QOL
values were carried forward for the five IM-
PACT study participants (three exercisers
and two controls) and 10 YES study par-
ticipants (five exercisers and five controls)
for whom six-month data were unavailable
Selective reporting (reporting bias) Low risk None, all outcomes reported
Other bias Low risk None
Campbell 2017
Methods • Study design: RCT individual participant level randomisation
• Study location: Vancouver, BC, Canada
• Funding source: Canadian Breast Cancer Foundation BC/Yukon.
• Inclusion criteria: all participants were ≥3 months and up to 3 years post
adjuvant treatment, physically able to undertake an exercise programme,
postmenopausal (natural or chemotherapy induced) at time of enrolment, and
receiving antihormonal treatment (i.e. aromatase inhibitor).
• Exclusion criteria: > 90 minutes/week of self-reported moderate-vigorous physical
activity (last 6 months); mini-mental status examination < 23; comorbid conditions
that could alter cognitive testing results, such as a psychiatric conditions, history of
substance use disorder, or other neurological disorder (i.e., head injury, epilepsy, and
neurodegenerative disease); and deemed unsafe for magnetic resonance imaging (MRI).
• CONSORT diagram included: yes
• Study recruitment rate:19/86
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 24 weeks.
Participants • Primary cancer diagnosis: stages I to IIIA breast cancer
• Current cancer treatment: following chemotherapy
• Metastatic disease: unclear
• Age, years, mean (SD): intervention = 53.2 (7.0), control = 51.4 (5.1)
• Gender: female
• BMI: intervention = 26.1 (5.5), control = 26.3 (5.7)
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 10), control (n = 9)
• Group or individual intervention: unclear
• Setting: research gym plus home-based
• Exercise prescription components: aerobic
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• Theoretical basis: none
• CALO-RE taxonomy components: programme set goal, #9
• Frequency of contact with researcher or exercise professional: two study visits at
baseline and at 24 weeks with trained study staff. 2 x 24 sessions per week were
supervised - unclear by whom.
• Frequency of contact with healthcare professional: 15 were referred by their
oncologists
• Instructions to controls: participants randomised to CON were asked to maintain
usual lifestyle and offered a 12-week exercise programme upon study completion.
Outcomes • Change in fitness reported: aerobic exercise tolerance using VO2 peak.
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: heart rate reserve, American College of
Sports Medicine metabolic equation for treadmill walking
• Aerobic exercise frequency: supervised- twice per week and unsupervised - twice
per week.
• Aerobic exercise duration: 30 to 45 minutes duration per session, 150 minutes per
week of moderate-vigorous aerobic exercise for 24 weeks.
• Aerobic exercise intensity: the prescription began at 60% of HRR for 20 minutes,
with a weekly increase in duration toward 45 minutes by week 6, followed by a weekly
increase in intensity toward 80% HRR by week 12.
• Description aerobic exercise mode: independent walking or exercises of
participants choice at home. Supervised sessions - treadmill walking.
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 19/19
• Adherence: participants attended 88% of supervised gym sessions (mean 1.8
sessions/ week and 87.5 minutes/week), and participants met 82% of the prescribed
exercise targets (mean intensity 74.5% HRR). Home session completion was 87%
(mean 2.4 sessions/week and 101.5 minutes/week), and participants met 87% of the
prescribed exercise targets (mean intensity 73.5% HRR).
• Attrition: 100%
• Adverse effects: none reported
• Achieves Rock et al guidelines: yes, 150 minutes of exercise per week.
Description of usual care Participants randomised to the control were asked to maintain usual lifestyle and offered
a 12-week exercise programme upon study completion
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Following completion of baseline mea-
sures, eligible participantswere randomised
using permutated blocks of 4 to 6 in a 1:
1 ratio to the aerobic exercise intervention
group or delayed exercise control
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk All data completed
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Low study recruitment rate
Cantarero-Villanueva 2012b
Methods • Study design: RCT individual participant level randomisation
• Study location: Granada, Spain
• Funding source: this study was funded by a research project grant (FISPI10/
02749) from the Health Institute Carlos III and PNI+D+I 2008-2011, Madrid,
Spanish Government, and from a grant of Andalusian Health Service, Junta de
Andalucia.
• Inclusion criteria: participants were eligible if they: 1) had a diagnosis of breast
cancer (stages I-IIIA); 2) had received a simple mastectomy or quadrantectomy with
posterior breast reconstruction; 3) between 25 and 65 years; 4) finished their co-
adjuvant treatment, except hormone therapy, at least 3 months before beginning the
study; 5) not having an active cancer; and, 6) having neck and shoulder pain that
began after the breast cancer surgery assessed with a visual analogue scale (VAS) (0-
100). Neck pain was defined as pain from the occipital to C7 vertebra, not including
the shoulder region, whereas shoulder axillary pain was defined as pain experienced in
the shoulder and/or the axillary region, not including the cervical spine.
• Exclusion criteria: participants were excluded if they: 1) were receiving
chemotherapy or radiotherapy at the time of the study; 2) suffer from an orthopaedic
disease that limit to follow the water programme; 3) had uncontrolled hypertension
(diastolic pressure >95 mm Hg); 4) had presence of lymphoedema; 5) had recurrent
cancer; or 6) had previous diagnosis of fibromyalgia.
• CONSORT diagram included: yes
• Study recruitment rate: 66/70
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 8 weeks.
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Participants • Primary cancer diagnosis: bBreast cancer
• Current cancer treatment: none
• Metastatic disease: unclear
• Age, years, mean (SD): intervention = 48 (8), control = 47 (9)
• Gender: female
• BMI: unclear
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 33), control (n = 33)
• Group or individual intervention: group
• Setting: a deep-water pool frequently used for swimming (water temperature: 28-
31°C; depth: 1.40 m in the lowest part and 1.80 m in the deepest part).
• Exercise prescription components: aerobic
• Theoretical basis: none
• CALO-RE taxonomy components: programme set goal, #9
• Frequency of contact with researcher or exercise professional: initial telephone
contact for recruitment with study researchers. Following that they attending the
exercise sessions three per week for eight weeks, supervised by two physical therapists.
• Frequency of contact with healthcare professional: after inclusion criteria was met,
they had a medical visit. Oncologist recommended a healthy lifestyle to patients as part
of usual care.
• Instructions to controls: participants followed usual care recommendations by an
oncologist in relation to a healthy lifestyle. Breast cancer survivors received a document
printable dossier from the oncologist where they found recommendations related to
nutrition, lifestyle behaviours, and exercise. A follow-up of the physical activity during
the control period was used to control bias detected in previous studies with exercise in
cancer survivors [35,36]. For that purpose, we used the Spanish version of the
Minnesota Leisure Time Physical Activity Questionnaire [37]. Control group were
offered the intervention after the 8 weeks.
Outcomes • Change in fitness reported: unclear
• Free-living energy expenditure: assessed by the leisure time physical activity
questionnaire.
Process measures • Method of measuring exercise behaviour: Minnesota Leisure Time Physical
Actiivty Questionnaire, adherence to exercise programme and the Borg scale
• Aerobic exercise frequency: three sessions per week for eight weeks.
• Aerobic exercise duration: 60 minutes per session.
• Aerobic exercise intensity: the intensity of the training was established following
the recommendations of the American College of Sports Medicine and American Heart
Association. Participants used the “Borg Rating of Perceived Exertion Scale” for rating
their fatigue during the exercise. Progression in the aerobic training was performed
throughout the 8 weeks by gradually increasing the intensity and the duration.
• Description aerobic exercise mode: swimming with use of pool noodles and
swimming belts.
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
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• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 33
• Adherence: a checklist of all sessions was completed by the participants to
determine adherence to the water exercise programme. One participant in the WATER
programme dropped out due to a recurrence of breast cancer during the programme.
All participants within the WATER group completed more than 85% of the 24 water
exercise sessions, showing a high adherence rate to the programme. Three women
reported a transient increase of oedema, and four women noted an increase in fatigue
immediately after the beginning of the first session, which improved in the next few
days. These women did not dropout of the study.
• Attrition: 3% drop out
• Adverse effects: one participant in the WATER programme dropped out due to a
recurrence of breast cancer during the programme. All participants within the WATER
group completed more than 85% of the 24 water exercise sessions, showing a high
adherence rate to the programme. Three women reported a transient increase of
oedema, and four women noted an increase in fatigue immediately after the beginning
of the first session, which improved in the next few days. These women did not
dropout of the study. No other adverse effects were reported.
• Achieves Rock et al guidelines: yes, aims to achieve 180 minutes of aerobic
exercise per week.
Description of usual care Participants followed usual care recommendations by an oncologist in relation to a
healthy lifestyle. Breast cancer survivors received a document printable dossier from the
oncologist where they found recommendations related to nutrition, lifestyle behaviours,
and exercise. A follow-up of the physical activity during the control period was used
to control bias detected in previous studies with exercise in cancer survivors [35,36].
For that purpose, we used the Spanish version of the Minnesota Leisure Time Physical
Activity Questionnaire [37]. Control group were offered the intervention after the 8
weeks
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A randomised, controlled clinical study
was conducted. Eligible participants who
agreed to participate were randomly as-
signed into two groups: WATER group
who received the water exercise programme
or CONTROL group who received the
usual care treatment for breast cancer
Allocation concealment (selection bias) Low risk We allocated patients toWATER or CON-
TROL groups into two randomisation cy-
cles using a computer-generated numbers.
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The sequence was entered into numbered
opaque envelopes by an external member,
and they were opened after completion of
the baseline assessment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome measures were assessed 1 week
before and after the intervention by an in-
dividual blind to group assignment
Incomplete outcome data (attrition bias)
All outcomes
Low risk All outcome data completed
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk None
Cavalheri 2017
Methods • Study design: RCT individual participant level randomisation
• Study location: Perth, Australia
• Funding source: the study received funding from Sir Charles Gairdner Hospital
Research Advisory Committee (grant number: 2011/12/013).
• Inclusion criteria: measurements were collected in people 6-10 weeks after
lobectomy for non-small cell lung cancer (stages I-IIIA) or, for those who required
post-operative chemotherapy, 4-8 weeks after their last chemotherapy cycle.
Participants were recruited from outpatient clinics and referrals to the pulmonary
rehabilitation programs at two hospitals and a private thoracic surgery clinic.
• Exclusion criteria: Exclusion criteria comprised: presence of any comorbid
condition that could compromise safety during assessments; severe neuro
musculoskeletal limitations; participation in a program of supervised exercise training
in the last 3 months; and inability to understand spoken or written English.
• CONSORT diagram included: yes
• Study recruitment rate: 17/50
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 8 weeks.
Participants • Primary cancer diagnosis: non-small cell lung cancer
• Current cancer treatment: measurements were collected in people 6-10 weeks
after lobectomy for NSCLC (stages I-IIIA) or, for those who required post-operative
chemotherapy, 4-8 weeks after their last chemotherapy cycle.
• Metastatic disease: unclear
• Age, years, mean (SD): intervention = 66 (10), control = 68 (9)
• Gender: female
• BMI: intervention = 25 (5), control = 27(6)
• Ethnicity: unclear
• Comorbidities reported: unclear
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Interventions • Sample size: intervention (n = 9), control (n = 8)
• Group or individual intervention: individual
• Setting: two hospital gyms
• Exercise prescription components: aerobic and resistance exercise
• Theoretical basis: none
• CALO-RE taxonomy components:programme set goal, #9
• Frequency of contact with researcher or exercise professional: three weekly
sessions for eight weeks ran by senior physical therapists. Three assessment points by an
independent researcher at baseline, post baseline and 8 weeks.
• Frequency of contact with healthcare professional: patients were recruited from
outpatient clinics but it is unclear by whom.
• Instructions to controls: participants in the control group were instructed to
continue to perform their usual activities during the period of the study. They received
weekly phone calls from a research assistant, which consisted of general conversation as
well as standardised questions about their health and well-being. These phone calls
allowed the investigators to maintain contact with those in the control group and
optimise their retention in the study and also served to minimise bias resulting from
differences in attention provided by the investigators to the participants during the
intervention period.
Outcomes • Change in fitness reported: aerobic exercise tolerance was measured using VO2
peak and the six-minute walk test.
• Free-living energy expenditure: yes, this was assessed using a step watch activity
monitor.
Process measures • Method of measuring exercise behaviour: activity monitors and adherence to
exercise protocol.
• Aerobic exercise frequency: three times a week for eight weeks.
• Aerobic exercise duration: 60 minutes per session.
• Aerobic exercise intensity: for treadmill walking, the initial average speed was set
at 70% of the average 6MWT speed. Average walking speed was increased if the
participant was able to walk for 20 minutes continuously providing symptoms and O2
were within acceptable limits (≥ 88%). Cycling consisted of 10 minutes of endurance
training (initial work rate was set at 60% of the max achieved during the CPET) and
two periods of 2 minutes of power training (initial work rate was set at 80% of the max
achieved during the CPET performed at the baseline assessment).
• Description aerobic exercise mode: walking or cycling
• Resistance exercise frequency: three times a week for eight weeks.
• Resistance exercise sets: two sets for lower limbs and three sets for upper limb
training
• Resistance exercise repetitions: 10 repetitions
• Resistance exercise intensity: lower limbs -In the last session, the number of step
ups performed was 69 ± 46% greater than in the first session (P = 0.004). Upper limbs
In the last session, the product of weights lifted, number of sets and number of
repetitions during the biceps brachii muscle training was 53 ± 52% greater than in the
first session (P = 0.02). There was no difference in the product of weights lifted,
number of sets and number of repetitions during the deltoid muscle training (P = 0.08)
• Description of resistance exercise: Step ups with parallel bars, hand weights for
elbow flexion and shoulder abduction.
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Compliance • Intervention uptake: 9
• Adherence: Adherence to exercise training was defined as a completion rate of ≥
60% of training sessions (i.e., ≥15 training sessions) and reported by the senior
physical therapists to the investigators. Of the nine participants randomised to the EG,
four (44%) adhered to exercise training by completing 15 or more training sessions (i.
e.,≥60%).
• Attrition: unclear
• Adverse effects: one participant completed four sessions and another completed
six sessions. Both stopped training as they felt unwell. They completed some of the
post-intervention assessments and were later diagnosed with a primary cancer other
than lung cancer.
• Achieves Rock et al guidelines: yes; six weeks of resistance exercise training.
Description of usual care Participants in the control group were instructed to continue to perform their usual
activities during the period of the study. They received weekly phone calls from a research
assistant, which consisted of general conversation as well as standardised questions about
their health and well-being. These phone calls allowed the investigators to maintain
contact with those in the control group and optimise their retention in the study and
also served to minimise bias resulting from differences in attention provided by the
investigators to the participants during the intervention period
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The randomisation sequence was gener-
ated and man-aged by an independent re-
searcher using a computer
Allocation concealment (selection bias) Low risk concealed using sequentially-numbered
opaque envelopes. The sequence was strat-
ified according to the hospital from which
the participant was recruited and for the
use (or not) of adjuvant chemotherapy
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The primary investigator, who was respon-
sible for the baseline and post-interven-
tion period assessments, was not aware of
whether a participant had been allocated
control or intervention
Incomplete outcome data (attrition bias)
All outcomes
High risk Missing patient data in both arms with rea-
sons not given
Selective reporting (reporting bias) Low risk All outcomes reported.
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Other bias High risk Poor adherence rates (44%)
Daley 2007a
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Sheffield, UK (high)
• Funding source: supported by Grant No. CE8304 from Cancer Research UK
• Inclusion criteria: women who were not regularly active (up to 2 × 20-minute
sessions a week at moderate intensity (researcher had to gauge with client whether it
was moderate intensity
fairly light to somewhat hard) RPE 11 to 13 were used); exercise ’pre-contemplators’,
’contemplators’ or ’prepares’ as defined by the trans theoretical model, who had been
treated for localised breast cancer 12 to 36 months previously, were eligible
• Exclusion criteria: women with metastases and inoperable or active locoregional
disease were ineligible (clinician determined)
• CONSORT diagram included: yes
• Study recruitment rate: 108/273
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 24 weeks
Participants • Primary cancer diagnosis: breast cancer survivors without metastases (inoperable
or active locoregional disease) were ineligible
• Current cancer treatment: 73.5%, 69.4% and 76.3% using hormone therapy in
the intervention, placebo and usual care groups, respectively
• Metastatic disease: none
• Age, years, mean (SD): 51.6 (8.8); 50.6 (8.7); 51.1 (8.6) (intervention; sham;
control, respectively)
• Gender: women
• BMI: mean (SD): 28.5 (4.4); 27.6 (4.1); 29.6 (5.1) (intervention; sham; control,
respectively)
• Ethnicity: two of 108 non-white
• Comorbidities reported: 45/108 had lymphoedema
Interventions • Sample size: intervention (n = 34), sham (n = 36) control (n = 38)
• Group or individual intervention: one-to-one supervised sessions
• Setting: university rehabilitation suite
• Exercise prescription components: aerobic
• Theoretical basis: trans theoretical model
• CALO-RE taxonomy components: #1, #5, #8, #9, #10, #13, #16, #17, #18, #20,
#21, #23, #26, #29, #35
• Frequency of contact with researchers or exercise professionals: every exercise
session was supervised
• Instructions to controls: the usual-care group continued with their lives as usual.
the exercise-placebo group attended 24 one-to-one 50-minute sessions during 8 weeks;
however, instead of aerobic exercise, they performed light-intensity body conditioning/
stretching (e.g. flexibility, passive stretching) exercises, during which HR was
maintained below 40% heart rate reserve (HR typically was kept below 100 beats per
minute). No exercise counselling or behavioural change advice was provided; instead,
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conversations were entered on topics of everyday life (i.e. weather, news items, and
families). HR and RPE were assessed every 5 minutes
Outcomes • Change in fitness reported: aerobic exercise tolerance was measured using the
submaximal, 8-minute, single-stage walking test performed on a treadmill
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: adherence was calculated from session
attendance, and the amount (duration, RPE, HR) of exercise achieved by participants
during sessions was calculated by abstraction from physical activity logs maintained by
the researcher
• Aerobic exercise frequency: three sessions per week
• Aerobic exercise duration: 27 minutes of exercise on average per session
• Aerobic exercise intensity: 65% to 85% of age-adjusted HR maximum and RPE
of 12 to 13
• Description aerobic exercise mode: treadmills, rowing ergometers and cycling
ergometers
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 34/34
• Adherence: adherence to the interventions was excellent; 77% of exercise therapy
and 88.9% of exercise-placebo groups, respectively, attended 70% (at least 17 of 24
sessions) or more of sessions. Mean HR for the exercise therapy group ranged from 117.
4 (SD, 12.9) to 121.5 (SD, 13.4) throughout the weeks. Mean HR for exercise-placebo
ranged from 92.5 (SD, 13.2) to 95.9 (SD, 9.5). Average durations of aerobic exercise
achieved by exercise therapy ranged from 25.7 (SD, 6.3) to 27.4 (SD, 6.2) minutes.
HR data indicated that both groups were exercising in accordance with the protocol
• Attrition: at 8 weeks, 1 ,0 and 5 women were lost to follow-up in the
intervention, sham and control groups, respectively. At 24 weeks, 3, 2 and 7 women
were lost to follow-up in the intervention, sham and control groups, respectively
• Adverse effects: three withdrawals in the intervention group: unclear as to why
this occurred. Some withdrawals due to medical complications in placebo and control
arms, but unclear if study related
• Achieves Rock et al guidelines: no
Description of usual care All participants continue to receive usual care from their health team
Notes Mean and SD data for aerobic exercise tolerance at 8 and 24 weeks provided by authors
in response to email request
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk A telephone randomisation servicewas pro-
vided by an independent studies unit. Ran-
domisation to the three treatment arms was
done on a 1:1:1 ratio and was performed
using stratified random permuted blocks
(with block size of six). Stratification factors
were chemotherapy (yes/no) and tamoxifen
(yes/no)
Allocation concealment (selection bias) Low risk Randomisation service was provided by an
independent studies unit telephone service
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcome assessors were not blinded to par-
ticipants’ group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Little’s D test indicated that missing data
were missing completely at random (2 88.
2; df 1290; P = 0.99). Data were analysed
on an intention-to-treat basis
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None
Drouin 2005
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): USA, Michigan (high)
• Funding source: this study was funded by grants from the Elsa U. Pardee
Foundation in Midland, Michigan, and the Max and Victoria Dreyfus Foundation in
White Plains, New York
• Inclusion criteria: sedentary females (less than 30 minutes of moderate intensity
exercise three times per week), between 20 and 65 years of age, with histologically-
established Stage 0 (ductal carcinoma in situ) to III breast cancer, with medical
clearance and signed informed consent
• Exclusion criteria: uncontrolled cardiac or hypertensive disease, orthopaedic
conditions that would limit exercise participation, refusal to accept randomisation or
participation in aerobic exercise within three months before the start of the study.
Medical clearance for this study was determined by the participant’s oncologist, the
results of a routine Multiple Uptake Gated Scan (MUGA) of heart function and a
symptom limited graded exercise test
• CONSORT diagram included: no
• Study recruitment rate: 23/39
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 8 weeks
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Participants • Primary cancer diagnosis: stage 0 (ductal carcinoma in situ) to III breast cancer
• Current cancer treatment: each participant was undergoing external beam
radiation five days per week for seven weeks. The affected breast and regional lymph
nodes received a 4500 to 5000 cGy dose in 200 cGy fractions with a boost of 1000 to
1600 cGy delivered to the primary tumour bed. Treatment dosages were similar
between groups
• Metastatic disease: no
• Age, years: mean (SD): intervention: 49.4 (7.0), controls: 51.9 (10.0)
• Sex: women
• BMI: unclear
• Ethnicity: 13 African American, 8 Caucasian
• Comorbidities reported: not clear
Interventions • Sample size: intervention (n = 13), control (n = 8)
• Group or individual intervention: unsupervised
members of the aerobic exercise group were instructed to perform self-monitored
walking in their neighbourhood or on a treadmill in their home
• Setting: home-based
• Exercise prescription components: aerobic
• Theoretical basis: not stated
• CALO-RE taxonomy components: #16, #17, #21, #26
• Frequency of contact with researchers or exercise professionals: weekly phone calls
with researcher
• Instructions to controls:participants in the placebo stretching group were
instructed to perform a general stretching protocol three to five days per week during
this same period. However, the control group was told not to begin any new exercise
activity other than a general flexibility programme that they were given
Outcomes • Change in fitness reported: VO2 peak assessed before and after intervention
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: all participants were provided a training
diary to record their training adherence in days per week and minutes per day;
members of the intervention group also recorded their training heart rate range. The
principal investigator communicated with all participants weekly in person or by
telephone. Participants in the intervention group wore heart rate monitors to record
training time and time spent in the training heart rate range to improve reporting of
data on exercise compliance, training intensity and training duration
• Aerobic exercise frequency: three to five times per week
• Aerobic exercise duration: 20 to 45 minutes
• Aerobic exercise intensity: exercise intensity was 50% to 70% of the maximal
heart rate achieved by the participant during a symptom limited graded exercise test
• Description aerobic exercise mode: self-monitored walking in the neighbourhood
or on a treadmill in the home
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
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• Description of resistance exercise: N/A
Compliance • Intervention uptake: 13/13
• Adherence: participants in the intervention group averaged 3.6 days per week of
aerobic exercise over an 8-week period, and placebo stretching subjects averaged 3.9
days per week of participation during this same time period. No details are available on
what ’participation’ for the placebo stretching group constituted
• Attrition: two women were lost to follow-up in the placebo stretching arm. Data
from one participant in the placebo stretching group were eliminated from the final
analysis because of marked irregularities in pretest and post-test physical measures from
moderate to severe fluid retention during the initial test session
• Adverse effects: none reported
• Achieves Rock et al guidelines: unclear
Description of usual care Each participant was treated with external beam radiation five days per week for seven
weeks. The affected breast and regional lymph nodes received a 4500 to 5000 cGy dose
in 200c Gy fractions with a boost of 1000 to 1600 cGy delivered to the primary tumour
bed. Treatment dosages were similar between groups
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A random number table was used
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2 of 23 participants lost to follow-up
Selective reporting (reporting bias) Low risk None
Other bias Low risk None
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Austrailia (high)
• Funding source: National Breast Cancer Foundation for funding Dr. Hayes’
fellowship
• Inclusion criteria: women younger than 76 years, who had completed treatment
for unilateral breast cancer at least six months before, subsequently had unilateral
upper limb lymphoedema diagnosed by a healthcare professional and were prepared to
travel to the exercise clinic for 12 weeks (if randomly allocated to the intervention
group (IG)) were eligible. All participants were doing < 90 minutes/week of moderate
intensity exercise (intensity was assessed by RPE)
• Exclusion criteria: no other exclusion criteria were applied
• CONSORT diagram included: no
• Study recruitment rate: 32/138
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 24 weeks
Participants • Primary cancer diagnosis: unilateral breast cancer
• Current cancer treatment: none
• Metastatic disease: no
• Age, years: mean (SD): control: 60 (11), intervention 59 (7)
• Sex: women
• BMI: unclear
• Ethnicity: unclear
• Comorbidities reported: all had lymphoedema
Interventions • Sample size: intervention (n = 16), control (n = 16)
• Group or individual intervention: a mix of supervised and non-supervised.
Supervised sessions were group based (up to 10 women)
◦ Weeks 1 to 4: three times per week (two supervised)
◦ Weeks 5 to 8: four times per week (two supervised)
◦ Weeks 9 to 12: at least four times per week (one supervised)
• Setting: unclear
• Exercise prescription components
◦ Weeks 1 to 2: aerobic only (floor-based aerobic exercise to music and
walking)
◦ Weeks 3 to 4: aerobic (floor-based aerobic exercise to music, water-based
aerobic exercise and walking) and water-based resistance exercises
◦ Weeks 5 to 8: aerobic (mix of all types) and water-based and free-weight
resistance exercises
◦ Weeks 9 to 12: aerobic (mix of all types) and machine-weight resistance
exercise
• Theoretical basis: not stated
• CALO-RE taxonomy components: #9, #26
• Frequency of contact with researchers or exercise professionals: 20 supervised
exercise sessions over 12 weeks
• Instructions to controls: the control group was instructed to continue habitual
activities
Outcomes • Change in fitness reported: none
• Free-living energy expenditure: unclear
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Process measures • Method of measuring exercise behaviour: together, exercise adherence rates and
qualitative comments were used to provide insight into the acceptability of the
programme
• Aerobic exercise frequency: three to four or more times per week
• Aerobic exercise duration: 20 to 45+ minutes
• Aerobic exercise intensity: 3 to 7 on a modified Borg scale
• Description aerobic exercise mode: floor-based aerobic exercise to music, water-
based aerobic exercise and walking
• Resistance exercise frequency: three to four or more times per week
• Resistance exercise sets: unclear
• Resistance exercise repetitions: 20 to 10
• Resistance exercise intensity: approximately 15 to 10 repetition max
• Description of resistance exercise: unclear
Compliance • Intervention uptake: 16/16
• Adherence: most women (88%) allocated to the intervention group participated
in 70% or more of scheduled supervised exercise sessions. The intervention was
scheduled over winter, and missed sessions were most often related to respiratory illness
(n = 10). Other reasons included having a skin lesion removed (n = 1), undergoing
gynaecological surgery (n = 1) and having work commitments (n = 2). One participant
missed 50% of supervised sessions. Unsupervised exercise adherence is unclear
Qualitative quotes:
• “Without having you to guide me, there is no way I would have ever done the
things I’ve done as part of this program”
• “You gave me the confidence to know what I and my arm can do”
• “I would not have tried the things I’ve done if not for the study. I now feel capable
of joining an aqua class”
• “You’ve shown me what I can do rather then tell me what I shouldn’t do”
• Attrition: one participant in each group at 24 weeks
• Adverse effects: none reported
• Achieves Rock et al guidelines: unclear
Description of usual care Physiotherapy, massage, compression, lymphatic drainage or laser therapy for lym-
phoedema
Notes Resistance aspect of this intervention will be excluded from analysis because of unclear
exercise metrics
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly allocated us-
ing a computer-generated table of random
numbers
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All measures were assessed pre-intervention
(time 1; T1), immediately postinterven-
tion (time 2; T2) and at 12-week follow-
up (time 3; T3) and were conducted by the
same assessor, who was blinded to partici-
pant group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants (n = 32) participated in T1
and T2, whereas data were unavailable for
two participants (one in the IG and one
in the CG) at T3. To ensure that missing
data did not contribute to the results found,
data analysis was repeated with these two
participants excluded, and no differences in
results were observed (data not shown)
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Adherence data on home-based aspect of
the intervention not clear
Irwin 2015
Methods • Study design: RCT individual participant level randomisation
• Study location: Yale and Connecticut
• Funding source: National Cancer Insitute
• Inclusion criteria: inclusion criteria required participating in less than 90 minutes/
week of physical activity in the past 6 months and no strength training in the past year.
Additionally, participants had to be experiencing at least mild arthralgias (as defined by
a score of 3 out of 10 on the worst pain item of the Brief Pain Inventory (BPI)) for at
least 2 months before enrolment.
• Exclusion criteria: see inclusion criteria.
• CONSORT diagram included: yes
• Study recruitment rate: 121/1016
• Length of follow-up: length of intervention = 12 months, length of follow-up
from baseline = 12 months.
Participants • Primary cancer diagnosis: breast cancer
• Current cancer treatment: chemotherapy, radiotherapy and none.
• Metastatic disease: unclear
• Age, years, mean (SD): intervention = 62.0 (7.0), control = 60.5 (7.0).
• Gender: female
• BMI: intervention = 30.0 (6.8), control = 28.7 (5.5)
• Ethnicity: intervention = 85% Non-Hispanic white, 2% Hispanic, 10% African
American, 2% Asian/Pacific Islander. Control = 84% Non-Hispanic white, 5%
Hispanic, 7% African American, 2% Asian/Pacific Islander, 2% American Indian.
• Comorbidities reported: unclear
68Interventions for promoting habitual exercise in people living with and beyond cancer (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Irwin 2015 (Continued)
Interventions • Sample size: intervention (n = 61), control (n = 60)
• Group or individual intervention: individual
• Setting: local health club and home-based.
• Exercise prescription components: aerobic and resistance.
• Theoretical basis: none
• CALO-RE taxonomy components: programme set goal, #9
• Frequency of contact with researcher or exercise professional:
• Frequency of contact with healthcare professional: twice-weekly supervised
resistance training programme, supervised by a certified cancer exercise trainer.
Assessments were carried out at baseline, 6 months and 12 months
• Instructions to controls: women in the usual care group were instructed to
continue with their usual activities. Participants in both groups were provided with a
breast cancer specific educational booklet developed for the HOPE study, which
discussed topics such as lymphoedema and fatigue. This booklet was individually
discussed during the exercise training for the exercise group and in a monthly phone
call for the usual care group.
Outcomes • Change in fitness reported: cardiorespiratory fitness was measured at baseline and
at 12 months with a standard maximal oxygen consumption (VO2 max) treadmill test.
• Free-living energy expenditure: measured using a physical activity questionnaire.
Process measures • Method of measuring exercise behaviour: heart rate monitors, exercise log books
and adherence to exercise programme
• Aerobic exercise frequency: twice weekly
• Aerobic exercise duration: 150 minutes per week.
• Aerobic exercise intensity: 50% HRMax and increased to 60-80% HRMax
• Description aerobic exercise mode: brisk walking, cycle ergometers and elliptical
trainers
• Resistance exercise frequency: twice weekly
• Resistance exercise sets: 3
• Resistance exercise repetitions: 8-12 reps
• Resistance exercise intensity: participants progressed up to three sets per exercise
over the first month. After two sessions during which a participant lifted the same
weight 12 times during each set, the weight was increased by the smallest possible
increment. One rep max was measured at baseline and 12 months.
• Description of resistance exercise: lower and upper body, leg press, leg extension,
leg curl, bench press and seated row. *from linked paper, Thomas 2017*
Compliance • Intervention uptake: 61
• Adherence: women randomly assigned to exercise also reported their exercise
prospectively in daily activity logs and reported an average 119 minutes per week of
aerobic exercise, with an average of 70% of strength-training sessions completed.
Women randomly assigned to exercise increased their physical activity by an average
159 minutes per week, compared with 49 minutes per week in the usual-care group.
Additionally, 53% of women adhered to monthly telephone calls.
• Attrition: 88.5% remained after 6 months, 69% at 12 months.
• Adverse effects: five participants had to discontinue the use of Atromatise
inhibitors
• Achieves Rock et al guidelines: yes, six weeks of resistance exercise.
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Description of usual care Women in the usual care group were instructed to continue with their usual activities.
Participants in both groups were provided with a breast cancer specific educational
booklet developed for the HOPE study, which discussed topics such as lymphoedema
and fatigue. This booklet was individually discussed during the exercise training for the
exercise group and in a monthly phone call for the usual care group
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were grouped according to
the intention-to-treat principle. Permuted
block randomisation (at 1:1 ratio)with ran-
dom block size was performed, stratified
by joint pain before AI therapy and cur-
rent bisphosphonate use (related to our sec-
ondary aim of bone mass)
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Balanced across both groups and intention
to treat applied to the analysis/
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk None.
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Greece (high)
• Funding source: unclear
• Inclusion criteria: participating only in the dancing exercising programme; none
of the participants had prior physical practise or experience in traditional Greek dances
or were participating in regular moderate intensity exercise. All participants had been
diagnosed and surgically treated for breast cancer. They had completed cancer
therapies, including surgery, radiotherapy and chemotherapy and had stopped all
medical treatments at least three months before the beginning of the study (mean time
post-treatment: 2.2 years)
• Exclusion criteria: included poorly controlled hypertension and any health
condition that would deter the participant from performing the exercises
• CONSORT diagram included: no
• Study recruitment rate: unclear
• Length of follow-up: length of intervention = 24 weeks, length of follow-up from
baseline = 24 weeks
Participants • Primary cancer diagnosis: all participants had been diagnosed and surgically
treated for breast cancer
• Current cancer treatment: participants had completed cancer therapies, including
surgery, radiotherapy and chemotherapy and had stopped all medical treatments at least
three months before the beginning of the study (mean time post-treatment: 2.2 years)
• Metastatic disease: unclear
• Age, years: mean (SD): intervention: 56.6 (4.2), control: 57.1 (4.1)
• Sex: women
• BMI: unclear
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 14), control (n = 13)
• Group or individual intervention: group
• Setting: supervised
• Exercise prescription components: aerobic training with Greek traditional dances,
upper body training and cool-down
• Theoretical basis: not stated
• CALO-RE taxonomy components: #9, #21, #22, #26
• Frequency of contact with researchers or exercise professionals: three supervised
exercise sessions per week
• Instructions to controls: asked to refrain from any form of recreational activity
during the study period
Outcomes • Change in fitness reported: aerobic exercise tolerance assessed by 6-minute walk
test
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: unclear
• Aerobic exercise frequency: three times per week
• Aerobic exercise duration: the aerobic training phase lasted 25 minutes and
included learning and practising Greek traditional dances
• Aerobic exercise intensity: all dances, practised throughout the intervention, were
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of moderate intensity (between 65% and 80% of maximum heart rate). Heart rate was
estimated by palpation by participants for four 15-second periods. Participants also
rated their perceived exertion on a Borg scale. They were encouraged to reach perceived
exertion 13 to 14 on the Borg 6 to 20 category scale. Intensity of exercise was
prescribed on an individual basis, and the workload was progressively increased
• Description aerobic exercise mode: Greek traditional dances
• Resistance exercise frequency: three times per week
• Resistance exercise sets: unclear
• Resistance exercise repetitions: unclear
• Resistance exercise intensity: unclear
• Description of resistance exercise: upper body exercise training and cool-down
lasted 25 minutes and emphasised stretching and resistance training with the use of
various resistance machines
Compliance • Intervention uptake: unclear
• Adherence: unclear
• Attrition: unclear
• Adverse effects: none reported
• Achieves Rock et al guidelines: unclear
Description of usual care Unclear
Notes Resistance aspect of this intervention will be excluded from analysis because of unclear
exercise metrics
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Method of measuring exercise behaviour
and adherence not reported
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): USA (high)
• Funding source: supported by an R01 grant from the National Institutes of
Health, National Institute of Nursing Research and a Postdoctoral Fellowship Award
from the Korea Science and Engineering Foundation KOSEF).
• Inclusion criteria: women newly diagnosed with breast cancer; no history of
cancer; all stages of breast cancer; age 40 years and above; and receiving cancer
treatment
• Exclusion criteria: women with known bony metastasis; high risk of fracture;
known psychiatric illness; uncontrolled cardiopulmonary or other serious medical
condition; and regular exercise at least two to three times a week of moderate intensity
(less than 90 minutes total) within the past two months
• CONSORT diagram included: no
• Study recruitment rate: unclear
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 24 weeks
Participants • Primary cancer diagnosis: women with newly diagnosed breast cancer were
stratified by the stage of breast cancer (Stages I to IIB vs locally advanced)
• Current cancer treatment: undergoing treatment
chemotherapy was the most common type of adjuvant therapy (48.8%), followed by
radiotherapy (34.1%) and a combination of chemotherapy and radiotherapy (17.1%)
• Metastatic disease: none
• Age, years: mean (SD): intervention: 51.3 (6.7), controls: 48.3 (8.8)
• Sex: women
• BMI: unclear; 33 women who had significantly higher BMI (34.3 ± 10.2)
excluded from analysis
• Ethnicity: 78% white reported
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 22), control (n = 19)
• Group or individual intervention: unclear
• Setting: cardiac rehabilitation unit with cardiac monitoring until participants
were released to be safe (for n = 2) and an exercise facility within the School of Nursing.
Although most participants continued their exercise intervention in this exercise
facility, a few opted to exercise at home on their own treadmill or to do fast walking
• Exercise prescription components: aerobic
• Theoretical basis: not stated
• CALO-RE taxonomy components: #1, #21, #26, #36
• Frequency of contact with researchers or exercise professionals: supervised exercise
sessions three times per week for the ’majority’
• Instructions to controls: Usual care participants were instructed to refrain from
starting a regular or structured exercise programme while participating in the study
Outcomes • Change in fitness reported: changes in VO2 peak at baseline at 8 weeks (although
it is not clear how VO2 was measured)
• Free-living energy expenditure: estimate of energy expenditure reported
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Process measures • Method of measuring exercise behaviour: frequency, intensity and duration of
exercise during the 8-week intervention period were monitored using Polar HR
monitors, which were provided to all participants. All participants in both groups
received a seven-day physical activity log to track their levels of exercise/physical
activity over 16 weeks after the eight-week intervention. The seven-day physical
activity log included five categories of the exercise/physical activity level, ranging from
vigorous to sleeping/reclining, with explicit examples given for each level, which made
monitoring feasible for participants. During 16 weeks of the postintervention follow-
up period, the exercise physiologist research member called participants regularly to
collect exercise/physical activity data from the log biweekly for participants in the
intervention group and monthly for participants in the control group. Participants in
the control group received less-frequent calls to minimise unintentional motivation or
a reminder for exercise, but data were recorded at 2-week intervals for both groups
• Aerobic exercise frequency: three days per week
• Aerobic exercise duration: 30 minutes of aerobic exercise and 5 minutes for warm-
up or cool-down
• Aerobic exercise intensity: moderate intensity to produce an HR corresponding to
60% to 70% of the individual’s HR reserve and/or VO2 peak achieved on a graded
exercise test at baseline
• Description aerobic exercise mode: cycling, walking, jogging or running on a
treadmill or track
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: not clear
• Adherence: average weekly frequency of exercise was 2.4 ± 0.6 sessions, and
average duration of exercise was 42.7 ± 8.0 minutes per session, including warm-up
and cool-down periods. Average duration of exercise within prescribed target HRs was
27.8 ± 8.1 minutes per session. Overall adherence to exercise intervention was 78.3% ±
20.1%, but week-to-week variations over the 8-week intervention period ranged from
68.3% at week 7 to 95.0% at week 3
• Attrition: of 74 women recruited, 11 women (6 control, 5 intervention) withdrew
from the study. Reasons for withdrawal included personal problems (n = 2), problems
at home (n = 2), problems related to chemotherapy (n = 3), thrombophlebitis in the
lower leg (n = 2), non
exercise-related injuries (n = 1) and death (n = 1). Twenty-two women (12 control
and 10 intervention) missed either a pre-intervention or a postintervention graded
exercise test (GXT), mainly because of scheduling conflicts, not keeping GXT
appointments more than twice or unwillingness to perform the GXT. Forty-one
women completed both pre-intervention and postintervention GXTs (i.e. 41/74)
• Adverse effects: see above
• Achieves Rock et al guidelines: no
Description of usual care Usual cancer care included general information on the benefits of exercise but did not
include specific instructions or further guidance for exercise. Seventy-eight per cent of
women had Stage I and Stage II breast cancer, and chemotherapy was the most common
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type of adjuvant therapy (48.8%), followed by radiotherapy (34.1%) and a combination
of chemotherapy and radiotherapy (17.1%). Regimens of adjuvant therapy most often
consisted of Adriamycin 60 mg/m2 and cytoxan 600 mg/m2 every 2 to 3 weeks for 3
doses with or without Taxol 145 mg/m2 every 2 to 3 weeks for 3 to 4 doses. Radiotherapy
was typically composed of delivering a total of 45 to 65Gy over 6 to 7 weeks with booster
doses of 20 Gy
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Data on only 41 of 74 randomly assigned
participants reported
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Women randomly assigned but excluded
had higher BMI and more advanced stages
of cancer
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Methods • Study design: RCT individual participant level randomisation
• Study location: Central Korea
• Funding source: no funding
• Inclusion criteria: participants were eligible to participate in this study if they met
the following criteria, with medical clearance from their oncologist: (1) diagnosed with
stage I ± III breast cancer, (2) 6 months after treatments with radio- and/or
chemotherapy subsequent to surgery, (3) absence of metastatic diseases and other
cancers, (4) < 60 minutes per week of physical activity including resistance exercise in
the past 6 months, (5) absence of cardiovascular and respiratory diseases, and (6) no
contraindicated medications and co morbidities that prohibit participation in a
moderate exercise programme.
• Exclusion criteria: history of chronic disease including diabetes, uncontrolled
hypertension or thyroid disease, Weight reduction >= 10% within past 6 months,
Metastatic disease, Participate in more than 60 minutes of exercise per week in the past
6 months, Cardiovascular, respiratory or musculoskeletal disease or joint problems that
preclude moderate physical activity
• CONSORT diagram included: yes
• Study recruitment rate: unclear
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 12 weeks.
Participants • Primary cancer diagnosis: breast cancer
• Current cancer treatment: none
• Metastatic disease: none
• Age, years, mean (SD): intervention = 56.0 (6.5), control = 49.3 (4.8)
• Gender: female
• BMI: intervention = 23.9 (2.7), control = 25.0 (4.7)
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 15), control (n = 15)
• Group or individual intervention: unclear
• Setting: unclear
• Exercise prescription components: aerobic and resistance
• Theoretical basis: none
• CALO-RE taxonomy components: programme set goal, #9
• Frequency of contact with researcher or exercise professional: baseline and follow-
up assessments by research staff. 180 minutes per week of supervision from (3 sessions)
exercise trainer
• Frequency of contact with healthcare professional: medical clearance from
oncologist before taking part in trial.
• Instructions to controls: instructed to maintain their routine physical activities
and not to participate any new exercise programmes during 12 weeks. After the final
assessments, they had the option of participation.
Outcomes • Change in fitness reported: unclear
• Free-living energy expenditure: unclear
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Process measures • Method of measuring exercise behaviour: adherence to exercise protocol and
health-related fitness tests.
• Aerobic exercise frequency: three supervised sessions per week
• Aerobic exercise duration: 20 minutes per session.
• Aerobic exercise intensity: RPE range 11-13, that was gradually increased at 4-
week intervals until reaching a rate of 13-15.
• Description aerobic exercise mode: step aerobics on 17 cm platforms for 20
minutes
• Resistance exercise frequency: three supervised sessions per week.
• Resistance exercise sets: 20 minutes per session.
• Resistance exercise repetitions: the strength training was designed to begin with
one set for the first two weeks, and the set number was increased every two weeks to
finally achieve three sets of each exercise performing 12
16 repetitions to volitional fatigue per set.
• Resistance exercise intensity: volitional fatigue per set. The exercise intensity and
the resistance of elastic band were progressively increased to maintain this range of
repetition.
• Description of resistance exercise: the strength training using body weight and
elastic bands consisting of shoulder press, black burn exercise, wall push-up, biceps
curl-up, plank exercise, leg bridge, squat, and calf raise for 20 minutes.
Compliance • Intervention uptake: 85.7%
• Adherence: two participants did not fulfil the required exercise
• Attrition: 7.23%
• Adverse effects: unclear
• Achieves Rock et al guidelines: yes, six weeks of resistance exercise training
Description of usual care Instructured to maintain their routine physical activities and not to participate any new
exercise programmes during 12 weeks. After the final assessments, they had the option
of participation
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Following baseline assessments, 30 partic-
ipants were randomly assigned to either
an exercise intervention group or a con-
trol groupusing a sealed, computer random
number generator with an allocation ratio
of 1 to 1
Allocation concealment (selection bias) Low risk Following baseline assessments, 30 partic-
ipants were randomly assigned to either
an exercise intervention group or a con-
trol groupusing a sealed, computer random
number generator with an allocation ratio
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of 1 to 1
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Four research staff members who were un-
aware of group assignment performed all
outcome assessments
Incomplete outcome data (attrition bias)
All outcomes
Low risk Dropouts similar in both groups and rea-
sons given. Reasons given for lack of inclu-
sion in final analysis
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias High risk Age differences between groups in base-
line demographics were present. Adherence
data is vague
McKenzie 2003
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Canada (high)
• Funding source: supported by the Canadian Breast Cancer Research Initiative
• Inclusion criteria: participants were eligible for the study if they had undergone
breast cancer treatment for Stage I or II breast cancer that had been completed more
than six months before enrolling in the study and had subsequently developed
unilateral lymphoedema that was greater than 2 cm and less than 8 cm on at least one
measurement point. Participants were not participating in > 90 minutes per week of
moderate intensity exercise
• Exclusion criteria: stage III lymphoedema, bilateral disease or cases for which
medication was required that might affect upper extremity swelling
• CONSORT diagram included: no
• Number of participants in each arm: 7 intervention, 7 control
• Study recruitment rate: unclear
• Length of follow-up: length of intervention = 8 weeks, length of follow-up from
baseline = 8 weeks
Participants • Primary cancer diagnosis: stage I or II breast cancer
• Current cancer treatment: all completed treatment six months before starting the
study
• Metastatic disease: no
• Age, years: mean (SD): intervention: 56.4 (10.4), control: 56.9 (8.2)
• Sex: women
• BMI: mean (SD): intervention: 29.1 (6.6), control: 25.6 (3.3)
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 7), control (n = 7)
• Group or individual intervention: unclear
• Setting: supervised
• Exercise prescription components: aerobic and resistance
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• Theoretical basis: not stated
• CALO-RE taxonomy components: #9, #26
• Frequency of contact with researchers or exercise professionals: supervised exercise
sessions three times per week
• Instructions to controls: Control participants were given no specific exercise
instruction until after they completed the study but were specifically asked to refrain
from initiating any new activity
Outcomes • Change in fitness reported: no
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: work in kilo joules was calculated for
each session for every participant, and this was used to calculate cumulative work done
over the course of the programme
• Aerobic exercise frequency: three days per week (initiated after week 2)
• Aerobic exercise duration: 5 to 20 minutes
• Aerobic exercise intensity: arm cycling at a resistance of 8.3 W to 25 W. Intensity
was also assessed with Polar HR monitors. Target HR was 60% to 80% of maximum
predicted by age
• Description aerobic exercise mode: arm cycling
• Resistance exercise frequency: three days per week
• Resistance exercise sets: two sets of 10 repetitions for each exercise were done for
the first week, three sets of 10 were done thereafter
• Resistance exercise repetitions: see above
• Resistance exercise intensity: unclear
• Description of resistance exercise: seated row, bench press, latissimus dorsi pull-
down, one arm bent-over rowing, triceps extension, and biceps curl
Compliance • Intervention uptake: unclear
• Adherence: unclear
• Attrition: no attrition reported
• Adverse effects: none reported
• Achieves Rock et al guidelines: no
Description of usual care Unclear
Notes Resistance aspect of this intervention will be excluded from analysis because of unclear
exercise metrics
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Adherence to prescribed exercise not re-
ported
Mohamady 2017
Methods • Study design: RCT individual participant level randomisation
• Study location: Cairo University
• Funding source: unclear
• Inclusion criteria: patients were selected to be enrolled into this study after they
had fulfilled the inclusion criteria of the study; female patients with breast cancer
undergoing chemotherapy, they were medically stable and not receiving Erythropoietin
therapy, their BMI ranged from 30 to 35, and they had an inactive lifestyle for at least
the previous 6 months.
• Exclusion criteria: BMI more than 35, age older than 70 or younger than 60
years. Patients who received erythropoietin treatments, suffered uncorrected visual
problems, had scars under their feet, and had a history of serious cerebrovascular or
cardiovascular diseases, or severe musculoskeletal problems restricting physical activity.
• CONSORT diagram included: no
• Study recruitment rate: unclear
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 12 weeks.
Participants • Primary cancer diagnosis: breast cancer
• Current cancer treatment: chemotherapy
• Metastatic disease: unclear
• Age, years, mean (SD): intervention = 54.6 (4.23), control = 58.25 (2.65)
• Gender: female
• BMI: intervention = 34.7 (3.44), control = 35.2 (3.36)
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 15), control (n = 15)
• Group or individual intervention: unclear
• Setting: lab
• Exercise prescription components: aerobic
• Theoretical basis: none
• CALO-RE taxonomy components: programme set goal, #9
• Frequency of contact with researcher or exercise professional: initial assessment
before baseline with oncologist. Assessments at baseline and 12 weeks. 3 times per week
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for 25 to 40 minutes at exercise sessions.
• Frequency of contact with healthcare professional: initial assessment before
baseline assessment with oncologist.
• Instructions to controls: the control group, who performed the usual daily living
activities in addition to administration of their medication and nutritional support.
Outcomes • Change in fitness reported: none reported
• Free-living energy expenditure: none reported
Process measures • Method of measuring exercise behaviour: heart rate monitor
• Aerobic exercise frequency: three sessions per week for 12 weeks
• Aerobic exercise duration: 3 25-40 minute sessions per week
• Aerobic exercise intensity: 50% to 70% Maximal HR. Aerobic exercise intensity
was determined using the Karvonen formula in which Target Heart Rate= [(max HR
resting HR) % intensity] + resting HR, where maximum heart rate = 220-age.
• Description aerobic exercise mode: treadmill
• Resistance exercise frequency: N/A
• Resistance exercise sets:N/A
• Resistance exercise repetitions:N/A
• Resistance exercise intensity:N/A
• Description of resistance exercise:N/A
Compliance • Intervention uptake: unclear
• Adherence: unclear
• Attrition: unclear
• Adverse effects: unclear
• Achieves Rock et al guidelines: unclear
Description of usual care The control group, who performed the usual daily living activities in addition to admin-
istration of their medication and nutritional support
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisationwas done via randomnum-
ber generator and opening opaque en-
velopes prepared by an independent indi-
vidual
Allocation concealment (selection bias) Low risk Randomisationwas done via randomnum-
ber generator and opening opaque en-
velopes prepared by an independent indi-
vidual
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Selective reporting (reporting bias) Low risk Reported on all outcomes.
Other bias High risk No adherence data.
Musanti 2012
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): New Jersey, USA (high)
• Funding source: supported by an award from the Greater NYC Affiliate of the
Susan G. Komen Breast Cancer Foundation, Inc., New York, NY
• Inclusion criteria: eligible survivors were English-speaking women diagnosed with
Stage I to IIIB breast cancer who had completed adjuvant chemotherapy at least three
months or radiation therapy at least 6 weeks before entry, and who were no more than
24 months beyond their last treatment. Hormonal therapy could be ongoing
• Exclusion criteria: women were excluded if medical history or physical
examination revealed evidence of anaemia (haemoglobin < 10 mg/dL), uncontrolled
hypertension, congestive heart failure, pulmonary disease, diabetes and thyroid or
musculoskeletal disease. Additional exclusion criteria included current enrolment in a
weight loss or exercise programme or a positive response to any question on the
Physical Activity Readiness Questionnaire, thus indicating the need for medical
clearance before starting an exercise programme
• CONSORT diagram included: no
• Study recruitment rate: 55/231
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 12 weeks
Participants • Primary cancer diagnosis: completed adjuvant chemotherapy at least three
months or radiation therapy at least six weeks before entry and were no more than 24
months beyond their last treatment
• Current cancer treatment: hormonal therapy could be ongoing: 56% on hormone
therapy
• Metastatic disease: none
• Age: overall mean (SD) = 50.5 (7.5)
• Sex: women
• BMI: unclear
• Ethnicity: unclear
• Comorbidities reported: unclear
Interventions • Sample size: flexibility group (n = 13), aerobic group (n = 12), resistance group (n
= 17), aerobic and resistance group (n = 13).
• Group or supervised intervention: individual
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• Setting: home-based
• Exercise prescription components: aerobic and resistance exercise
• Theoretical basis: exercise and self-esteem model
• CALO-RE taxonomy components: #9, #16, #17, #21, #22, #26
• Frequency of contact with researchers or exercise professionals: weekly contact via
phone or e-mail. Content included exercise programme adherence, the need for
progression of the exercise prescription and adverse effect reporting
• Instructions to controls: all participants were prescribed flexibility exercise. In-
person verbal instruction plus demonstration was used to teach participants how to do
their assigned exercises. In addition, each participant received a written guidebook that
included general information about exercise participation, such as clothing and safety
tips, as well as their individualised exercise prescription, exercise instructions and an
exercise log sheet
Outcomes • Change in fitness reported: prediction of VO2 max from submaximal treadmill
testing using the Bruce protocol; change in upper body weight lifted and endurance
reported
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: Adherence to the exercise prescription
was calculated as a proportion of completed sessions over the total possible number of
sessions in the assigned exercise programme. Mean percentage scores were as follows:
flexibility = 85, aerobic = 81, resistance = 91 and aerobic plus resistance = 86. Although
participants were encouraged to complete their exercise log, only 50% of participants
successfully did so
• Aerobic exercise frequency: three times per week. Women who participated in the
aerobic and resistance group followed instructions similar to those given to the aerobic
and resistance only groups; however, the frequency of aerobic exercise progressed to
four to five days per week, and resistance was maintained at two times per week
• Aerobic exercise duration: 15 to 30 minutes
• Aerobic exercise intensity: 40% to 65% of the calculated heart rate max
• Description aerobic exercise mode: walking
• Resistance exercise frequency: times per week. A+R group performed resistance
exercise twice per week
• Resistance exercise sets: one
• Resistance exercise repetitions: women started with one set of 10 to 12
repetitions. Progression through more resistive bands occurred so that RPE rose to
around seven to eight at the completion of 12 repetitions
• Resistance exercise intensity: women in the resistance group were prescribed a
Thera-Band that produced an RPE of 3 to 5 on a scale of 0 to 10. Progression through
more resistive bands occurred so that RPE rose to around seven to eight at the
completion of 12 repetitions
• Description of resistance exercise: Women started with one set of 10 to 12
repetitions of the following exercises: shoulder flexion, shoulder press, latissimus pull-
down, seated row, chest press, elbow press (triceps), elbow curl (biceps), hip flexion, hip
extension, abdominal crunches, leg press and squat
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Compliance • Intervention uptake: 13/13,12/12,17/17,13/13 for flexibility, aerobic, resistance
and combined groups, respectively
• Adherence: adherence to the exercise prescription was calculated as a proportion
of completed sessions over the total possible number of sessions in the assigned exercise
programme. Mean percentage scores were as follows: flexibility = 85, aerobic = 81,
resistance = 91 and aerobic plus resistance = 86. Although participants were
encouraged to complete their exercise log, only 50% successfully did so
• Attrition: 42/55. Forty-two women completed the study; however, five of these
women returned the survey data form but refused final fitness testing because of time
constraints related to work and family obligations. Thirteen women (24%) did not
complete their assigned 12-week programme. All dropped out by week 6, except one
woman, who developed appendicitis after the 12-week exercise programme but before
she could complete the postintervention testing. No post study assessments were
obtained from these women. The most frequently cited reason given for discontinuing
the exercise programme was perceived difficulty fitting the exercise into their lives
because of work and/or family responsibilities (seven women). One woman had her
breast reconstruction surgery rescheduled so that completion became impossible, one
did not give a reason, and one could not complete the initial fitness testing because of
an elevated HR. Two women cited the need for additional supervised exercise sessions
because they could not maintain motivation on their own
• Adverse effects: adverse effects were reported in two women during the study. In
both cases, the women developed tendonitis: one in the shoulder and the other in the
foot. Both had a history of tendonitis, and both received standard treatment (i.e. rest,
anti-inflammatory medication, and gentle movement). Both women resumed exercise
at a lesser intensity, progressed their exercise over time and completed the study
without further incident
• Achieves Rock et al guidelines: 12 weeks of resistance exercise at two or three
times per week. Aerobic prescription: unclear
Description of usual care Unclear
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation table
Allocation concealment (selection bias) Low risk Computer-generated randomisation table
maintained by office staff in the clinical re-
search office
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Physical fitness testing was performed at
a hospital-based fitness centre. The same
research assistant, blinded to participant
group allocation, performed thesemeasure-
ments at pre-intervention and postinter-
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vention measurement time points
Incomplete outcome data (attrition bias)
All outcomes
High risk Thirteen women (24%) did not complete
their assigned 12-week programme
Selective reporting (reporting bias) High risk Waist, upper and mid and lower arm cir-
cumference measures not reported
Other bias High risk • A significant number of the dropouts
belonged to the resistance exercise group
(n = 8/13). These women did not verbalise
any discontent with this specific modality
of exercise; their reasons for dropping out
were as previously described. Of note,
these women had significantly stronger
muscular endurance measurements than
were reported in the non-dropout group
• Second, significant differences were
noted in baseline levels of fatigue (P = 0.
003), with the dropout group perceiving a
greater level of fatigue. Baseline leisure
time activity was also markedly different.
Women in the completion group reported
a significantly greater weekly volume of
low to moderate physical activity. In the
dropout group, however, scores ranged
from 0 to 12, indicating very little general
activity
• Only 50% of activity logs were
returned
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Maryland, USA (high)
• Funding source: funded by the National Cancer Institute (CA R01-78801)
• Inclusion criteria: (a) English speaking, (b) between 21 and 75 years of age, (c)
sedentary lifestyle (i.e. exercise fewer than three times per week for greater than 30
minutes/session, at a moderate intensity, in last six months), (d) average or below
average fitness as determined by a graded exercise test (GXT) and (e) recent diagnosis
of breast cancer (Stage 0, I, II or IIIa)
• Exclusion criteria: (a) non
cancer-related contraindications to aerobic walking exercise (e.g. symptomatic
coronary artery disease, psychotic spectrum mental illness, orthopaedic problems), (b)
pre-existing metabolic disease (e.g. diabetes, uncontrolled hypertension) and (c) a
contraindication to exercise discovered on the exercise stress test
• CONSORT diagram included: no
• Study recruitment rate: 51/57
• Length of follow-up: length of intervention = 3 months, length of follow-up from
baseline = 3 months
Participants • Primary cancer diagnosis: breast cancer (Stage 0, I, II or IIIa)
• Current cancer treatment: most (52.9%) women had Stage I breast cancer and
underwent lumpectomy surgery (74.1%). Many (44.1%) women received both
radiation and chemotherapy, 26.5% received radiation only, 8.8% received
chemotherapy only and 20.6% received no adjuvant therapy
• Metastatic disease: none
• Age, years: overall mean (SD) = 50.8 (11.8)
• Sex: female
• BMI: overall mean (SD): 28.8 (6.1)
• Ethnicity: a large percentage of women were black (44.1%), and total ethnic
minority group membership was high (45.1%)
• Comorbidities reported: 23.5% of women had CESD depression scores above the
clinical cut-off
Interventions • Sample size: intervention (n = 51 in total), numbers randomly assigned to each
arm are unclear
• Group or supervised intervention: unclear
• Setting: supervised hospital-based and subsequently home-based intervention
• Exercise prescription components: aerobic and resistance
• Theoretical basis: trans theoretical model
• CALO-RE taxonomy components: #1, #5, #8, #9, #10, #12, #15, #16, #19, #20,
#21, #22, #23, #24, #25, #26, #29, #35
• Frequency of contact with researchers or exercise professionals: supervised exercise
sessions three times a week for 4 weeks during hospital phase. Thereafter, intervention
participants received weekly contact by telephone or electronic mail according to
participant preference
• Instructions to controls: women in the information control group received a 45-
minute session covering their fitness, strength and flexibility assessment results and an
informational brochure. The session specifically excluded discussion of strategies
addressing exercise barriers, and participants who asked about exercise were told to “do
the best you can”. To facilitate participant retention, the control group was contacted
once per month, and one week before follow-up assessment, they were given a
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pedometer for data collection purposes (Note: Pedometer data were not part of the
article)
Outcomes • Change in fitness reported: no
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: participants were provided with
monthly calendars to record their exercise activity and were contacted weekly by
telephone or electronic mail according to their preference. Godin Leisure Time
Exercise Questionnaire and the LTEQ self-report instrument surveys were also used
• Aerobic exercise frequency
◦ Hospital-based phase (first 4 weeks): three times per week
◦ Home-based phase: at least three days per week
• Aerobic exercise duration
◦ Hospital-based phase (first 4 weeks): 15 to 45 minutes
◦ Home-based phase: 30 minutes or longer
• Aerobic exercise intensity
◦ Hospital-based phase: 50% to 85% max HR
◦ Home-based phase: moderate intensity, RPE 11 to 16
• Description aerobic exercise mode: home or treadmill walking
• Resistance exercise frequency
◦ Hospital-based phase: three per week
◦ Home-based phase: participants were asked to continue resistance training
three times a week
• Resistance exercise sets
◦ Hospital-based phase: 1 to 2 sets
◦ Home-based phase: maintaining the same numbers of sets and repetitions
• Resistance exercise repetitions
◦ Hospital-based phase: 12 to 15
◦ Home-based phase: maintaining the same numbers of sets and repetitions
• Resistance exercise intensity
◦ Hospital-based phase: 12 repetitions at the lightest weight, and, as tolerated,
repetitions were increased to 15 after the first week. After a participant could perform
15 repetitions of an exercise, another set was added. Upper body exercises were
performed with a padded weight belt with interchangeable 1.0 lb bars used to adjust
the total weight up to a maximum of 20 lb. Participant body weight was used for lower
body exercises
◦ Home-based phase: maintain
• Description of resistance exercise: The resistance programme consisted of upper
body (biceps curl, triceps extension, chest fly, military press, upright row and shoulder
shrug) and lower body (leg squat and lunge) exercises
Compliance • Intervention uptake: unclear
• Adherence: women assigned to the structured intervention completed an average
of 83% of their scheduled hospital-based exercise sessions (mean = 9.9, SD = 3.3
sessions), and 76.9% completed all 12 sessions. LTEQ scores increased from baseline
by 157% (from M = 9.7, SD = 8.1 to M = 25.0, SD = 13.1) in the intervention group
and by 32.7% among the control group (fromM = 10.7, SD = 12.8 to M = 14.2, SD =
11.8). Home-based adherence is not clear
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• Attrition: unclear. No details on numbers randomly assigned to each arm. An
overall study completion figure of 80.4% is cited (i.e. participants completing follow-
up assessments)
• Adverse effects: unclear
• Achieves Rock et al guidelines: unclear
Description of usual care unclear
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were stratified by cancer stage
and were randomly assigned to groups
Allocation concealment (selection bias) Low risk Participant assignment to groups at enrol-
ment was concealed from the project direc-
tor
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Physicians monitoring graded exercise tests
were blinded to participant group assign-
ment. Similarly, a physical therapist or an
exercise physiologist, blinded to partici-
pant assignment, performed strength as-
sessments
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intent-to-treat analysis done and multiple
imputation used
Selective reporting (reporting bias) Low risk None
Other bias High risk Numbers randomly assigned to interven-
tion and control groups are unclear, as are
numbers completing in each arm
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Rhode Island, USA (High)
• Funding source: this study was supported by Grant RO3 MH55570 from the
National Institute of Mental Health to Dr Pinto
• Inclusion criteria: sedentary women (exercised fewer than three times per week for
20 minutes per session) who had been diagnosed with breast cancer (Stage 0, I or II)
over the past 3 years. Post-surgery patients who had completed chemotherapy or
radiation treatment were invited to participate in a 12-week exercise programme or a
wait-list control group (CG)
• Exclusion criteria: medical or current psychiatric illness that would make
compliance with the study protocol difficult or dangerous (e.g. coronary artery disease,
hypertension, diabetes), orthopaedic problems or neuropathies that would limit
exercise training. Medications that would alter training responses (e.g. beta blockers) or
affect distress outcomes (e.g. antidepressants) were also reasons for exclusion
• CONSORT diagram included: no
• Study recruitment rate: 24/53*
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 12 weeks
Participants • Primary cancer diagnosis: stage 0 to II breast cancer, postsurgery participants who
had completed chemotherapy or radiation treatment
• Current cancer treatment: none
• Metastatic disease: none
• Age, years: overall mean (SD): 52.5 (6.8)
• Gender: women
• BMI: overall mean (SD): 26.8 (4.1)
• Ethnicity: all white
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 12), waiting list control (n = 12)
• Group or supervised intervention: unclear
• Setting: supervised and home-based exercise
• Exercise prescription components: aerobic and resistance exercise (resistance
exercise was introduced only for last 4 weeks of the 12-week programme)
• Theoretical basis: none
• CALO-RE taxonomy components: programme set goal, #9, #15, #16, #21, #26
• Frequency of contact with researchers or exercise professionals: an exercise
physiologist monitored participants’ blood pressure and heart rate once a week before,
during and after exercise. Individual exercise prescriptions were updated before each
session. Unclear whether physiologist was present at each exercise session
• Instructions to controls: asked not to change their current level of physical activity
Outcomes • Change in fitness reported: aerobic exercise tolerance test performed but no
control group comparison data reported
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: attendance at supervised exercise
sessions. Individual exercise prescriptions were updated before each session
• Aerobic exercise frequency: three times per week
• Aerobic exercise duration: over the 12 weeks, the exercise session developed into
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10 minutes of warm-up (cardiovascular and flexibility), 10 minutes of cool-down
(cardiovascular and flexibility) and 30 minutes of cardiovascular activity within an
individual’s target heart rate zone
• Aerobic exercise intensity: 60% to 70% of peak heart rate by the end of the 12-
week intervention
• Description aerobic exercise mode: Cardiovascular activities included treadmill
walking, arm and leg ergometers, arm cycling, stationary cycling and rowing. To tailor
the programme for women who had undergone breast surgery and to improve upper
body endurance, investigators encouraged arm cycling and rowing during the sessions.
Participants used at least three modes of physical activity per session that would ensure
at least one cardiovascular arm activity
• Resistance exercise frequency: N/A less than 6 weeks
• Resistance exercise sets: N/A less than 6 weeks
• Resistance exercise repetitions: N/A less than 6 weeks.
• Resistance exercise intensity: N/A less than 6 weeks
• Description of resistance exercise: N/A less than 6 weeks
Compliance • Intervention uptake: unclear
Quote: “Three women discontinued participation within the first four weeks of the
12-week programme”
• Adherence: Of the 12 participants in the exercise group, three women
discontinued participation within the first four weeks of the 12-week programme
(reasons included child care responsibilities and inconvenience of travelling to the
hospital). These individuals provided questionnaire data at post assessments but did
not complete post-treatment exercise tolerance tests. The remaining participants
attended a mean of 88% of the 36-session exercise programme and completed the
exercise tolerance test and questionnaire assessments at post-treatment. Adherence rate
to the home-based component of the exercise prescription was unclear
• Attrition: nine participants were lost to follow-up (three in the exercise group, six
in the control group)
• Adverse effects: not reported; however, it is unclear why the six controls dropped
out
• Achieves Rock et al guidelines: unclear
Description of usual care Unclear
Notes *We estimated study recruitment rate on the basis of numbers randomly assigned of
those approached and eligible
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Exercise tolerance test performed but no
control group comparison data reported.
38% lost to follow-up
Selective reporting (reporting bias) High risk None of the physiological assessments were
performed for the control group at 12
weeks
Other bias High risk A statistically significant difference was
noted between groups for body esteem at
baseline (weight concerns and physical
condition sub scales)
Pinto 2005
Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Rhode Island, USA (high)
• Funding source: supported by National Cancer Institute Grant No. CA 75452
(BMP)
• Inclusion criteria: eligibility criteria included age 18 years; currently sedentary
(exercised one time per week for 20 minutes at vigorous intensity or two times per
week for 30 minutes at moderate intensity for the past six months)*; diagnosed with
Stage 0 to II breast cancer over the past 5 years; completed surgery, chemotherapy and/
or radiation; ambulatory (able to walk a mile without assistive devices); and willing to
be randomly assigned
• Exclusion criteria: participants were excluded if they had a prior history of cancer
(exception: non-melanoma skin cancer), or if they had a medical or current psychiatric
illness that could make compliance with the study protocol difficult or dangerous (e.g.
cardiovascular disease, diabetes, orthopaedic problems that limit exercise training)
• CONSORT diagram included: yes
• Study recruitment rate: 86/123
• Length of follow-up: 12 weeks of ’treatment’ with nine months of follow-up from
baseline
Participants • Primary cancer diagnosis: breast cancer Stage 0 to II
• Current cancer treatment: 49% of intervention group and 74% of control group
receiving hormone treatment
• Metastatic disease: none
• Age, years: mean (SD): intervention: 53.4 (9.1), control: 52.9 (10.4)
• Sex: women
• BMI: mean (SD): intervention: 27.5 (5.0), control: 28.6 (5.5)
• Ethnicity: 95% white
• Comorbidities reported: unclear
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Interventions • Sample size: intervention (n = 43), control (n = 43)
• Group or supervised intervention: individual
• Setting: home-based
• Exercise prescription components: aerobic
• Theoretical basis: trans theoretical model
• CALO-RE taxonomy components: #5, #8, #12, #16, #17, #19
• Frequency of contact with researchers or exercise professionals: after
randomisation, each intervention participant received in-person instructions on how to
exercise at a moderate-intensity level, how to monitor heart rate, and how to warm up
before exercise and cool down after exercise. Also, intervention participants received
weekly phone calls for 12 weeks, then calls every month for three months
• Instructions to controls: control participants were asked to refrain from changing
their current level of activity during the 12 weeks. They received a weekly phone call
from research staff for 12 weeks to match the frequency of contact with the intervention
group. These women received the same cancer survivorship tip sheets as the PA group
Outcomes • Change in fitness reported: aerobic exercise tolerance assessed by a timed one-mile
walk test
• Free-living energy expenditure: total weekly energy expenditure (kcal/kg/week)
calculated from the seven-day physical activity recall questionnaire
Process measures • Method of measuring exercise behaviour: seven-day physical activity recall
questionnaire and accelerometer data providing kcal/hour
• Aerobic exercise frequency: two to five days per week
• Aerobic exercise duration: 10 to 30 minutes
• Aerobic exercise intensity: The programme promoted moderate intensity activities
at 55% to 65% of maximum heart rate
• Description of aerobic exercise mode: brisk walking, biking, swimming or use of
home exercise equipment
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 43/43
• Adherence:
◦ Pinto 2005: 15 of 43 in the intervention group and 0 of 41 in the control
group accumulated at least 30 minutes of moderate intensity physical activity (e.g.,
walking briskly, heavy house work) on most, ideally all, days of the week as reported by
seven-day recall questionnaires. No changes were reported in accelerometer data in the
intervention group (change score = -0.33 kcal/hour).
◦ Pinto 2009: from heart rate data: At week 1, participants reported an average
of 43.12 minutes of exercise (SD 44.32) and at week 12, a mean of 128.53 minutes/
week of exercise (SD 76.82), at between 55% and 65% of predicted max heart rate.
However, less than 75% of the intervention group were meeting the prescribed goal
after week 4.
• Attrition: Four dropped out in the intervention arm and did not provide data at
92Interventions for promoting habitual exercise in people living with and beyond cancer (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pinto 2005 (Continued)
the post-treatment assessment. Reasons for dropout included no time (n = 1); could
not be contacted to determine reasons (n = 2); and participation terminated (n = 1)
(the study team terminated one woman’s participation because of symptoms of chest
pain during exercise and her refusal to have these symptoms evaluated by her physician)
• Adverse effects: not clear whether chest pain was related to exercise in dropout
whose participation was terminated
• Achieves Rock et al guidelines: no
Description of usual care Unclear
Notes *Data from baseline questionnaires indicated that two participants in the intervention
group were active at baseline (i.e. a discrepancy was noted between telephone screening
and assessment). However, the author has advised that outliers were removed during data
analysis of study outcomes. Author advised that accelerometer data should have been
reported as kcal/hour)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention-to-treat approach used and low
attrition reported (5%)
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias High risk Significantly more control group partici-
pants were receiving hormone treatment:
49% versus 74% in the intervention and
control groups, respectively (P = 0.015).
Objective accelerometer data do not sup-
port the self-reported physical activity be-
haviour
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Methods • Study design: RCT individual participant level randomisation
• Study location (WHO income taxonomy): Rhode Island, USA (high)
• Funding source: this study was funded by the National Cancer Institute (CA
101770 to Dr Pinto)
• Inclusion criteria: (i) men and women aged ≥ 18 years; (ii) completed primary
and adjuvant treatments for colon or rectal cancer (Stages I to III); (iii) ≤ 5 years since
treatment completion; (iv) able to read and speak English; (v) provided consent for
medical chart review; (vi) able to walk unassisted; (vii) sedentary, which was defined as
exercising < 60 minutes/week at moderate intensity PA or < 20 minutes/week of
vigorous intensity PA over the past six months; and (viii) had access to a telephone
• Exclusion criteria: patients with a prior history of cancer were excluded. Another
exclusion criterion was a medical or current psychiatric illness (e.g. orthopaedic
problems) that could make compliance with the study protocol difficult or unsafe.
Patients with cardiovascular disease and/or diabetes were included if their treating
physicians approved of their study participation
• CONSORT diagram included: yes
• Study recruitment rate: 46/66
• Length of follow-up: 12 weeks of counselling with 12 months of follow-up from
baseline
Participants • Primary cancer diagnosis: 57% colon cancer, 43% rectal cancer
• Current cancer treatment: none
• Metastatic disease: none
• Age, years: mean (SD): control: 55.6 (8.24), intervention: 59.5 (11.2)
• Gender: 56% female
• BMI: mean (SD): control: 29.4 (6.1), intervention: 27.9 (6.0)
• Ethnicity: 1 of 46 non white
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 20), control (n = 26)
• Group or supervised intervention: individual
• Setting: home-based and facilitated with phone calls
• Exercise prescription components: aerobic
• Theoretical basis: trans theoretical model, social cognitive theory
• CALO-RE taxonomy components: #5, #8, #9, #12, #16, #17, #19, #21, #23, #
24, #26
• Frequency of contact with researchers or exercise professionals: after an initial one-
to-one consultation, each participant received a weekly call over 12 weeks from research
staff to monitor physical activity participation, identify relevant health problems, solve
any barriers to physical activity and reinforce participants for their efforts
• Instructions to controls: were asked not to change their usual level of activity
Outcomes • Change in fitness reported: timed one-mile walk with estimation of VO2 peak
• Free-living energy expenditure: calories per week estimated from CHAMPS
questionnaire
Process measures • Method of measuring exercise behaviour: questionnaires
seven-day physical activity recall; community healthy activities model programme for
seniors (CHAMPS); stage of motivational readiness for physical activity. Accelerometer
data also collected
94Interventions for promoting habitual exercise in people living with and beyond cancer (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pinto 2011 (Continued)
• Aerobic exercise frequency: two to five times per week
• Aerobic exercise duration: 10 to 30 minutes
• Aerobic exercise intensity: the programme promoted moderate intensity aerobic
activities at 64% to 76% of estimated maximum heart rate
• Description aerobic exercise mode: Brisk walking, biking, or use of home exercise
equipment was recommended
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 20/20
• Adherence:
◦ Goal of 150 minutes/week of physical activity was met or exceeded by 64.
7% of the intervention group versus 40.9% of the control group at three months, by
38.9% of the intervention group versus 27.3% of the control group at six months and
by 31.6% of the intervention group versus 21.7% of the control group at 12 months
◦ Physical activity of moderate intensity (recorded using the three-day PAR
questionnaire) was compared with the corresponding accelerometer data over three
days. Spearman rank correlations were weak at baseline (r = 0.12) because of a high
proportion of sedentary participants. Correlation at the three-month follow-up showed
the only significant between-group change reported in exercise minutes: r = 0.32
• Attrition: 1/20 at three, six and 12 months in the intervention arm; 2/26 at three,
3/26 at six and 12 months in the control group
• Adverse effects: one cancer recurrence in the control group at three months
• Achieves Rock et al guidelines: self-report indicates that 64.7% of the
intervention group and 40.9% of the control group were achieving the guidelines.
However, accelerometer data are not provided to support this. Further, only a weak
correlation was reported between self-report and accelerometer data at three months
Description of usual care Unclear
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Allocation concealment (selection bias) Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information to permit a ’low’
or ’high’ risk judgement
95Interventions for promoting habitual exercise in people living with and beyond cancer (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pinto 2011 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk < 10% attrition reported
Selective reporting (reporting bias) High risk Accelerometer data not reported
Other bias High risk Accelerometer correlation with self-re-
port questionnaires is weak at follow-up
points when significant differences be-
tween groups in physical activity are re-
ported (i.e. r = 0.32 at 3 months). Substan-
tial contamination in the control group
Rogers 2015
Methods • Study design: RCT individual participant level randomisation
• Study location: Springfield, IL, USA *from linked to study Rogers 2012*
• Funding source: this project was supported by the National Cancer Institute
R01CA136859. Kerry S. Courneya is supported by the Canada Research Chairs
Program.
• Inclusion criteria: women (ages 18-70) with history of ductal carcinoma in situ
(DCIS) or stage I-IIIA breast cancer who self-reported engaging in B30 minutes of
vigorous or B60 minutes of moderate intensity physical activity per week on average
over the past 6 months were enrolled. Participants had to be postprimary treatment,
C8 weeks post surgery, English speaking, and medically cleared by their physician.
*from linked to study Rogers 2012*
• Exclusion criteria: women (ages 18-70) with history of ductal carcinoma in situ
(DCIS) or stage I-IIIA breast cancer who self-reported engaging in less than 30
minutes of vigorous or less 0 minutes of moderate intensity physical activity per week
on average over the past 6 months were enrolled. Participants had to be postprimary
treatment, C8 weeks post surgery, English speaking, and medically cleared by their
physician. *from linked to study Rogers 2012*
• CONSORT diagram included: yes
• Study recruitment rate: 222/288
• Length of follow-up: length of intervention = 12 weeks, length of follow-up from
baseline = 6 months.
Participants • Primary cancer diagnosis: breast cancer
• Current cancer treatment: post primary treatment and/or hormone treatment
• Metastatic disease: unclear
• Age, years, mean (SD): intervention = 54.9 (9.3), control = 53.9 (7.7)
• Gender: female
• BMI: intervention = 30.8 (6.9), control = 30.5 (6.8) *from linked paper Rogers
2016*
• Ethnicity: 1.8% Hispanic and 98.2% non-Hispanic
• Comorbidities reported: unclear
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Interventions • Sample size: intervention (n = 110), control (n = 112)
• Group or individual intervention: both
• Setting: home-based and university
• Exercise prescription components: aerobic
• Theoretical basis: social cognitive theory
• CALO-RE taxonomy components: #1 programme set goal, #8 #9 #10 #15 #17 #
19 #20 #21 #22 #26 #35
• Frequency of contact with researcher or exercise professional: this intervention
includes 12 supervised exercise sessions tapered over 6 weeks followed by three face-to-
face update counselling sessions every 2 weeks with a trained exercise specialist. Six
group sessions led by trained facilitators provided additional behavioural counselling
(e.g. time management, stress management, behavioural modification strategies, etc.).
Outcomes were measured at baseline, 3 months, 6 months and 12 months by blinded
members of the team.
• Frequency of contact with healthcare professional: unclear
• Instructions to controls: usual care participants received printed American Cancer
Society materials describing physical activity recommendations for cancer survivors (e.
g. Living Smart: The American Cancer Society’s guide to eating healthy and being
active). No additional instructions regarding physical activity were given with the
materials.
Outcomes • Change in fitness reported: aerobic fitness was measured using a submaximal
treadmill test and modified Naughton protocol
• Free-living energy expenditure: assessed using self-report and accelerometers.
Process measures • Method of measuring exercise behaviour: HR monitor, Accelerometers, use of
Godin questionnaire and activity log.
• Aerobic exercise frequency: 150 minutes per week.
• Aerobic exercise duration: 20-30 minutes per session, three times per week.
• Aerobic exercise intensity: the programme used the rating of perceived exertion,
progressing from 1.5-5.5 over the programme.
• Description aerobic exercise mode: walking on a treadmill in supervised sessions,
after supervised sessions other aerobic exercises could be chosen by the participant as
long as target intensity and duration was met
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity: N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 222/288
• Adherence: adherence to the intervention was 98 % for supervised exercise
sessions, 96 % for update sessions, and 91 % for discussion group sessions. Only five
intervention participants did not receive the allocated intervention (i.e. did not
complete C75 % of all intervention components combined).
• Attrition: 3% at month 3, 4% at month 6.
• Adverse effects: related expected adverse events in the intervention group included
back or lower extremity musculoskeletal pain or injury (n = 14), heart rate monitor
rash (n = 1), fall while walking (n = 1), breast reconstruction (n = 3), and chest pain
97Interventions for promoting habitual exercise in people living with and beyond cancer (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rogers 2015 (Continued)
during treadmill fitness test (n = 1)
• Achieves Rock et al guidelines: yes, 150 minutes per week was the total aim of
moderate intensity exercise per week, 96% to 98% achieved this.
Description of usual care Usual care participants received printed American Cancer Society materials describing
physical activity recommendations for cancer survivors (e.g. Living Smart: The American
Cancer Society’s guide to eating healthy and being active). No additional instructions
regarding physical activity were given with the materials
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation to one of the two study
group conditions was completed using
computer-generated numbers in blocks of
4 within each recruiting site to facilitate an
even distribution between study conditions
during each recruitment wave
Allocation concealment (selection bias) Low risk Random assignment was kept in sealed,
opaque envelopes which were opened in
the order in which participants completed
baseline testing
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes were measured at baseline, 3
months, 6 months and 12 months by
blinded members of the team
Incomplete outcome data (attrition bias)
All outcomes
Low risk Dropouts similar in both groups with rea-
sons given.
Selective reporting (reporting bias) Low risk All outcomes were reported.
Other bias High risk Physical activity reported at baseline, dif-
fered between objective and subjective
measures
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Methods • Study design: RCT individual participant level randomisation
• Study location: Sheffield, UK
• Funding source: American Institue for cancer research grant
• Inclusion criteria: this study recruited 90 overweight women with a BMI >25 kg/
m2
• Exclusion criteria: included concomitant hormone replacement therapy (HRT) or
oral contraceptives; metastatic or active loco-regional disease; physical or psychiatric
impairment limiting physical mobility; severe nausea, anorexia or other conditions
precluding participation in exercise, the consumption of alternative/complementary
diets or use of high-dose antioxidant supplements; and those already engaged in regular
exercise.
• CONSORT diagram included: yes
• Study recruitment rate: 47, 43 (intervention vs control)
• Length of follow-up: length of intervention = 24 weeks, length of follow-up from
baseline = 24 weeks.
Participants • Primary cancer diagnosis: breast cancer
• Current cancer treatment: none or receiving adjuvant endocrine treatment
• Metastatic disease: unclear
• Age, years, mean (SD): intervention = 55.8 (10.0), control = 55.3 (8.8).
• Gender: female
• BMI: intervention = 29.7 (3.5), control = 31.1 (5.7)
• Ethnicity: white
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 47), control (n = 43)
• Group or individual intervention: individually tailored but in groups of 1-3.
• Setting: university exercise research facility
• Exercise prescription components: aerobic and resistance
• Theoretical basis: none
• CALO-RE taxonomy components: programme set goal, #21
• Frequency of contact with researcher or exercise professional: assessments at
baseline and 24 weeks by a trained technician blinded to the group allocation. Three
weekly supervised sessions and an additional weekly small-group nutrition education
seminar.
• Frequency of contact with healthcare professional: unclear
• Instructions to controls: in the control group contact with researchers was limited
to assessment sessions. Participants in the control group were offered three exercise
sessions at the university exercise research facility and general exercise and dietary
advice after the final follow-up.
Outcomes • Change in fitness reported: aerobic exercise tolerance was tested using a
submaximal, 8-minute single stage walking test on a treadmill.
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: heart rate monitor and adherence to
exercise protocol.
• Aerobic exercise frequency: three sessions per week.
• Aerobic exercise duration: thirty minutes per session.
• Aerobic exercise intensity: 65% to 85% age predicted maximum heart rate
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• Description aerobic exercise mode: treadmill, cross-trainer, cycle-ergometer and/
or rowing ergometer
• Resistance exercise frequency: three sessions per week. Resistance exercise sets: 3
sets
• Resistance exercise repetitions: 12 reps
• Resistance exercise intensity: resistance training was individually tailored to the
women’s ability at the time (strength, range of motion). For upper body, we initially
worked on range of motion then built up to 3 sets of 12 reps using light hand weights
(1 kg, 2 kg or 3 kg) or resistance bands (according to patient preference) for a range of
exercises focusing on the arms, chest and back. We also used the exercise balls for core
stability work and some upper body work (e.g. press ups against the wall). Did not do
much leg strengthening as they were using the exercise bike, treadmill, cross-trainer for
the aerobic section of the session, but some women progressed to using the exercise
balls for assisted squats against the wall. Women with lymphoedema did the same as
the others but stuck to very light weights, e.g. 1 kg. The focus was light weights and
lots of reps, as per the lymphoedema avoidance/ management guidance at the time.
• Description of resistance exercise: resistance bands, hand weights and stability
balls.
Compliance • Intervention uptake: 47/238
• Adherence: 80% of all sessions.
• Attrition: 10%
• Adverse effects: none reported.
• Achieves Rock et al guidelines: yes, 6 weeks of resistance exercise.
Description of usual care The control group received a healthy eating booklet (Eat well), which also included brief
advice on keeping active
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patients were randomised using minimisa-
tion (on the advice of statistician at the
Leeds CTU [we used their distant ran-
domisation service]) to balance the poten-
tial confounding variables of chemother-
apy, hormone treatment or no hormone
treatment. Using this approach, the first
participant is allocated a treatment at ran-
dom. For each subsequent participant a de-
cision has to be made about which treat-
ment would lead to better balance between
the groups in the variables of interest. The
randomisation ratio was 1:1
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Allocation concealment (selection bias) Low risk Randomisation conducted by and inde-
pendent researcher and not revealed until
baseline assessment was complete
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk A trained technician was blinded to carry
out outcome assessments
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss to follow-up disclosed.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk None
Thomas 2013
Methods • Study design: RCT individual participant level randomisation
• Study location: Yale
• Funding source: National Cancer Institue
• Inclusion criteria: the inclusion criteria required participating in less than 90
minutes of physical activity per week prior to enrolment; participants were nonsmokers
and were free of other serious health problems. Only those women who were sedentary
or reported less than 90 minutes of moderate to vigorous physical activity per week and
were not currently participating in a weight loss diet programme were eligible.
• Exclusion criteria: exclusion criteria for the study included women younger than
40 years of age due to potential differences in disease aetiology and women over 75
years of age due to likelihood of significant co morbidities and safety concerns for
elderly exercise participants.
• CONSORT diagram included: yes *from linked study Irwin 2008*
• Study recruitment rate: 75/788 *from linked study Irwin 2008*.
• Length of follow-up: length of intervention = 6 months, length of follow-up from
baseline = 6 months.
Participants • Primary cancer diagnosis: breast cancer
• Current cancer treatment: previous chemotherapy, radiotherapy, hormone
therapy and none
• Metastatic disease: unclear
• Age, years, mean (SD): intervention = 56.5 (9.8), control = 55.1 (7.6).
• Gender: female
• BMI: intervention = 30.8 (5.9), control = 29.4 (7.4).
• Ethnicity: intervention = 83% white, 17% African American, control = 90%
white, 7% African-American, 3% Asian/Pacific islander.
• Comorbidities reported: unclear
Interventions • Sample size: intervention (n = 35), control (n = 30)
• Group or individual intervention: individual
• Setting: local health club
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Thomas 2013 (Continued)
• Exercise prescription components: aerobic
• Theoretical basis: none
• CALO-RE taxonomy components: #5 #9 #17
• Frequency of contact with researcher or exercise professional: 3 weekly supervised
sessions with a certified exercise trainer.
• Frequency of contact with healthcare professional: unclear
• Instructions to controls: women in the usual care group were instructed to
continue with their usual activities. If a participant wanted to exercise, she was told she
could, but the exercise programme and training materials would not be offered to her
until the end of the study. At the end of the study, women in the usual care condition
were offered three supervised training sessions, a pedometer, exercise handouts, and the
results of their clinical tests. Additionally, all study participants received quarterly
newsletters that highlighted issues relevant to breast cancer survivorship.
Outcomes • Change in fitness reported: unclear
• Free-living energy expenditure: unclear
Process measures • Method of measuring exercise behaviour: physical activity questionnaire, 7-day
physical activity log and heart rate monitors.
• Aerobic exercise frequency: five weekly sessions, three supervised and two
unsupervised.
• Aerobic exercise duration: 30 minutes per session
• Aerobic exercise intensity: 50% HRMax and increased to 60% to 80% HRMax
• Description aerobic exercise mode:
• Resistance exercise frequency: N/A
• Resistance exercise sets: N/A
• Resistance exercise repetitions: N/A
• Resistance exercise intensity:N/A
• Description of resistance exercise: N/A
Compliance • Intervention uptake: 75/88
• Adherence: the goal of the intervention was for participants to achieve 150
minutes of moderate intensity exercise per week; 33% of the intervention group
achieved 150 minutes per week, 56% of the intervention group achieved 120 minutes
per week and 75% achieved 90 minutes per week.
• Attrition: among the 75 women randomised, complete 6-month data were
available for 67 women (89%); 34 women randomised to exercise and 33 women
randomised to usual care. *from linked study Irwin 2008*
• Adverse effects: five of the 37 women randomised to exercise experienced an
adverse event; 2 events were related to the study (plantar fascitis), and 3 were unrelated
(swollen achilles, stress fracture in foot, and plantar fascitis) to the study. No women
developed lymphoedema during the study. *from linked study Irwin 2008*
• Achieves Rock et al guidelines: no
Description of usual care Women in the usual care group were instructed to continue with their usual activities. If
a participant wanted to exercise, she was told she could, but the exercise programme and
training materials would not be offered to her until the end of the study. At the end of the
study, women in the usual care condition were offered three supervised training sessions,
a pedometer, exercise handouts, and the results of their clinical tests. Additionally, all
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Thomas 2013 (Continued)
study participants received quarterly newsletters that highlighted issues relevant to breast
cancer survivorship
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk After completion of all baseline measures,
each participant was randomly assigned
with equal probability to either the exercise
or usual-care group
Allocation concealment (selection bias) Low risk Randomisation was performed by using a
random number generation, and group as-
signment was placed in a sealed envelope,
which was opened by the study coordina-
tor at the time of randomisation
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk For each participant, the same data that
were collected at the baseline visit were col-
lected in a similar manner at 6 months pos-
trandomisation by staff blinded to the par-
ticipant’s group, *from linked study Irwin
2008*
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data were present for 89% of the
participants at 6 months
Selective reporting (reporting bias) High risk No body fat or lean mass values given.
No data given from food frequency ques-
tionnaire.
Other bias High risk Poor recruitment rate (9.5%)
ADP: androgen-deprivation therapy; BMI: body mass index; BPI: Brief Pain Inventor; yHR: heart rate; m: metre; MRI: magnetic
resonance imaging; NSCLC: non-small cell lung cancer; PAR: Physical Activity Recall; QoL: quality of life; RPE: Rating of Perceived
Exertion; SD: standard deviation; VAS: visual analogue scale;
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adams 2016 Participants were not sedentary at baseline
Ahmed 2006 Sedentary status at baseline is unclear
Alibhai 2014 Participants were not sedentary at baseline
Ames 2011 Exercise prescription metrics are unclear
Anderson 2012 Sedentary status at baseline is unclear
Anderson 2013 Not a homogenous cancer cohort
Anderson 2015 Report - not a full-text paper
Anulika 2015 Unable to access full text
Arbane 2011 Author advised that baseline sedentary status was not assessed
Arbane 2014 Patients were hospitalised
Arikawa 2013 Not a cancer cohort
Banerjee 2013 Poster
Baruth 2015 Unclear if participants were meeting the baseline moderate exercise sedentary criteria
Battaglini 2007 Author advised that baseline sedentary status was not assessed
Battaglini 2008 Linked to Battaglini 2007
Bloom 2013 Poster
Bracha 2012 Unclear of duration and intensity of prescribed exercise
Brdareski 2012 No usual care comparison
Brown 2012 Linked to Schmitz 2009 and Schmitz 2010
Bruno 2018 Participants were not sedentary at baseline
Buchan 2016 No usual care comparison
Buffart 2013 Poster
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Buffart 2014a Not a homogenous cancer cohort
Buffart 2014b Not a homogenous cancer cohort
Campbell 2005 Unclear if participants were meeting the baseline moderate exercise sedentary criteria
Cantaero-Villanueva 2013 Participants were not sedentary
Cantaero-Villanueva 2016 Unclear if participants were meeting the baseline moderate exercise sedentary criteria
Cantarero-Villanueva 2011 Intervention exercise prescription metrics unclear
Cantarero-Villanueva 2012a Linked to Cantarero-Villanueva 2011
Carmack Taylor 2004 Linked to Carmack Taylor 2006
Carmack Taylor 2006 Exercise prescription metrics are unclear
Carmack Taylor 2007 Linked to Carmack Taylor 2006
Carson 2009 Author advised that baseline sedentary status was not assessed
Casla 2015 Participants were not sedentary at baseline
Cerulli 2014 Unknown exercise prescription
Chen 2015 Baseline exercise activity inclusion criteria is greater then 90 minutes
Chen 2016 Baseline exercise activity inclusion criteria is greater then 90 minutes
Cho 2006 Sedentary status at baseline is unclear
Christensen 2014 Participants not sedentary at baseline
Chuang 2017 Exercise prescription is not clear
Coleman 2003 Exercise prescription metrics are unclear
Cornette 2016 Exercise prescription is not clear
Cornie 2013a Participants not sedentary at baseline
Cornie 2013b Sedentary status at baseline is unclear
Cornie 2014 Protocol paper
Cornie 2015 Participants not sedentary at baseline
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Courneya 2012 Participants not sedentary at baseline
Courneya 2013 Participants not sedentary at baseline
Courneya 2014a Author advised us that the participants were not sedentary at baseline
Courneya 2014b Author advised us that the participants were not sedentary at baseline
Courneya 2015 Participants not sedentary at baseline
Courneya 2016a Participants not sedentary at baseline
Courneya 2016b Linked to Courneya 2013 paper
Culos Reed 2010 Exercise prescription metrics are unclear
Danhauer 2009 Sedentary status at baseline is unclear
Daubenmier 2006 Linked to Ornish 2005
De Jesus 2013 Poster
Demark-Wahnefried 2015 No usual care comparison
DeNysschen 2011 Sedentary status at baseline is unclear
Dieli-Conwright 2014 Protocol paper
Dieperink 2017 Authors confirmed that participants were not sedentary at baseline
Diepold 2016 The participants were in palliative care
Do 2015 Cross-over trial
Dolan 2010 START trial includes non-sedentary participants
Dolan 2014 Poster
Dolan 2016 Participants not sedentary at baseline
Donmez 2017 Exercise prescription is not clear
Donnelly 2011 Author advised that cohort was not sedentary at baseline
Edvarsen 2015 Sedentary status at baseline is unclear
Emslie 2007 Linked to Mutrie 2007
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Eriksen 2017 Participants were not sedentary at baseline
Fan-Ko 2017 Exercise prescription is not clear
Fernandez-Lao 2012 Intervention exercise prescription metrics unclear
Fields 2015 Poster
Fields 2017 Participants were not sedentary at baseline
Forbes 2017 Mixed cancer cohort
Frattaroli 2008 Linked to Ornish 2005
Friedenrich 2016 Participants were not cancer patients
Furzer 2016 Not a homogenous cancer cohort
Galiano-Castillo 2017 Unclear whether the participants were sedentary at baseline
Galvão 2010 Sedentary status at baseline is unclear
Galvão 2011 Linked to Galvão 2010
Galvão 2017 Participants were not sedentary at baseline
Gaskin 2016 Participants were not sedentary at baseline
Gehring 2014 Poster
Gehring 2015 Poster
Gehring 2018 Authors confirmed participants were not sedentary at baseline
Gerland 2012 Abstract
Giallauria 2014 Sedentary behaviour was not assessed
Gokal 2016 Participants were not sedentary at baseline
Granger 2013 Participants were hospitalised
Greenlee 2013 Cross-over trial
Gruenigen 2012a Participants were not sedentary at baseline
Gruenigen 2012b Linked to Gruenigen 2012a
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Guinan 2013 Participants were not sedentary at baseline
Guinan 2017 Authors confirmed participants were not sedentary at baseline
Gómez 2011 Cohort not sedentary at baseline
Haines 2010 Sedentary status at baseline is unclear
Hanssens 2012 Abstract
Hartman 2015 Protocol paper
Hatchett 2013 Intensity of exercise is unclear
Hayes 2011 Author advised that baseline sedentary status was not assessed
Hayes 2012 Paper not published yet
Hayes 2013 Author clarified that the participants were not sedentary at baseline
Hayes 2014 Trial still ongoing, paper not published yet
Headley 2004 Sedentary status at baseline is unclear
Heim 2007 Sedentary status at baseline is unclear
Herbert 2012 Participants were not sedentary at baseline.
Herrero 2006 Sedentary status at baseline is unclear
Ho 2016 No intensity reported
Hoffman 2013 Poster
Hoffman 2017 Unclear whether the participants were sedentary at baseline
Hojan 2016 Unable to gain copy of paper
Hojan 2017 Unsure whether participants were sedentary at baseline
Huang 2015 Participants were not sedentary at baseline
Hubbard 2016 Participants were not sedentary at baseline
Husebo 2014 Participants were not sedentary at baseline
Hwang 2012 Not all participants were randomised
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James 2012 Poster
Jarden 2013 Study protocol
Jeffs 2013 intensity of the exercise is unclear
Jensen 2015a Abstract
Jensen 2015b Participants were hospitalised
Jensen 2016 Length of follow-up is less than 6 weeks
Jones 2014a Participants were not sedentary at baseline
Jones 2014b Participants were not sedentary at baseline
Kalter 2015 Moderator paper on previous excluded study
Kampshoff 2015 Not homogenous cancer cohort
Kampshoff 2016 Mixed cancer cohort
Kanera 2016 Mixed cancer cohort
Kanera 2017 Mixed cancer cohort
Kavanagh 2009 Sedentary status at baseline is unclear
Kilbreath 2006 Sedentary status at baseline is unclear
Kilbreath 2012 Sedentary status at baseline is unclear
Kim 2010 Sedentary status at baseline is unclear
Klepin 2015 Abstract
Klinkhammer-Schalke 2012 Sedentary status at baseline is unclear
Kwiatkowski 2013 Participants were not sedentary at baseline
Lahart 2016 Participants were not sedentary at baseline
Lai 2017 Follow-up is less than 6 weeks
Lee 2012a Study protocol
Lee 2012b Study protocol
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Lee 2014 Participants were not sedentary at baseline
Leone 2016 No frequency/duration/intensity of exercise reported
Ligibel 2008 Author advised that exercise intensity was not clear
Ligibel 2009 Linked to Ligibel 2008
Ligibel 2016 Exercise intensity was unclear
Lin 2014 Not randomised controlled trial
Litterini 2013 Not homogenous cancer cohort
Livingston 2015 Participants were not sedentary at baseline
Lynch 2014 No frequency/duration/intensity data
Lyons 2016 Exercise is carried out for couples
MacVicar 1989 Sedentary status at baseline is unclear
Manassero 2007 Exercise prescription metrics are unclear
Martin 2013 Unclear if the participants were sedentary at baseline
Mayo 2014 Not homogenous cancer cohort
McClure 2010 Sedentary status at baseline is unclear
McGowan 2013 No frequency/duration/intensity data
McGuire 2011 Linked to Waltman 2010
McNeely 2004 Author advised that cohort was not sedentary
Milecki 2013 Participants were not sedentary at baseline
Mina 2013 No usual care comparison
Mock 1994 Sedentary status at baseline is unclear
Mock 1997 Sedentary status at baseline is unclear
Mock 2005 Sedentary status at baseline is unclear
Molassiotis 2015 Inspiratory muscle training
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Moller 2015 Unable to source copy of full-text paper
Monga 2007 Sedentary status at baseline is unclear
Morielli 2018 Not a randomised controlled trial
Mustian 2008 Exercise prescription metrics are unclear
Mustian 2015 Poster
Mutrie 2007 Author advised that cohort was not sedentary at baseline
Naumann 2012 Not a randomised controlled trial
Newton 2014 Poster
Nieman 1995 Sedentary status at baseline is unclear
Nikander 2007 Sedentary status at baseline is unclear
Nikander 2012 Participants were not sedentary at baseline.
Nilsen 2015 Unclear whether participants were sedentary at baseline or not
Nobes 2012 Poster
Nuri 2012 Unclear on inclusion or exclusion criteria
Nuri 2016 Unclear whether participants were sedentary at baseline or not
Nyrop 2017 Not sedentary at baseline
O’Neil 2015 Unclear on intensity of prescribed exercise
Ohira 2006 Linked to Schmitz 2005
Ornish 2005 Sedentary status at baseline is unclear
Ornish 2008a Linked to Ornish 2005
Ornish 2008b Linked to Ornish 2005
Park 2012 The interventions were prescribed continence exercises rather than aerobic/resistance exercise
Park 2016 Author confirmed participants were not sedentary at baseline
Payne 2008 Sedentary status at baseline is unclear
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Philips 2012 Not a homogenous cancer cohort
Pickett 2002 Sedentary status at baseline is unclear
Pinto 2013a No usual care comparison
Pinto 2013b No usual care comparison
Pinto 2015 No usual care comparison
Porserud 2014 Intensity of prescribed exercise was unclear
Portela 2008 Author advised that baseline sedentary status was not assessed
Rabin 2016 The cancer cohort was not homogenous
Rahnama 2010 Author not able to confirm sedentary status
Rao 2012 Unclear whether participants were sedentary at baseline or not
Reis 2013 Did not report or measure intensity
Rogers 2009 Author advised that cohort was not sedentary at baseline
Rogers 2012 Author advised that cohort was not sedentary at baseline
Rogers 2013a No usual care comparison
Rogers 2013b Participants were not sedentary at baseline
Rogers 2014 Participants were not sedentary at baseline
Rogers 2015b Linked to Rogers 2014
Saarto 2012a Participants were not sedentary at baseline
Saarto 2012b Participants were not sedentary at baseline
Sajid 2013 No usual care comparison
Samuel 2013 Control was advised to keep physically active as possible
Sandel 2005 Sedentary status at baseline is unclear
Schmidt 2015 No usual care comparison
Schmidt 2017a Linked to Schmidt 2015
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Schmidt 2017b Unclear whether participants were sedentary or not at baseline
Schmitz 2009 Author advised intensity not assessed
Schmitz 2010 Author advised intensity not assessed
Schmitz 2015a Linked to Schmitz 2015b
Schmitz 2015b Participants were not cancer survivors
Schuler 2017 Not homogenous cancer cohort
Schwartz 2015 Not homogenous cancer cohort
Scruggs 2018 Exercise prescription is not clear
Sebio Garcia 2017 Unclear if the participants were sedentary at baseline
Segal 2001 Author advised exercise behavior not formally assessed at baseline
Segal 2003 Author advised exercise behavior not formally assessed at baseline
Segal 2009 Author advised exercise behavior not formally assessed at baseline
Sener 2017 Intensity of exercise is not clear
Sheppard 2016 Intensity of exercise is not clear
Shobeiri 2016 Participants were not sedentary at baseline
Short 2012 Poster
Short 2017a Participants were not sedentary at baseline
Short 2017b Participants were not sedentary at baseline
Singh 2015 Cross-over trial
Skinner 2016 Participants were not sedentary at baseline
Sohl 2016 No usual care comparison
Spahn 2013 No usual care comparison
Stacey 2016 Mediator paper reporting on previous unsuitable randomised controlled trial
Stefanelli 2013 Unclear whether the participants were sedentary at baseline or not
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Stolley 2017 Unclear whether participants were sedentary at baseline
Streckman 2014 Participants were hospitalised
Sturgeon 2017 Participants were not sedentary at baseline
Swisher 2015 Participants were not sedentary at baseline
Taafe 2017 Usual care participants were active
Taleghani 2012 Participants were not adults
Taso 2014 Intensity not reported
Terranova 2017 Unclear whether participants were sedentary at baseline
Tomasello 2017 Compared with a ’healthy’ control
Tometich 2017 Participants were not sedentary at baseline
Travier 2015 Participants were not sedentary at baseline
Trinh 2014 Linked to Mutrie 2007
Uth 2014 Participants were not sedentary at baseline
Uth 2016 Participants were not sedentary at baseline
Van Vulpen 2016 Not a homogenous cancer cohort
van Waart 2015 Unclear whether participants were sedentary at baseline
von Gruenigen 2008 Author advised that cohort was not sedentary at baseline
von Gruenigen 2009 Linked to von Gruenigen 2008
von Gruenigen 2012 Author advised that cohort was not sedentary
Waltman 2010 Author advised that cohort was not sedentary
Wang 2012 Sedentary status at baseline is unclear
Wasley 2018 Mixed cancer cohort
Wiskemann 2017 Participants were not sedentary at baseline
Xu 2015 Participants were not sedentary at baseline
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Yang 2011 Sedentary status at baseline is unclear
Yeo 2012 Author not able to clarify exercise metrics
Yuen 2007 Author advised that cohort was not sedentary at baseline
Yun 2013 Not homogenous cancer cohort
Zhang 2018 Unclear whether participants were sedentary at baseline
Zhao 2016 Not a randomised controlled trial
Zhou 2015 Conference paper
Zimmer 2014 Compared with a ’healthy control’
Zimmer 2016 Protocol paper
Zopf 2012 Poster
Characteristics of studies awaiting assessment [ordered by study ID]
Bai 2004
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Bai S-M, Ma C, Liu Y-M, Xue W-P, Luo M, Ou Z-H. Effects of cognitive behavior
intervention and cinesiateics on the quality of life of patients with nasopharyngeal carcinoma after radiotherapy.
Chinese Journal of Clinical Rehabilitation 2004;8(29):6312-3
Chen 2010
Methods
Participants
Interventions
Outcomes
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Chen 2010 (Continued)
Notes Study awaiting translation: Chen J, Luo A, He Y. Influence of postoperative rehabilitation exercises on functional
recovery of ill limb of breast cancer patients. Chinese Nursing Research 2010;24(4A):875-7
Cho 2004
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Cho OH. Effects of a comprehensive rehabilitation programme for mastectomy patients.
Taehan Kanho Hakhoe Chi 2004;34(5):809-19
Choi 2012
Methods
Participants
Interventions
Outcomes
Notes Still awaiting translation: Choi, J. Y. Kang, H. S. Effects of a home-based exercise program for patients with stomach
cancer receiving oral chemotherapy after surgery. Journal of Korean Academy of Nursing, 2012; 42(1):95-104
Dong 2006
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Dong HY,Wang ZF, Cai L. Correlation between quality of life and rehabilitative guidance
education in the postoperative patients with breast cancer. Chinese Journal of Clinical Rehabilitation 2006; 10(42),
28-30
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Guo 2004
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Guo Y-M. Effects of moderate strength and endurance exercise on emotion and quality
of sleep in patients with malignant tumor. Chinese Journal of Clinical Rehabilitation 2004;8(35):7896-7
Hu 2013
Methods
Participants
Interventions
Outcomes
Notes Still awaiting translation: Hu, H. F. Li, T. C. Liu, L. C. Wu, C. T. Wang, Y. J. Effects of a walking program on fatigue
and exercise capacity in post-surgery breast cancer women, Hu li za zhi [Journal of nursing]. 2013 Oct;60(5):53-63
LeVu 1997
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Le Vu B, Dumortier A, Guillaume MV, Mouriesse H, Barreau-Pouhaer L. Efficacy of
massage and mobilization of the upper limb after surgical treatment of breast cancer. Bulletin du Cancer 1997;80
(10):957-61
Oliveira 2010
Methods
Participants
Interventions
Outcomes
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Oliveira 2010 (Continued)
Notes Study awaiting translation: Oliveira MM, Souza GA, Miranda Mde S, Okubo MA, Amaral MT, Silva MP, Gurgel
MS. Upper limb exercises during radiotherapy for breast cancer and quality of life. Revista Brasileira de Ginecologia
e Obstetrícia 2010;32(3):133-8
Park 2006
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Park HS, Cho GY, Park KY. The effects of a rehabilitation program on physical health,
physiological indicator and quality of life in breast cancer mastectomy patients. Taehan Kanho Hakhoe Chi 2006;36
(2):310-20
Wang 2005
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Wang Y;Yao J-F;Yang J-Y. Effect of rehabilitation exercises on the recovery outcomes of
lung function in postoperative patients with lung cancer. Zhongguo Linchuang Kangfu (Chinese Journal of Clinical
Rehabilitation) 2005; 9(39):14-16
Zhang 2005
Methods
Participants
Interventions
Outcomes
Notes Study awaiting translation: Zhang T, Chang XM, He YG, Huang HX, Fan KS. Effects of rehabilitation therapy in
relieving pain and improving quality of life in patients with advanced cancer. Zhongguo Linchuang Kangfu (Chinese
Journal of Clinical Rehabilitation) 2005;40:59-61
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D A T A A N D A N A L Y S E S
Comparison 1. Aerobic exercise tolerance
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Aerobic exercise tolerance (all
cancers: 8 to 12 weeks of
follow-up)
10 604 Std. Mean Difference (IV, Fixed, 95% CI) 0.54 [0.37, 0.70]
2 Aerobic exercise tolerance (all
cancers: 8 to 12 weeks of
follow-up sensitivity analysis)
4 201 Std. Mean Difference (IV, Fixed, 95% CI) 0.85 [0.56, 1.14]
3 Aerobic exercise tolerance (all
cancers: 6 months of follow-up)
7 591 Std. Mean Difference (IV, Fixed, 95% CI) 0.56 [0.39, 0.72]
4 Aerobic exercise tolerance
(breast cancer: 8-12 weeks of
follow-up)
6 441 Std. Mean Difference (IV, Random, 95% CI) 0.57 [0.22, 0.93]
5 Aerobic exercise tolerance
(all cancers: combination of
supervised and home-based
exercise: 8 to 12 weeks of
follow-up)
4 357 Std. Mean Difference (IV, Random, 95% CI) 0.53 [0.01, 1.04]
6 Aerobic exercise tolerance (all
cancers: home-based exercise: 8
to 12 weeks of follow-up)
3 155 Std. Mean Difference (IV, Fixed, 95% CI) 0.70 [0.37, 1.03]
7 Aerobic exercise tolerance (all
cancers:supervised exercise: 8
to 12 weeks of follow-up)
3 92 Std. Mean Difference (IV, Random, 95% CI) 1.07 [0.26, 1.89]
8 Aerobic exercise tolerance (all
cancers: undergoing active
treatment: 8 to 12 weeks
follow-up)
6 313 Std. Mean Difference (IV, Fixed, 95% CI) 0.72 [0.49, 0.95]
9 Aerobic exercise tolerance (all
cancers: no active treatment: 8
to 12 weeks follow-up
4 291 Std. Mean Difference (IV, Random, 95% CI) 0.61 [0.10, 1.12]
Comparison 2. Strength tests (all cancers)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Strength tests (all cancers, 12
weeks of follow-up)
4 278 Std. Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.03, 0.44]
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2 Strength tests (all cancers: 12
weeks of follow-up: sensitivity
analysis)
2 231 Std. Mean Difference (IV, Fixed, 95% CI) 0.17 [-0.09, 0.43]
Analysis 1.1. Comparison 1 Aerobic exercise tolerance, Outcome 1 Aerobic exercise tolerance (all cancers:
8 to 12 weeks of follow-up).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 1 Aerobic exercise tolerance (all cancers: 8 to 12 weeks of follow-up)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
al-Majid 2015 6 24.7 (2.5) 6 17.6 (2.8) 1.0 % 2.47 [ 0.82, 4.12 ]
Bourke 2011a 9 528.2 (114.5) 9 376.7 (125.7) 2.6 % 1.20 [ 0.18, 2.22 ]
Bourke 2014 43 475.6 (130.8) 42 375 (121.8) 13.8 % 0.79 [ 0.35, 1.23 ]
Cavalheri 2017 6 0.85 (0.9052) 8 -0.55 (1.854) 2.1 % 0.86 [ -0.27, 1.98 ]
Daley 2007a 33 35 (4.4) 33 31.5 (5.1) 10.8 % 0.73 [ 0.23, 1.23 ]
Kim 2006 22 1810.1 (369.4) 19 1630.4 (351.5) 6.9 % 0.49 [ -0.14, 1.11 ]
Musanti 2012 11 24.7 (4.1) 12 23 (4.3) 3.9 % 0.39 [ -0.44, 1.22 ]
Pinto 2005 43 -16.3 (2.1) 43 -17.9 (2.2) 14.1 % 0.74 [ 0.30, 1.17 ]
Pinto 2011 20 27.7 (5.3) 26 23.7 (4.7) 7.3 % 0.79 [ 0.18, 1.40 ]
Rogers 2015 105 23.6 (4.8) 108 22.7 (5.3) 37.3 % 0.18 [ -0.09, 0.45 ]
Total (95% CI) 298 306 100.0 % 0.54 [ 0.37, 0.70 ]
Heterogeneity: Chi2 = 17.45, df = 9 (P = 0.04); I2 =48%
Test for overall effect: Z = 6.42 (P < 0.00001)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [usual care] Favours [exercise]
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Analysis 1.2. Comparison 1 Aerobic exercise tolerance, Outcome 2 Aerobic exercise tolerance (all cancers:
8 to 12 weeks of follow-up sensitivity analysis).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 2 Aerobic exercise tolerance (all cancers: 8 to 12 weeks of follow-up sensitivity analysis)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Pinto 2005 43 -16.3 (2.1) 43 -17.9 (2.2) 44.8 % 0.74 [ 0.30, 1.17 ]
Bourke 2014 43 475.6 (130.8) 42 375 (121.8) 43.9 % 0.79 [ 0.35, 1.23 ]
Bourke 2011a 9 528.2 (114.5) 9 376.7 (125.7) 8.2 % 1.20 [ 0.18, 2.22 ]
al-Majid 2015 6 24.7 (2.5) 6 17.6 (2.8) 3.1 % 2.47 [ 0.82, 4.12 ]
Total (95% CI) 101 100 100.0 % 0.85 [ 0.56, 1.14 ]
Heterogeneity: Chi2 = 4.46, df = 3 (P = 0.22); I2 =33%
Test for overall effect: Z = 5.70 (P < 0.00001)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [usual care] Favours [exercise]
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Analysis 1.3. Comparison 1 Aerobic exercise tolerance, Outcome 3 Aerobic exercise tolerance (all cancers:
6 months of follow-up).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 3 Aerobic exercise tolerance (all cancers: 6 months of follow-up)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bourke 2014 35 443.6 (127.1) 32 380.4 (120.6) 11.5 % 0.50 [ 0.02, 0.99 ]
Daley 2007a 31 33.8 (4.8) 31 30.5 (4) 10.2 % 0.74 [ 0.22, 1.25 ]
Kaltsatou 2011 14 483.3 (85.9) 13 403.1 (71.9) 4.2 % 0.98 [ 0.17, 1.78 ]
Pinto 2005 43 -16.79 (1.7) 43 -17.71 (1.6) 14.7 % 0.55 [ 0.12, 0.98 ]
Pinto 2011 20 28.4 (5.5) 26 24.4 (5) 7.4 % 0.75 [ 0.15, 1.36 ]
Rogers 2015 105 23.7 (5.2) 108 21.8 (4.9) 37.1 % 0.37 [ 0.10, 0.65 ]
Scott 2013 47 31.2 (5.2) 43 27.3 (5.8) 14.9 % 0.70 [ 0.28, 1.13 ]
Total (95% CI) 295 296 100.0 % 0.56 [ 0.39, 0.72 ]
Heterogeneity: Chi2 = 4.16, df = 6 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 6.60 (P < 0.00001)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [usual care] Favours [exercise]
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Analysis 1.4. Comparison 1 Aerobic exercise tolerance, Outcome 4 Aerobic exercise tolerance (breast
cancer: 8-12 weeks of follow-up).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 4 Aerobic exercise tolerance (breast cancer: 8-12 weeks of follow-up)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
al-Majid 2015 6 24.7 (2.5) 6 17.6 (2.8) 4.1 % 2.47 [ 0.82, 4.12 ]
Daley 2007a 33 35 (4.4) 33 31.5 (5.1) 19.6 % 0.73 [ 0.23, 1.23 ]
Kim 2006 22 1810.1 (369.4) 19 1630.4 (351.5) 16.2 % 0.49 [ -0.14, 1.11 ]
Musanti 2012 11 24.7 (4.1) 12 23 (4.3) 11.8 % 0.39 [ -0.44, 1.22 ]
Pinto 2005 43 -16.3 (2.1) 43 -17.9 (2.2) 21.5 % 0.74 [ 0.30, 1.17 ]
Rogers 2015 105 23.6 (4.8) 108 22.7 (5.3) 26.9 % 0.18 [ -0.09, 0.45 ]
Total (95% CI) 220 221 100.0 % 0.57 [ 0.22, 0.93 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 12.52, df = 5 (P = 0.03); I2 =60%
Test for overall effect: Z = 3.14 (P = 0.0017)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours [usual care] Favours [exercise]
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Analysis 1.5. Comparison 1 Aerobic exercise tolerance, Outcome 5 Aerobic exercise tolerance (all cancers:
combination of supervised and home-based exercise: 8 to 12 weeks of follow-up).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 5 Aerobic exercise tolerance (all cancers: combination of supervised and home-based exercise: 8 to 12 weeks of follow-up)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bourke 2011a 9 528.2 (114.5) 9 376.7 (125.7) 14.8 % 1.20 [ 0.18, 2.22 ]
Bourke 2014 43 475.6 (130.8) 42 375 (121.8) 28.6 % 0.79 [ 0.35, 1.23 ]
Kim 2006 22 1810.1 (369.4) 19 1630.4 (351.5) 23.6 % 0.49 [ -0.14, 1.11 ]
Rogers 2015 105 23.6 (4.8) 108 22.7 (53) 33.0 % 0.02 [ -0.24, 0.29 ]
Total (95% CI) 179 178 100.0 % 0.53 [ 0.01, 1.04 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 12.06, df = 3 (P = 0.01); I2 =75%
Test for overall effect: Z = 2.01 (P = 0.045)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours [usual care] Favours [exercise]
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Analysis 1.6. Comparison 1 Aerobic exercise tolerance, Outcome 6 Aerobic exercise tolerance (all cancers:
home-based exercise: 8 to 12 weeks of follow-up).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 6 Aerobic exercise tolerance (all cancers: home-based exercise: 8 to 12 weeks of follow-up)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Musanti 2012 11 24.7 (4.1) 12 23 (4.3) 15.5 % 0.39 [ -0.44, 1.22 ]
Pinto 2005 43 -16.3 (2.1) 43 -17.9 (2.2) 55.6 % 0.74 [ 0.30, 1.17 ]
Pinto 2011 20 27.7 (5.3) 26 23.7 (4.7) 28.9 % 0.79 [ 0.18, 1.40 ]
Total (95% CI) 74 81 100.0 % 0.70 [ 0.37, 1.03 ]
Heterogeneity: Chi2 = 0.66, df = 2 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 4.20 (P = 0.000027)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours [usual care] Favours [exercise]
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Analysis 1.7. Comparison 1 Aerobic exercise tolerance, Outcome 7 Aerobic exercise tolerance (all
cancers:supervised exercise: 8 to 12 weeks of follow-up).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 7 Aerobic exercise tolerance (all cancers:supervised exercise: 8 to 12 weeks of follow-up)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
al-Majid 2015 6 24.7 (2.5) 6 17.6 (2.8) 17.7 % 2.47 [ 0.82, 4.12 ]
Cavalheri 2017 6 0.85 (0.9052) 8 -0.55 (1.854) 29.3 % 0.86 [ -0.27, 1.98 ]
Daley 2007a 33 35 (4.4) 33 31.5 (5.1) 53.0 % 0.73 [ 0.23, 1.23 ]
Total (95% CI) 45 47 100.0 % 1.07 [ 0.26, 1.89 ]
Heterogeneity: Tau2 = 0.26; Chi2 = 3.91, df = 2 (P = 0.14); I2 =49%
Test for overall effect: Z = 2.58 (P = 0.0097)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours [usual care] Favours [exercise]
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Analysis 1.8. Comparison 1 Aerobic exercise tolerance, Outcome 8 Aerobic exercise tolerance (all cancers:
undergoing active treatment: 8 to 12 weeks follow-up).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 8 Aerobic exercise tolerance (all cancers: undergoing active treatment: 8 to 12 weeks follow-up)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
al-Majid 2015 6 24.7 (2.5) 6 17.6 (2.8) 2.0 % 2.47 [ 0.82, 4.12 ]
Bourke 2014 43 475.6 (130.8) 42 375 (121.8) 27.3 % 0.79 [ 0.35, 1.23 ]
Daley 2007a 33 35 (4.4) 33 31.5 (5.1) 21.4 % 0.73 [ 0.23, 1.23 ]
Kim 2006 22 1810.1 (369.4) 19 1630.4 (351.5) 13.7 % 0.49 [ -0.14, 1.11 ]
Musanti 2012 11 24.7 (4.1) 12 23 (4.3) 7.8 % 0.39 [ -0.44, 1.22 ]
Pinto 2005 43 -16.3 (2.1) 43 -17.9 (2.2) 27.9 % 0.74 [ 0.30, 1.17 ]
Total (95% CI) 158 155 100.0 % 0.72 [ 0.49, 0.95 ]
Heterogeneity: Chi2 = 5.54, df = 5 (P = 0.35); I2 =10%
Test for overall effect: Z = 6.12 (P < 0.00001)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours [usual care] Favours [exercise]
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Analysis 1.9. Comparison 1 Aerobic exercise tolerance, Outcome 9 Aerobic exercise tolerance (all cancers:
no active treatment: 8 to 12 weeks follow-up.
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 1 Aerobic exercise tolerance
Outcome: 9 Aerobic exercise tolerance (all cancers: no active treatment: 8 to 12 weeks follow-up
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Bourke 2011a 9 528.2 (114.5) 9 376.7 (125.7) 16.1 % 1.20 [ 0.18, 2.22 ]
Cavalheri 2017 6 0.85 (0.9052) 8 -0.55 (1.854) 14.3 % 0.86 [ -0.27, 1.98 ]
Pinto 2011 20 27.7 (5.3) 26 23.7 (4.7) 28.1 % 0.79 [ 0.18, 1.40 ]
Rogers 2015 105 23.6 (4.8) 108 22.7 (5.3) 41.5 % 0.18 [ -0.09, 0.45 ]
Total (95% CI) 140 151 100.0 % 0.61 [ 0.10, 1.12 ]
Heterogeneity: Tau2 = 0.14; Chi2 = 7.04, df = 3 (P = 0.07); I2 =57%
Test for overall effect: Z = 2.36 (P = 0.018)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours [usual care] Favours [exercise]
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Analysis 2.1. Comparison 2 Strength tests (all cancers), Outcome 1 Strength tests (all cancers, 12 weeks of
follow-up).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 2 Strength tests (all cancers)
Outcome: 1 Strength tests (all cancers, 12 weeks of follow-up)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bourke 2011a 9 189.2 (27.7) 9 169 (45.6) 6.3 % 0.51 [ -0.43, 1.45 ]
Kim 2017 11 25.4 (3.1) 13 24.9 (4.4) 8.6 % 0.12 [ -0.68, 0.93 ]
Musanti 2012 (1) 11 48.3 (14.8) 12 36.75 (20) 7.9 % 0.63 [ -0.21, 1.47 ]
Rogers 2015 105 62.2 (24.7) 108 58.9 (20.6) 77.2 % 0.14 [ -0.12, 0.41 ]
Total (95% CI) 136 142 100.0 % 0.20 [ -0.03, 0.44 ]
Heterogeneity: Chi2 = 1.60, df = 3 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 1.69 (P = 0.091)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [usual care] Favours [exercise]
(1) 12 weeks?
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Analysis 2.2. Comparison 2 Strength tests (all cancers), Outcome 2 Strength tests (all cancers: 12 weeks of
follow-up: sensitivity analysis).
Review: Interventions for promoting habitual exercise in people living with and beyond cancer
Comparison: 2 Strength tests (all cancers)
Outcome: 2 Strength tests (all cancers: 12 weeks of follow-up: sensitivity analysis)
Study or subgroup Exercise intervention Usual care
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bourke 2011a 9 189.2 (27.7) 9 169 (45.6) 7.5 % 0.51 [ -0.43, 1.45 ]
Rogers 2015 105 62.2 (24.7) 108 58.9 (20.6) 92.5 % 0.14 [ -0.12, 0.41 ]
Total (95% CI) 114 117 100.0 % 0.17 [ -0.09, 0.43 ]
Heterogeneity: Chi2 = 0.53, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 1.31 (P = 0.19)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours [usual care] Favours [exercise]
A D D I T I O N A L T A B L E S
Table 1. Summary of included studies
Study Exercise
components
n Meets Rock
et al guide-
lines?
Adherence
summary
At least 75%
adherence?
High risk of
bias?
Change
in AET re-
ported?
Adverse ef-
fects
Cadmus
2009
Aerobic 37, 38 (in-
tervention
vs control)
33% re-
ported 150
min-
utes/week of
moder-
ate intensity
aerobic exer-
cise at an av-
er-
age of 76%
HR, for six
months
75% of
women were
do-
ing between
90 and 119
min-
utes of mod-
erate inten-
sity aerobic
activity per
week at six
months
Yes; for up to
119 minutes
per week
No Not
reported
Five of the
37
women ran-
domly as-
signed to ex-
ercise expe-
ri-
enced an ad-
verse effect;
two were re-
lated to the
study (plan-
tar fasciitis)
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Table 1. Summary of included studies (Continued)
Daley 2007a Aerobic 34,
36, 38 (in-
tervention,
sham, con-
trol, respec-
tively)
No 77% of the
exercise
therapy; at-
tended 70%
(at least 17
of
24 sessions)
or more of
sessions
Unclear Yes;
outcome as-
sessors were
not blinded
to partici-
pants’ group
allocation
Yes Three with-
drawals
in the inter-
ven-
tion group:
unclear as to
why this oc-
curred.
Some with-
drawals be-
cause of
medical
com-
plications in
placebo and
control arms
but unclear
whether
study related
Drouin
2005
Aerobic 13 interven-
tion, 8
placebo
stretching
controls
Unclear Partic-
ipants in the
intervention
group aver-
aged
3.6 days per
week of aer-
obic exercise
over an 8-
week period
Unclear No Yes None
reported
Kaltsatou
2011
Aerobic 14, 13 (in-
tervention
vs control)
Unclear Not
reported
Not
reported
Yes; method
of mea-
suring exer-
cise and ad-
herence not
reported
Not
reported
None
reported
Kim 2006 Aerobic 22,19 (in-
tervention
vs control).
No Av-
erage weekly
frequency of
exercise was
2.4 ± 0.6
sessions, and
average du-
ration of ex-
ercise within
prescribed
Yes Yes;
data missing
for 45% of
the cohort
Yes Reasons for
withdrawal
in-
cluded per-
sonal prob-
lems (n =
2), problems
at home (n
= 2), prob-
lems related
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Table 1. Summary of included studies (Continued)
target HR
was 27.8 ±
8.1 minutes
per session.
Overall ad-
herence was
78.3% ± 20.
1%
to chemo-
therapy (n
= 3), throm-
bophlebitis
in
the lower leg
(n = 2), non
exercise-
related
injuries (n =
1), and
death (n = 1)
. Unclear to
which
arm of the
study these
date relate
Pinto 2003 Aerobic 12, 12 (in-
tervention
vs
control)
Unclear Participants
attended
a mean of
88% of the
36-session
supervised
exercise pro-
gramme
Yes Yes; 38%
lost to fol-
low-up. Ex-
ercise toler-
ance test was
performed
but no con-
trol group
comparison
data were re-
ported
Yes None
reported;
however, it is
unclear why
the six con-
trols
dropped out
Pinto 2005 Aerobic 43, 43 (in-
tervention
vs control)
Unclear At week 12,
inter-
vention par-
ticipants re-
ported
a mean of
128.53 min-
utes/week of
mod-
erate inten-
sity exercise.
However, no
changes
were re-
ported in the
accelerome-
ter data
in the inter-
Less than
75% of the
intervention
group
was meeting
the pre-
scribed goal
after week 4
Yes; signifi-
cantly more
control
group
participants
were re-
ceiving hor-
mone treat-
ment.
Accelerom-
eter data do
not support
the self-re-
ported phys-
ical activity
behaviour
Yes Not clear
whether
chest pain
was related
to exercise in
dropout
whose par-
ticipa-
tion was ter-
minated
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Table 1. Summary of included studies (Continued)
vention
group
(change
score = -0.33
kcal/hour)
Pinto 2011 Aerobic 20, 26 (in-
tervention
vs control)
Three-day
PAR ques-
tionnaire in-
dicates that
64.7%
of the inter-
vention
group
and 40.9%
of the con-
trol group
were achiev-
ing the
guidelines at
three
months
Correlation
between
self-re-
ported mod-
erate in-
tensity exer-
cise and ac-
celerom-
eter data at
three-
month fol-
low-up,
when
the only sig-
nificant be-
tween-
group
change is re-
ported: r = 0.
32
No Yes;
accelerome-
ter data were
not re-
ported; also,
cited corre-
lation
is weak (0.
32). Further,
substan-
tial contam-
ination was
noted in the
control
group
Yes One cancer
recurrence
in the con-
trol group at
three
months
Bourke
2011a
Aerobic and
resistance
9,
9 (interven-
tion vs con-
trol)
Six weeks of
re-
sistance ex-
ercise twice a
week
90% atten-
dance at the
su-
pervised ses-
sions. 94%
of indepen-
dent exercise
sessions
were
completed
Yes No Yes One stroke
in the inter-
vention
group, unre-
lated to the
exercise pro-
gramme
Hayes 2009 Aerobic and
resistance
16, 16 (in-
tervention
vs control)
Unclear Most
women
(88%) allo-
cated to the
intervention
group
participated
in 70% or
more
of scheduled
supervised
Unclear Yes; ad-
herence data
on unsuper-
vised aspect
of the inter-
vention are
not clear
No None
reported
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Table 1. Summary of included studies (Continued)
exercise ses-
sions
McKenzie
2003
Aerobic and
resistance
7,
7 (interven-
tion vs con-
trol)
No Unclear Unclear Yes; adher-
ence to exer-
cise not re-
ported
Not
reported
None
reported
Musanti
2012
Aerobic and
resistance
Flexibil-
ity group (n
= 13), aero-
bic group (n
= 12), resis-
tance group
(n = 17), aer-
obic and re-
sis-
tance group
(n = 13)
12
weeks of re-
sistance ex-
ercise two or
three times
per week
Mean
percentages
of adherence
were as fol-
lows:
flexibility =
85%, aero-
bic = 81%,
resistance
= 91% and
aerobic plus
resistance =
86%
Unclear Yes; a signifi-
cant number
of dropouts
belonged to
the re-
sistance ex-
ercise group
(n = 8/13)
. Only 50%
of activ-
ity logs were
returned
Yes Adverse
effects were
reported in
two women
during
the study. In
both cases,
the
women de-
veloped ten-
donitis: one
in the shoul-
der and the
other in the
foot. Both
had a his-
tory of ten-
donitis,
and both re-
ceived stan-
dard
treatment
Perna 2010 Aerobic and
resistance
51 par-
ticipants in
total. Num-
bers
randomly
assigned to
each arm are
unclear
Three
months
of resistance
exercise
three times
per week
Women as-
signed to the
structured
intervention
completed
an average of
83% of their
sched-
uled hospi-
tal-based ex-
ercise ses-
sions (only 4
weeks in du-
ration), and
76.9% com-
pleted all 12
sessions.
Home-
Unclear Yes; num-
bers ran-
domly as-
signed to in-
tervention
and control
groups are
unclear, as
are numbers
completing
in each arm
Not
reported
Unclear
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Table 1. Summary of included studies (Continued)
based com-
ponent (8
weeks in du-
ration)
al-Majid
2015
Aerobic 7,
7 (interven-
tion vs con-
trol)
No Adher-
ence to per-
protocol ex-
ercise
sessions was
very high,
ranging be-
tween 95%
and 97%
Yes No Yes None
reported
Bourke
2014
Aerobic and
resistance
25,25 (in-
tervention
vs control)
Yes; 6 weeks
of resistance
exercise
Adherence
was 94% for
the su-
pervised and
82% of the
prescribed
indepen-
dent exercise
sessions over
the first 12
week
Yes Yes incom-
plete out-
come data at
6 months.
Yes None
reported
Campbell
2017
Aerobic 10 in exer-
cise inter-
vention,
9 in delayed
exercise con-
trol
150 minut-
ess per week
of moder-
ate-vigorous
aerobic exer-
cise for 24
weeks
Participants
attended
88% of
supervised
gym sessions
(mean 1.
8 sessions/
week and
87.5 min-
utes/week),
and partic-
ipants met
82% of the
prescribed
exercise tar-
gets (mean
intensity 74.
5% HRR)
. Home
session
completion
Yes Yes; Low
study
recruitment
rate.
Yes None
reported
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Table 1. Summary of included studies (Continued)
was 87%
(mean 2.
4 sessions/
week and
101.5 min-
utes/week),
and partic-
ipants met
87% of the
prescribed
exercise tar-
gets (mean
intensity 73.
5% HRR)
Cantarero-
Villanueva
2012b
Aerobic 33,33 (in-
tervention
vs control)
Three
sixty minute
sessions per
week for 8
weeks.
All interven-
tion
group com-
pleted more
than 85% of
the 24 water
exercise ses-
sions, show-
ing a
high adher-
ence rate to
the program
Yes No Not
reported
One partici-
pant in the
intervention
dropped out
due to a re-
currence of
breast
cancer dur-
ing the pro-
gram. Three
women
reported a
transient in-
crease of
oedema, and
four women
noted an in-
crease in fa-
tigue imme-
diately after
the
beginning of
the first ses-
sion, which
improved in
the next few
days. These
women did
not dropout
of the study.
No other ad-
verse ef-
fects were re-
ported
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Table 1. Summary of included studies (Continued)
Cavalheri
2017
Aerobic and
resistance
9,
8 (interven-
tion vs con-
trol)
Yes; six
weeks of re-
sistance ex-
ercise.
Nine
of the partic-
ipants ran-
domised to
the EG, four
(44%) ad-
hered to ex-
ercise train-
ing by com-
pleting 15 or
more train-
ing sessions
(i.e.,≥60%)
No Yes; missing
patient data
in both arms
with no rea-
sons given
Yes One partic-
ipant com-
pleted
four sessions
and another
completed
six sessions.
Both
stopped
train-
ing as they
felt unwell.
They com-
pleted some
of the post-
interven-
tion assess-
ments and
were later di-
agnosed
with a pri-
mary cancer
other than
lung cancer
Kim 2017 Aerobic and
resistance
15, 15 (in-
tervention
vs control)
Three
sixty minute
sessions per
week for 12
weeks.
Vague state-
ment: Two
participants
did not fulfil
the required
exercise
Unclear Yes; Age dif-
ferences be-
tween
groups in
baseline de-
mographics
were
present. Ad-
herence data
is vague
Not
reported
None
reported
Mohamady
2017
Aerobic 15, 15 (in-
tervention
vs control)
No Unclear Unclear Yes; No ad-
herence
data.
Unclear Unclear
Rogers 2015 Aerobic 110, 112
(interven-
tion vs con-
trol)
Yes Adherence
to the inter-
vention was
98 % for su-
pervised ex-
er-
cise sessions,
96% for up-
Yes Yes; differ-
ences in ob-
jec-
tive and sub-
jective mea-
sures of
physical ac-
tivity
Yes Related
expected ad-
verse events
in the inter-
vention
group in-
cluded back
or lower ex-
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Table 1. Summary of included studies (Continued)
date
sessions, and
91% for dis-
cussion
group
sessions
reported tremity
muscu-
loskeletal
pain or in-
jury (n = 14)
, heart rate
moni-
tor rash (n =
1), fall while
walking (n =
1), breast re-
construc-
tion (n = 3)
, and chest
pain during
treadmill fit-
ness test (n =
1)
Scott 2013 Aerobic and
resistance
47, 43 (in-
tervention
vs control)
Yes, six
weeks of re-
sistance ex-
ercise.
Adherence
for the inter-
vention
group was
80%
Yes No Yes None
reported.
Thomas
2013
Aerobic 35, 30 (in-
tervention
vs control)
Yes The exercise
goal was 150
min-
utes/week of
moder-
ate intensity
aerobic exer-
cise; 33% of
women
achieved
this amount.
57% of
women
achieved
80% of the
exercise goal
or 120 min-
utes/week,
and 75% of
women
achieved
90 minutes/
week.
No Yes;
not all out-
comes were
reported and
low recruit-
ment rate
Not
reported
None
reported.
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Table 1. Summary of included studies (Continued)
Irwin 2015 Aerobic and
resistance
61, 60 (in-
tervention
vs control)
Yes Women ran-
domly as-
signed to ex-
er-
cise also re-
ported their
exer-
cise prospec-
tively in
daily activ-
ity logs and
reported an
average 119
minutes per
week of aer-
o-
bic exercise,
with an aver-
age of 70%
of strength-
training ses-
sions com-
pleted.
Women ran-
domly
assigned to
exercise in-
creased their
physical ac-
tivity by an
average 159
minutes per
week, com-
pared with
49 minutes
per week
in the usual-
care group
No No Yes 5 partici-
pants had to
dis-
continue the
use of Atro-
matise
inhibitors
AET = aerobic exercise tolerance.
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Table 2. Original review Behaviour change components
Be-
haviour
change
tech-
nique
Bourke
2011a
Cad-
mus
2009
YALE
Daley
2007a
Drouin
2005
Hayes
2009
Kalt-
satou
2011
McKen-
zie
2003
Mu-
santi
2012
Perna
2010
Kim
2006
Pinto
2003
Pinto
2005
Pinto
2011
The-
ory
TTM
EXSEM
TTM TTM TTM
SCT
1. Pro-
vide
Info
on
conse-
quences
of be-
haviour
in
general
X X X X
2. Pro-
vide
Info
on
conse-
quences
of be-
haviour
to the
indi-
vidual
3. Pro-
vide
Info
about
oth-
ers’ ap-
proval
4. Pro-
vide
nor-
mative
info
about
others’
be-
haviour
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Table 2. Original review Behaviour change components (Continued)
Pro-
gramme
set
goal
X X X X X X X X X X X X X
5.
Goal
setting
(be-
haviour)
X X X X X X
6. Goal
setting
(out-
come)
7. Ac-
tion
plan-
ning
8. Bar-
rier
identi-
fica-
tion/
Prob-
lem
solving
X X X X X
9. Set-
ting of
graded
tasks
X X X X X X X X X
10.
Prompt
review
of be-
havioural
goals
X X
11.
Prompt
review
of out-
come
goals
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Table 2. Original review Behaviour change components (Continued)
12.
Prompt
re-
wards
con-
tingent
on
effort
or
progress
to-
wards
goal
X X X
13.
Pro-
vide
re-
wards
con-
tingent
on suc-
cessful
be-
haviour
X
14.
Shap-
ing
15.
Prompt
gener-
alisa-
tion of
a target
be-
haviour
X X X X
16.
Prompt
self-
moni-
toring
of be-
haviour
X X X X X X X X X
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Table 2. Original review Behaviour change components (Continued)
17.
Prompt
self-
moni-
toring
of be-
havioural
out-
come
X X X X X X
18.
Prompt
focus
on past
success
X
19.
Feed-
back
on per-
for-
mance
pro-
vided
X X X X
20.
Infor-
mation
pro-
vided
on
where
and
when
to per-
form
be-
haviour
X X
21. In-
struc-
tion
pro-
vided
on
how
to per-
form
the be-
X X X X X X X X X
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Table 2. Original review Behaviour change components (Continued)
haviour
22.
Mod-
elling/
Demon-
stra-
tion
of be-
haviour
X X X
23.
Teach-
ing to
use
prompts/
cues
X X X
24.
Envi-
ron-
men-
tal re-
struc-
turing
X X
25.
Agree-
ment
on be-
havioural
con-
tract
X
26.
Prompt
prac-
tise
X X X X X X X X X X X X X
27.
Use of
follow-
up
prompts
X
28. Fa-
cilitat-
ing so-
cial
com-
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Table 2. Original review Behaviour change components (Continued)
pari-
son
29.
Plan-
ning
social
sup-
port/
social
change
X X X
30.
Prompt
iden-
tifica-
tion
as role
model/
posi-
tion
advo-
cate
31.
Prompt
antici-
pated
regret
32.
Fear
arousal
33.
Prompt
self-
talk
34.
Prompt
use of
im-
agery
35. Re-
lapse
pre-
ven-
tion/
X X
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Table 2. Original review Behaviour change components (Continued)
coping
plan-
ning
36.
Stress
man-
age-
ment/
emo-
tional
control
train-
ing
X
37.
Moti-
va-
tional
inter-
view-
ing
38.
Time
man-
age-
ment
39.
Gen-
eral
com-
muni-
cation
skills
train-
ing
40.
Stimu-
lation
of an-
ticipa-
tion of
fu-
ture re-
wards
EXSEM = exercise self-esteem model; SCT = social cognitive theory; TTM = trans-theoretical model.
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Table 3. 2018 Update Behaviour change components
Be-
haviour
change
tech-
nique
al-Majid
2015
Bourke
2014
Camp-
bell
2017
Cantarero-
Vil-
lanueva
2012b
Caval-
heri
2017
Irwin
2015
Kim
2017
Mo-
hamady
2017
Rogers
2015
Scott
2013
Thomas
2013
Theory SCT
1. Pro-
vide Info
on con-
se-
quences
of be-
haviour
in
general
x x
2. Pro-
vide Info
on con-
se-
quences
of be-
haviour
to the in-
dividual
3. Pro-
vide Info
about
others’
approval
4. Pro-
vide nor-
ma-
tive info
about
others’
be-
haviour
Pro-
gramme
set goal
x x x x x x x x x x x
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Table 3. 2018 Update Behaviour change components (Continued)
5.
Goal set-
ting (be-
haviour)
x x
6. Goal
setting
(out-
come)
7.
Action
plan-
ning
8.
Barrier
identifi-
cation/
Problem
solving
x x
9. Set-
ting of
graded
tasks
x x x (im-
plicit)
x x x x x x x
10.
Prompt
review
of be-
havioural
goals
x
11.
Prompt
review of
outcome
goals
12.
Prompt
rewards
contin-
gent on
effort or
progress
towards
goal
x
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Table 3. 2018 Update Behaviour change components (Continued)
13. Pro-
vide re-
wards
contin-
gent on
success-
ful be-
haviour
14.
Shaping
15.
Prompt
generali-
sation of
a target
be-
haviour
x (from
linked
paper
Gilbert
2016*
x
16.
Prompt
self-
moni-
toring of
be-
haviour
17.
Prompt
self-
moni-
toring
of be-
havioural
outcome
x x x
18.
Prompt
focus on
past suc-
cess
19.
Feed-
back on
perfor-
mance
x
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Table 3. 2018 Update Behaviour change components (Continued)
provided
20. In-
forma-
tion pro-
vided on
where
and
when to
per-
form be-
haviour
x x
21.
Instruc-
tion pro-
vided on
how to
perform
the be-
haviour
x x x
22.
Mod-
elling/
Demon-
stration
of be-
haviour
x
23.
Teach-
ing
to use
prompts/
cues
24. En-
viron-
mental
restruc-
turing
25.
Agree-
ment
on be-
havioural
contract
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Table 3. 2018 Update Behaviour change components (Continued)
26.
Prompt
practise
x x
27. Use
of fol-
low-up
prompts
28. Fa-
cilitating
social
compar-
ison
29.
Plan-
ning so-
cial sup-
port/
social
change
x
30.
Prompt
identifi-
cation as
role
model/
position
advocate
31.
Prompt
antici-
pated re-
gret
32. Fear
arousal
33.
Prompt
self-talk
34.
Prompt
use of
imagery
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Table 3. 2018 Update Behaviour change components (Continued)
35. Re-
lapse
preven-
tion/
cop-
ing plan-
ning
x
36.
Stress
manage-
ment/
emo-
tional
control
training
37. Mo-
tiva-
tional
inter-
viewing
38.
Time
manage-
ment
39. Gen-
eral
commu-
nication
skills
training
40.
Stimula-
tion
of antici-
pation
of future
rewards
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Table 4. Tier 1 BCTs - trials which had 75% adherence to the Rock resistance or aerobic guidelines
BCT Bourke
2014
Campbell
2017
Cantarero-
Villanueva
2012b
Bourke
2011a
Rogers
2015
Scott 2013 Kim 2017 Irwin 2015
Resistance Aerobic Aerobic Resistance Aerobic Resistance Resistance Aerobic Frequency
of BCTs
Pro-
gramme
set goal
x x x x x x x x 8
9. Setting
of graded
tasks
x x x x x x x 7
21. In-
struction
provided
on how
to perform
behaviour
x x x 3
26.
Prompt
practise
x x 2
5.Goal set-
ting (out-
come)
x x 2
8. Bar-
rier identi-
fication/
problem
solving
x x 2
1. Pro-
vide infor-
mation on
conse-
quences of
behaviour
in general
x x 2
15.
Prompt
gener-
alisation of
a target be-
x x 2
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Table 4. Tier 1 BCTs - trials which had 75% adherence to the Rock resistance or aerobic guidelines (Continued)
haviour
17.
Prompt
self-
monitor-
ing of be-
havioural
outcome
x x 2
20. Infor-
mation
provided
on where
and when
to perform
behaviour
x x 2
19. Feed-
back
on perfor-
mance
provided
x 1
22. Mod-
elling/
demon-
stration of
behaviour
x 1
12.
Prompt re-
wards con-
tingent on
effort
or progress
towards
goal
x 1
29. Plan-
ning social
support/
social
x 1
35. Re-
lapse pre-
vention/
coping
planning
x 1
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BCTs: behaviour change techniques
Table 5. Tier 2 BCTs - trials which had 75% adherence to their specified aerobic exercise prescription
BCT Bourke 2011a al-Majid 2015 Bourke 2014 Cadmus 2009 Scott 2013 Kim 2017
Frequency of BCTs
Programme
set goal
x x x x x x 6
9. Setting of
graded tasks
x x x x x 5
21. In-
struction pro-
vided on how
to perform be-
haviour
x x x 3
1. Provide in-
forma-
tion on conse-
quences of be-
haviour in gen-
eral
x x 2
26. Prompt
practise
x x 2
8.
Barrier identi-
fication/prob-
lem solving
x x 2
15. Prompt
generalisa-
tion of a target
behaviour
x x 2
5. Goal setting
(outcome)
x 1
16. Prompt
self-
monitoring of
behaviour
x 1
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Table 5. Tier 2 BCTs - trials which had 75% adherence to their specified aerobic exercise prescription (Continued)
17. Prompt
self-mon-
itoring of be-
havioural out-
come
x 1
20. Informa-
tion provided
on where and
when
to perform be-
haviour
x 1
29. Planning
social
support/social
x 1
27.
Use of follow-
up prompts
x 1
BCTs: behaviour change techniques
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
CENTRAL 2018 update search
#1 MeSH descriptor Neoplasms explode all trees
#2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*)
#3 (#1 OR #2)
#4 MeSH descriptor Exercise explode all trees
#5 MeSH descriptor Exercise Movement Techniques explode all trees
#6 MeSH descriptor Exercise Therapy explode all trees
#7 MeSH descriptor Physical Fitness, this term only
#8 (physical* adj5 (fit* or activ*))
#9 (exercis* or aerobic* or resistance* or strength* or walk* or endurance* or lifestyle* or behav*)
#10 (#4 OR #5 OR #6 OR #7 OR #8 OR #9)
#11 #3 and #10
#12 MeSH descriptor: [Health Behavior] explode all trees
#13 MeSH descriptor: [Risk Reduction Behavior] this term only
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#14 ((promot* or motivat* or advis* or encourag* or assist* or develop* or stimulat* or help* or support* or organis* or aid* or assist* or
endors* or prompt* or driv* or inspire* or lead* or inspir* or further* or advocat* or recommend* or endorse* or foster* or champion*)
near/5 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*))
#15 #12 or #13 or #14
#16 #11 and #15
CENTRAL 2012 search
#1 MeSH descriptor Neoplasms explode all trees
#2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*)
#3 (#1 OR #2)
#4 MeSH descriptor Exercise explode all trees
#5 MeSH descriptor Exercise Movement Techniques explode all trees
#6 MeSH descriptor Exercise Therapy explode all trees
#7 MeSH descriptor Physical Fitness, this term only
#8 (physical* adj5 (fit* or activ*))
#9 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*)
#10 (#4 OR #5 OR #6 OR #7 OR #8 OR #9)
#11 MeSH descriptor Patient Education as Topic, this term only
#12 (educat* or inform* or teach* or supervis* or communicat* or leaflet*)
#13 MeSH descriptor Survivors, this term only
#14 survivor*
#15 MeSH descriptor Behavior Therapy explode all trees
#16 (behaviour* or behavior* or cognit* or CBT)
#17 MeSH descriptor Motivation explode all trees
#18 MeSH descriptor Interview, Psychological, this term only
#19 (motivat* or interview*)
#20 (#11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19)
#21 (#3 AND #10 AND #20)
Appendix 2. MEDLINE search strategy
MEDLINE 2018 update search
1. exp Neoplasms/
2. (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).ti,ab.
3. 1 or 2
4. exp Exercise/
5. exp Exercise Movement Techniques/
6. exp Exercise Therapy/
7. Physical Fitness/
8. (physical* adj5 (fit* or activ*)).ti,ab.
9. (exercis* or aerobic* or resistance* or strength* or walk* or endurance* or lifestyle* or behave*).mp.
10. 4 or 5 or 6 or 7 or 8 or 9
11. 3 and 10
12. exp Health Behavior/
13. risk reduction behavior/
14. ((promot* or motivat* or advis* or encourag* or assist* or develop* or stimulat* or help* or support* or organis* or aid* or assist* or
endors* or prompt* or driv* or inspire* or lead* or inspir* or further* or advocat* or recommend* or endorse* or foster* or champion*)
adj5 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*)).ti,ab.
15. 12 or 13 or 14
16. 11 and 15
17. randomized controlled trial.pt.
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18. controlled clinical trial.pt.
19. randomized.ab.
20. placebo.ab.
21. clinical trials as topic.sh.
22. randomly.ab.
23. trial.ti.
24. 17 or 18 or 19 or 20 or 21 or 22 or 23
25. (animals not (humans and animals)).sh.
26. 24 not 25
27. 16 and 26
key:
mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supple-
mentary concept, unique identifier
pt=publication type
ab=abstract
ti=title
sh=subject heading
MEDLINE 2012 search
1. exp Neoplasms/
2. (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).mp.
3. 1 or 2
4. exp Exercise/
5. exp Exercise Movement Techniques/
6. exp Exercise Therapy/
7. Physical Fitness/
8. (physical* adj5 (fit* or activ*)).mp.
9. (exercis* or aerobic* or resistance* or strength* or walk* or endurance*).mp.
10. 4 or 5 or 6 or 7 or 8 or 9
11. Patient Education as Topic/
12. Patient education handout/
13. (educat* or inform* or teach* or supervis* or communicat* or leaflet*).mp.
14. Survivors/ or survivor*.mp.
15. exp Behavior Therapy/
16. (behaviour* or behavior* or cognit* or CBT).mp.
17. exp Motivation/
18. Interview, Psychological/
19. (motivat* or interview*).mp.
20. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19
21. 3 and 10 and 20
22. randomized controlled trial.pt.
23. controlled clinical trial.pt.
24. randomized.ab.
25. placebo.ab.
26. clinical trials as topic.sh.
27. randomly.ab.
28. trial.ti.
29. 22 or 23 or 24 or 25 or 26 or 27 or 28
30. 21 and 29
31. exp animals/ not humans.sh.
32. 30 not 31
key:
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mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supple-
mentary concept, unique identifier
pt=publication type
ab=abstract
ti=title
sh=subject heading
Appendix 3. Embase search strategy
Embase 2018 update search
1. exp neoplasm/
2. (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).ti,ab.
3. 1 or 2
4. exp exercise/
5. exp kinesiotherapy/
6. fitness/
7. (physical* adj5 (fit* or activ*)).ti,ab.
8. (exercis* or aerobic* or resistance* or strength* or walk* or endurance* or lifestyle* or behav*).mp.
9. 4 or 5 or 6 or 7 or 8
10. 3 and 9
11. exp health behavior/
12. risk reduction/
13. ((promot* or motivat* or advis* or encourag* or assist* or develop* or stimulat* or help* or support* or organis* or aid* or assist* or
endors* or prompt* or driv* or inspire* or lead* or inspir* or further* or advocat* or recommend* or endorse* or foster* or champion*)
adj5 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*)).ti,ab.
14. 11 or 12 or 13
15. 10 and 14
16. crossover procedure/
17. double-blind procedure/
18. randomized controlled trial/
19. single-blind procedure/
20. random*.mp.
21. factorial*.mp.
22. (crossover* or cross over* or cross-over*).mp.
23. placebo*.mp.
24. (double* adj blind*).mp.
25. (singl* adj blind*).mp.
26. assign*.mp.
27. allocat*.mp.
28. volunteer*.mp.
29. 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28
30. 15 and 29
31. (exp animal/ or nonhuman/ or exp animal experiment/) not human/
32. 30 not 31
key:
[mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device
trade name, keyword]
Embase 2012 search
1 exp neoplasm/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).mp.
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3 1 or 2
4 exp exercise/
5 exp kinesiotherapy/
6 fitness/
7 (physical* adj5 (fit* or activ*)).mp.
8 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*).mp.
9 4 or 5 or 6 or 7 or 8
10 patient education/
11 (educat* or inform* or teach* or supervis* or communicat* or leaflet*).mp.
12 survivor/ or survivor*.mp.
13 behavior therapy/
14 cognitive therapy/
15 (behaviour* or behavior* or cognit* or CBT).mp.
16 motivation/
17 interview/
18 (motivat* or interview*).mp.
19 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
20 3 and 9 and 19
21 crossover procedure/
22 double-blind procedure/
23 randomized controlled trial/
24 single-blind procedure/
25 random*.mp.
26 factorial*.mp.
27 (crossover* or cross over* or cross-over*).mp.
28 placebo*.mp.
29 (double* adj blind*).mp.
30 (singl* adj blind*).mp.
31 assign*.mp.
32 allocat*.mp.
33 volunteer*.mp.
34 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33
35 20 and 34
36 (exp animal/ or nonhuman/ or exp animal experiment/) not human/
37 35 not 36
key:
[mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device
trade name, keyword]
Appendix 4. AMED search strategy
Amed Ovid 2018 update search
1 exp neoplasms/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).mp.
3 1 or 2
4 exp exercise/
5 exp exercise therapy/
6 physical fitness/
7 (physical* adj5 (fit* or activ*)).mp.
8 (exercis* or aerobic* or resistance* or strength* or walk* or endurance* or lifestyle* or behav*).mp.
9 4 or 5 or 6 or 7 or 8
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10 exp Health behavior/
11 ((promot* or motivat* or advis* or encourag* or assist* or develop* or stimulat* or help* or support* or organis* or aid* or assist* or
endors* or prompt* or driv* or inspire* or lead* or inspir* or further* or advocat* or recommend* or endorse* or foster* or champion*)
adj5 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*)).ti,ab.
12 10 or 11
13 3 and 9 and 12
key:
mp=abstract, heading words, title
Amed Ovid 2012 search
1 exp neoplasms/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).mp.
3 1 or 2
4 exp exercise/
5 exp exercise therapy/
6 physical fitness/
7 (physical* adj5 (fit* or activ*)).mp.
8 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*).mp.
9 4 or 5 or 6 or 7 or 8
10 exp patient education/
11 (educat* or inform* or teach* or supervis* or communicat* or leaflet*).mp.
12 survivors/ or survivor*.mp.
13 exp behavior therapy/
14 (behaviour* or behavior* or cognit* or CBT).mp.
15 exp motivation/
16 interviews/
17 (motivat* or interview*).mp.
18 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
19 3 and 9 and 18
key:
mp=abstract, heading words, title
Appendix 5. CINAHL search strategy
CINAHL 2018 update search
1 exp NEOPLASMS/
2 (cancer* OR tumor* OR tumour* OR neoplas* OR malignan* OR carcinoma* OR adenocarcinoma* OR choriocarcinoma* OR
leukemia* OR leukaemia* OR metastat* OR sarcoma* OR teratoma*).af
3 1 OR 2
4 exp EXERCISE/
5 exp THERAPEUTIC EXERCISE/
6 exp PHYSICAL FITNESS/
7 (physical* AND (fit* OR activ*)).af
8 (exercis* OR aerobic* OR resistance* OR strength* OR walk* OR endurance* or lifestyle* or behave*).af
9 4 OR 5 OR 6 OR 7 OR 8
10 3 and 9
11 exp BEHAVIOR THERAPY/
12. (risk reduction*) AND (behav*)
13 ((promot* or motivat* or advis* or encourag* or assist* or develop* or stimulat* or help* or support* or organis* or aid* or assist* or
endors* or prompt* or driv* or inspire* or lead* or inspir* or further* or advocat* or recommend* or endorse* or foster* or champion*)
adj5 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*)).ti,ab.
14 11 or 12 or 13
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15 10 AND 14
16 Randomized controlled trials
17 Randomised controlled trials
18 16 or 17
19 15 AND 18
key
af=any field
CINAHL 2012 search
1 exp NEOPLASMS/
2 (cancer* OR tumor* OR tumour* OR neoplas* OR malignan* OR carcinoma* OR adenocarcinoma* OR choriocarcinoma* OR
leukemia* OR leukaemia* OR metastat* OR sarcoma* OR teratoma*).af
3 1 OR 2
4 exp EXERCISE/
5 exp THERAPEUTIC EXERCISE/
6 exp PHYSICAL FITNESS/
7 (physical* AND (fit* OR activ*)).af
8 (exercis* OR aerobic* OR resistance* OR strength* OR walk* OR endurance*).af
9 4 OR 5 OR 6 OR 7 OR 8
10 exp PATIENT EDUCATION/
11 (educat* OR inform* OR teach* OR supervis* OR communicat* OR leaflet*).af
12 CANCER SURVIVORS/
13 survivor*.af
14 exp BEHAVIOR THERAPY/
15 (behaviour* OR behavior* OR cognit* OR CBT).af
16 exp MOTIVATION/
17 MOTIVATIONAL INTERVIEWING/
18 (motivat* OR interview*).af
19 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18
20 3 AND 9 AND 19
21 RANDOMIZED CONTROLLED TRIALS/
22 20 and 21
Appendix 6. PsycINFO search strategy
PsycINFO 2018 update search
1 neoplasms.af
2 ((cancer* OR tumor* OR tumour* OR neoplas* OR malignan* OR carcinoma* OR adenocarcinoma* OR choriocarcinoma* OR
leukemia* OR leukaemia* OR metastat* OR sarcoma* OR teratoma*)).ti,ab
3 exercise.af
4 (physical AND fitness).af
5 ((physical* adj5 (fit* OR activ*))).ti,ab
6 ((exercis* OR aerobic* OR resistance* OR strength* OR walk* OR endurance* OR lifestyle* OR behave*)).af
7 1 OR 2
8 3 OR 4 OR 5 OR 6
9 (health AND behaviour).af
10 (risk AND reduction AND behaviour).af
11 (((promot* ORmotivat* OR advis* OR encourag* OR assist* OR develop* OR stimulat* OR help* OR support* OR organis* OR
aid* OR assist* OR endors* OR prompt* OR driv* OR inspire* OR lead* OR inspir* OR further* OR advocat* OR recommend*
OR endorse* OR foster* OR champion*) adj5 (exercis* OR aerobic* OR resistance* OR strength* OR walk* OR endurance*))).ti,ab
12 9 OR 10 OR 11
13 7 AND 8 AND 12
PsycINFO Ovid 2012 search
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1 exp neoplasms/
2 (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinoma* or adenocarcinoma* or choriocarcinoma* or leukemia* or
leukaemia* or metastat* or sarcoma* or teratoma*).mp.
3 1 or 2
4 exp exercise/
5 physical fitness/
6 (physical* adj5 (fit* or activ*)).mp.
7 (exercis* or aerobic* or resistance* or strength* or walk* or endurance*).mp.
8 4 or 5 or 6 or 7
9 client education/
10 (educat* or inform* or teach* or supervis* or communicat* or leaflet*).mp.
11 survivors/ or survivor*.mp.
12 exp cognitive behavior therapy/
13 exp behavior therapy/
14 (behaviour* or behavior* or cognit* or CBT).mp.
15 exp motivation/
16 motivational interviewing/
17 (motivat* or interview*).mp.
18 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
19 3 and 8 and 18
20 clinical trials/
21 (random* or trial* or group* or placebo*).mp. mp=title, abstract, heading word, table of contents, key concepts, original title, tests
& measures
22 20 or 21
23 19 and 22
key:
[mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures]
Appendix 7. PEDro search strategy
PEDro 2012 search
• Title and abstract: “cancer”
• Therapy: fitness training (selected)
• Sub discipline: oncology (selected)
• Method: clinical trial (selected)
Appendix 8. SPORTS DISCUS search strategy (EBSCO host)
Sports discus update 2018 search
1. TX cancer* OR tumor* OR tumour* OR neoplas* OR malignan* OR carcinoma* OR adenocarcinoma* OR choriocarcinoma*
OR leukemia* OR leukaemia* OR metastat* OR sarcoma* OR teratoma* (26,616)
2. TX randomi*ed controlled trial (12,682)
3. (TX randomi*ed controlled trial) AND (S4 AND S5) (636)
4. Limiters - Published Date: 20120101-20171231 (411)
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Appendix 9. Cochrane Collaboration’s tool for assessing risk of bias
Random sequence generation
• Low risk of bias (e.g. participants assigned to treatments on basis of a computer-generated random sequence or a table of random
numbers)
• High risk of bias (e.g. participants assigned to treatments on basis of date of birth, clinic ID number or surname, or no attempt to
randomly assign participants)
• Unclear risk of bias (e.g. not reported, information not available)
Allocation concealment
• Low risk of bias (e.g. when the allocation sequence could not be foretold)
• High risk of bias (e.g. allocation sequence could be foretold by participants, investigators or treatment providers)
• Unclear risk of bias (e.g. not reported)
Blinding of participants and personnel
• Low risk of bias, if participants and personnel were adequately blinded
• High risk of bias, if participants were not blinded to the intervention that the participant received
• Unclear risk of bias, if this was not reported or was unclear
Blinding of outcome assessors
• Low risk of bias, if outcome assessors were adequately blinded
• High risk of bias, if outcome assessors were not blinded to the intervention that the participant received
• Unclear risk of bias, if this was not reported or was unclear
Incomplete outcome data
We recorded the proportions of participants whose outcomes were not reported at the end of the study. We coded a satisfactory level
of loss to follow-up for each outcome as follows
• Low risk of bias, if fewer than 20% of participants were lost to follow-up and reasons for loss to follow-up were similar in both
treatment arms
• High risk of bias, if more than 20% of participants were lost to follow-up or reasons for loss to follow-up differed between treatment
arms
• Unclear risk of bias, if loss to follow-up was not reported
Selective reporting of outcomes
• Low risk of bias (e.g. review reports all outcomes specified in the protocol)
• High risk of bias (e.g. if it is suspected that outcomes have been selectively reported)
• Unclear risk of bias (e.g. if it is unclear whether outcomes were selectively reported)
Other bias
• Low risk of bias, if no other source of bias is suspected and the trial appears to be methodologically sound
• High risk of bias, if it is suspected that the trial was prone to an additional bias
• Unclear risk of bias, if uncertainty exists about whether an additional bias may have been present
WH A T ’ S N E W
Last assessed as up-to-date: 3 May 2018.
Date Event Description
3 May 2018 New citation required but conclusions have not changed Reviewupdatedwith the inclusion of 10 additional studies
but conclusions remain unchanged
3 May 2018 New search has been performed Literature searches updated to 3 May 2018.
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C O N T R I B U T I O N S O F A U T H O R S
All authors contributed to the design, development and drafting of the protocol for this review. RT, LS, RG and HQ conducted
screening and data extraction, with assistance from LB. LS and RT conducted analysis of the studies according to the CALO-RE
taxonomy. MAT, LS, DJR, KAR, SJCT and JMS assisted with interpretation of results and drafting of the final report. RT led the final
report.
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S O U R C E S O F S U P P O R T
Internal sources
• None, Other.
External sources
• None, Other.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
• We have highlighted reasons why we contacted corresponding authors and have quantified how many times we attempted to do
this by email (please see Selection of studies; Excluded studies).
• We did not examine funnel plots because too few studies were identified (please see Assessment of risk of bias in included studies).
• We carried out a GRADE assessment on the quality of our meta-analysis data and included a ’Summary of findings’ table
(Summary of findings for the main comparison) with this information.
• We were not able to find any studies describing ’pattern’ of resistance exercise (i.e. the period of rest in between sets) and hence
did not discount any studies for not reporting this. We judged that it would be more informative to include the studies that we found
than to not report on resistance exercise interventions at all.
• In the 2018 update, we added contact with healthcare professionals to our secondary objectives. Healthcare professionals have a
role to play in the integration of exercise in the cancer care pathway and therefore it would be useful to understand if the exercise
studies incorporate healthcare professionals in the role of recruitment or behavioural support during the intervention.
• In the 2018 update, we did not search Metaregister (http://www.controlled-trials.com/rct) website as it is now unavailable.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Exercise; ∗Habits; ∗Sedentary Lifestyle; ∗Survivors; Breast Neoplasms [rehabilitation]; Colorectal Neoplasms [rehabilitation]; Health
Promotion; Muscle Strength; Neoplasms [∗rehabilitation]; Patient Compliance [statistics & numerical data]; Physical Endurance;
Prostatic Neoplasms [rehabilitation]; Randomized Controlled Trials as Topic; Time Factors
MeSH check words
Female; Humans; Male
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